<SEC-DOCUMENT>0001683168-24-002737.txt : 20240426
<SEC-HEADER>0001683168-24-002737.hdr.sgml : 20240426
<ACCEPTANCE-DATETIME>20240426160531
ACCESSION NUMBER:		0001683168-24-002737
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20240612
FILED AS OF DATE:		20240426
DATE AS OF CHANGE:		20240426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		24883546

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>radnet_idef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:RDNT="http://radnet.com/20231231">
<head>
     <title>RADNET, INC. DEF 14A</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_ECD%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_RDNT_radnet.com_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230101_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0010" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20231231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentTypeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentTypeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType4Member_custom_HowardBergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType4Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType5Member_custom_HowardBergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType5Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType6Member_custom_HowardBergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType6Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType7Member_custom_HowardBergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType7Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType8Member_custom_HowardBergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType8Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType9Member_custom_HowardBergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType9Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType10Member_custom_HowardBergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType10Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentTypeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentTypeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:MeasureAxis">
            <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_2">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:MeasureAxis">
            <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_3">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:MeasureAxis">
            <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000015" toRefs="Footnote000078"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000078"/>
  <ix:relationship fromRefs="Fact000047" toRefs="Footnote000078"/>
  <ix:relationship fromRefs="Fact000063" toRefs="Footnote000078"/>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000083"/>
  <ix:relationship fromRefs="Fact000033" toRefs="Footnote000083"/>
  <ix:relationship fromRefs="Fact000049" toRefs="Footnote000083"/>
  <ix:relationship fromRefs="Fact000065" toRefs="Footnote000083"/>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000084"/>
  <ix:relationship fromRefs="Fact000035" toRefs="Footnote000084"/>
  <ix:relationship fromRefs="Fact000051" toRefs="Footnote000084"/>
  <ix:relationship fromRefs="Fact000067" toRefs="Footnote000084"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000085"/>
  <ix:relationship fromRefs="Fact000037" toRefs="Footnote000085"/>
  <ix:relationship fromRefs="Fact000053" toRefs="Footnote000085"/>
  <ix:relationship fromRefs="Fact000069" toRefs="Footnote000085"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000086"/>
  <ix:relationship fromRefs="Fact000039" toRefs="Footnote000086"/>
  <ix:relationship fromRefs="Fact000055" toRefs="Footnote000086"/>
  <ix:relationship fromRefs="Fact000071" toRefs="Footnote000086"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000087"/>
  <ix:relationship fromRefs="Fact000041" toRefs="Footnote000087"/>
  <ix:relationship fromRefs="Fact000057" toRefs="Footnote000087"/>
  <ix:relationship fromRefs="Fact000073" toRefs="Footnote000087"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000088"/>
  <ix:relationship fromRefs="Fact000043" toRefs="Footnote000088"/>
  <ix:relationship fromRefs="Fact000059" toRefs="Footnote000088"/>
  <ix:relationship fromRefs="Fact000075" toRefs="Footnote000088"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000089"/>
  <ix:relationship fromRefs="Fact000045" toRefs="Footnote000089"/>
  <ix:relationship fromRefs="Fact000061" toRefs="Footnote000089"/>
  <ix:relationship fromRefs="Fact000077" toRefs="Footnote000089"/>
  <ix:relationship fromRefs="Fact000097" toRefs="Footnote000104"/>
  <ix:relationship fromRefs="Fact000099" toRefs="Footnote000105"/>
  <ix:relationship fromRefs="Fact000101" toRefs="Footnote000106"/>
  <ix:relationship fromRefs="Fact000108" toRefs="Footnote000135"/>
  <ix:relationship fromRefs="Fact000110" toRefs="Footnote000135"/>
  <ix:relationship fromRefs="Fact000112" toRefs="Footnote000135"/>
  <ix:relationship fromRefs="Fact000114" toRefs="Footnote000135"/>
  <ix:relationship fromRefs="Fact000116" toRefs="Footnote000135"/>
  <ix:relationship fromRefs="Fact000118" toRefs="Footnote000135"/>
  <ix:relationship fromRefs="Fact000130" toRefs="Footnote000136"/>
  <ix:relationship fromRefs="Fact000132" toRefs="Footnote000136"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><a href="#a_001">Table of Contents&#160;</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--DocumentType_dxL_c20230101__20231231_zdMFX728P0Jb" title="::XDX::DEF%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE 14A</span></span> INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proxy Statement Pursuant to Section&#160;14(a)&#160;of
the Securities<br/>
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amendment No. )</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Filed by the Registrant&#160;<span style="font-family: Wingdings">&#253;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Filed by a party other than the Registrant&#160;<span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#168;</span>&#160;Preliminary
Proxy Statement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#168;</span>&#160;<b>Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#253;</span>&#160;Definitive
Proxy Statement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#168;</span>&#160;Definitive
Additional Materials</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#168;</span>&#160;Soliciting
Material Pursuant to &#167;240.14a-12</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityRegistrantName_c20230101__20231231_zSSMbVpv0jrf"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000011" name="dei:EntityRegistrantName">RADNET, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified In Its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">__________________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check all boxes that apply):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#253;</span>&#160;No
fee required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#168;</span>&#160;Fee
paid previously with preliminary materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings">&#168;</span>&#160;Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1)&#160;and 0-11.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="image_001.jpg" alt="" style="height: 111px; width: 210px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RADNET, INC.<br/>
1510 Cotner Ave.<br/>
Los Angeles, CA 90025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">April 26, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Stockholder:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On behalf of the Board of
Directors and management, we cordially invite you to attend the 2024 Annual Meeting of Stockholders of RadNet, Inc. (the &#8220;Annual
Meeting&#8221;), to be held at our principal executive office at 1510 Cotner Avenue, Los Angeles, CA 90025, on Wednesday, June 12, 2024,
at 10:00 a.m. (Pacific Time) or at any adjournment or postponement thereof. At the Annual Meeting, stockholders will vote on matters set
forth in the accompanying Notice of Annual Meeting of Stockholders and Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also enclose a copy of
our annual report on Form 10-K for our fiscal year ended December 31, 2023 (the &#8220;2023 Annual Report&#8221;). We encourage you to
read our 2023 Annual Report, which includes information on our business, as well as our audited financial statements for the fiscal year
ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are mailing a Notice of
Internet Availability of Proxy Materials (the &#8220;Notice of Availability&#8221;) to most of our stockholders on or about April 26,
2024. The Notice of Availability contains instructions on how to access our proxy materials, including the Notice of Annual Meeting of
Stockholders, Proxy Statement, 2023 Annual Report and a Proxy Card or voting instruction form and on how to cast your vote online or by
phone. The Notice of Availability also contains instructions on how to request a printed copy of our proxy materials. All stockholders
who do not receive the Notice of Availability will receive a printed copy of the proxy materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Your vote is very important.
Regardless of the number of shares you own, and whether or not you plan to attend the Annual Meeting, please vote. We hope you will vote
as soon as possible.</b>&#160;You may vote by submitting your proxy via the Internet, by phone, or if you have elected to receive printed
proxy materials, by completing, signing, dating and returning the Proxy Card enclosed with your printed proxy materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Thank you for your continued
support and ownership of RadNet, Inc. We look forward to seeing you at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; font-size: 10pt; text-align: justify">&#160;</td>
    <td style="width: 50%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><img src="image_002.jpg" alt="" style="height: 62px; width: 115px"/></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David Katz</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Corporate Secretary</i></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Important Notice: The Proxy
Statement for the 2024 Annual Meeting of Stockholders, the Proxy Card and the 2023 Annual Report are available at&#160;<i>www.proxyvote.com</i>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_001.jpg" alt=""/>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RADNET, INC.<br/>
1510 Cotner Ave.<br/>
Los Angeles, CA 90025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS<br/>
TO BE HELD JUNE 12, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet, Inc. will hold its
2024 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) on Wednesday, June 12, 2024, at 10:00 a.m. (Pacific Time) or any
adjournment or postponement thereof, at our principal executive office at 1510 Cotner Avenue, Los Angeles, CA 90025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following items are on
the agenda and are more fully described in the accompanying Proxy Statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A non-binding advisory vote to approve the compensation of our Named Executive Officers; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other business that may properly come before the Annual Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors fixed
April 17, 2024 as the record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are mailing a Notice of
Internet Availability of Proxy Materials to our stockholders on or about April 26, 2024, containing instructions on how to access our
Proxy Statement and our Annual Report on Form 10-K for our fiscal year ended December&#160;31, 2023 online, and how to vote online or
by phone. The Notice of Internet Availability of Proxy Materials also contains instructions on how our stockholders can request a printed
copy of the proxy materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; text-align: justify">&#160;</td>
    <td style="width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Order of the Board of Directors,</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><img src="image_002.jpg" alt=""/><span style="font-family: Times New Roman, Times, Serif"></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David Katz</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Corporate Secretary</i></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">April 26, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Los Angeles, California</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Whether or not you expect
to attend the Annual Meeting, please vote as soon as possible to ensure your representation at the Annual Meeting. You may vote online,
by phone, or if you have elected to receive printed proxy materials, by completing, signing, dating and returning the Proxy Card enclosed
with your printed proxy materials. Even if you give your proxy, you may still vote in person if you attend the meeting. If a broker, bank
or other nominee is the record holder of your shares, then you must obtain from the record holder a proxy issued in your name in order
to vote at the Annual Meeting.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;<img src="image_001.jpg" alt=""/></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RADNET, INC.<br/>
1510 Cotner Ave.<br/>
Los Angeles, CA 90025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROXY STATEMENT<br/>
FOR ANNUAL MEETING OF STOCKHOLDERS<br/>
TO BE HELD JUNE 12, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors of
RadNet, Inc., a Delaware corporation (&#8220;RadNet&#8221; or the &#8220;Company&#8221;), is providing these proxy materials to you in
connection with the solicitation of the accompanying proxy for use at our 2024 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Annual Meeting will be
held at our principal executive office at 1510 Cotner Avenue, Los Angeles, CA 90025, on Wednesday, June 12, 2024, at 10:00 a.m. (Pacific
Time) or at any adjournment or postponement thereof, for the purposes stated in this Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On or about April 26, 2024,
we are mailing a Notice of Internet Availability of Proxy Materials (the &#8220;Notice of Availability&#8221;) containing instructions
on how to access our Proxy Statement and our Annual Report on Form 10-K for our fiscal year ended December&#160;31, 2023 (the &#8220;2023
Annual Report&#8221;), via the Internet and how to vote online or by phone. The Notice of Availability also contains instructions on how
you can receive a printed copy of the proxy materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Proxy Statement summarizes
certain information to assist you in voting in an informed manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All stockholders are cordially
invited to attend the Annual Meeting in person. Whether you expect to attend the meeting or not, please vote as soon as possible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_001"></span>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><b>Page</b></td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; width: 90%; vertical-align: bottom"><a href="#a_002">THE PROXY PROCESS AND THE ANNUAL MEETING</a></td>
    <td style="vertical-align: bottom; text-align: right; width: 10%">1</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_003">ENVIRONMENTAL</a></td>
    <td style="vertical-align: bottom; text-align: right">6</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_004">SOCIAL RESPONSIBILITY</a></td>
    <td style="vertical-align: bottom; text-align: right">7</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_005">CORPORATE GOVERNANCE</a></td>
    <td style="vertical-align: bottom; text-align: right">9</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_006">DIRECTORS</a></td>
    <td style="vertical-align: bottom; text-align: right">15</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_007">COMPENSATION OF DIRECTORS</a></td>
    <td style="vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_008">EXECUTIVE OFFICERS</a></td>
    <td style="vertical-align: bottom; text-align: right">22</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_009">COMPENSATION DISCUSSION AND ANALYSIS</a></td>
    <td style="vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_010">COMPENSATION COMMITTEE REPORT</a></td>
    <td style="vertical-align: bottom; text-align: right">35</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_011">EXECUTIVE COMPENSATION TABLES</a></td>
    <td style="vertical-align: bottom; text-align: right">36</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_012">EQUITY COMPENSATION PLAN INFORMATION</a></td>
    <td style="vertical-align: bottom; text-align: right">55</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_013">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></td>
    <td style="vertical-align: bottom; text-align: right">56</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_014">DELINQUENT SECTION 16(a) REPORTS</a></td>
    <td style="vertical-align: bottom; text-align: right">58</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_015">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</a></td>
    <td style="vertical-align: bottom; text-align: right">59</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_016">PROPOSAL NO. 1: ELECTION OF DIRECTORS</a></td>
    <td style="vertical-align: bottom; text-align: right">60</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_017">PROPOSAL NO. 2: RATIFICATION OF THE APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="vertical-align: bottom; text-align: right">61</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_018">PROPOSAL NO. 3: ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</a></td>
    <td style="vertical-align: bottom; text-align: right">62</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: middle">
    <td style="text-align: left; vertical-align: bottom"><a href="#a_019">OTHER MATTERS</a></td>
    <td style="vertical-align: bottom; text-align: right">63</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: bottom"><a href="#a_020">ADDITIONAL INFORMATION</a></td>
    <td style="vertical-align: bottom; text-align: right">63</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_002"></span>THE PROXY PROCESS AND THE ANNUAL MEETING</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following discussion is
intended to provide general information about the proxy process and the Annual Meeting under the rules and regulations of the Securities
and Exchange Commission (the &#8220;SEC&#8221;). If you have questions about this Proxy Statement or the Annual Meeting, please contact
our Corporate Secretary at: RadNet, Inc., 1510 Cotner Avenue, Los Angeles, CA 90025, Attention: Corporate Secretary, Telephone: (310)
445-2800.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2024 Annual Meeting of Stockholders</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 15%; text-align: justify">&#160;</td>
    <td style="width: 55%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RADNET, INC.</span></td>
    <td style="width: 30%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 12, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1510 Cotner Ave.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10:00 a.m. Pacific Time</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los Angeles, CA 90025</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only stockholders of record
as of the close of business on April 17, 2024 (the &#8220;Record Date&#8221;) are entitled to vote at the Annual Meeting. RadNet is soliciting
proxies for use at the Annual Meeting, including any postponements or adjournments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attending the Annual Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a stockholder of
record as of the Record Date, you have the right to vote in person at the Annual Meeting. You will need to bring either the Notice of
Availability or any Proxy Card that is sent to you to the meeting. Otherwise, you will be admitted only if we can verify your ownership
of common stock on the Record Date. If you own shares held in street name, please bring with you to the meeting either the Notice of Availability
or any voting instruction form, your most recent brokerage statement or a letter from your bank, broker or other record holder indicating
that you beneficially owned shares of our common stock on the Record Date. We can use that information to verify your beneficial ownership
of common stock and admit you to the meeting. Additionally, all persons will need to bring a valid government-issued photo ID to gain
admission to the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Even if you plan to attend
the Annual Meeting, we recommend that you submit your proxy or voting instructions in advance of the meeting so that your vote will be
counted if you later decide not to attend the Annual Meeting.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Purpose</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Annual Meeting, our
stockholders will vote on the following items:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The election of seven nominees as directors to hold office until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A non-binding advisory vote to approve the compensation of our Named Executive Officers; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other business that may properly come before the Annual Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Proxy Materials</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following proxy materials
were first sent or made available to stockholders on April 26, 2024, and include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Annual Meeting of Stockholders</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy Statement for the Annual Meeting</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023 Annual Report </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you requested printed versions
of these proxy materials by mail, the printed proxy materials also include the Proxy Card or voting instruction form for the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notice of Internet Availability</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are sending the Notice
of Availability to our stockholders with instructions on how to access the proxy materials online or request a printed copy of the materials.
Stockholders may follow the instructions in the Notice of Availability to elect to receive future proxy materials in print by mail or
electronically by email. We encourage stockholders to take advantage of the availability of the proxy materials online to help reduce
the environmental impact of our annual meetings and reduce RadNet&#8217;s printing and mailing costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quorum for the Annual Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of a majority of the
shares entitled to vote at the Annual Meeting must be present at the Annual Meeting in person or by proxy for the transaction of business.
This is called a quorum. On the Record Date there were 73,895,688 of our common stock issued and outstanding. Consequently, we will need
to have 36,947,845 shares present in person or represented by proxy at the Annual Meeting in order to establish a quorum. Your shares
will be counted for purposes of determining if there is a quorum if:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify; text-indent: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You are entitled to vote and you are present in person at the Annual Meeting; or</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify; text-indent: 1pt">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You have properly voted by proxy online, by phone, or by submitting a Proxy Card or voting instruction form by mail.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker non-votes and abstentions
are counted for purposes of determining whether a quorum is present. If a quorum is not present, we may propose to adjourn the Annual
Meeting to solicit additional proxies and reconvene the Annual Meeting at a later date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inspector of Election</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An officer of RadNet will
count the votes and act as the inspector of election. The inspector of election will separately tabulate affirmative and negative votes,
abstentions and broker non-votes. RadNet has also engaged Broadridge Financial Solutions, Inc. as its proxy distribution agent and tabulation
service provider and they will also be calculating the votes received prior to the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Proxy Solicitation Costs</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet is paying the costs
of the solicitation of proxies. We will also make solicitation materials available to banks, brokerage houses, fiduciaries and custodians
holding shares of our common stock in their names but that are beneficially owned by others for forwarding to the beneficial owners. We
may reimburse persons representing beneficial owners of common stock for their costs of forwarding solicitation materials to the beneficial
owners. Solicitations will be made primarily through the Notice of Availability, but may be supplemented by telephone, facsimile, Internet
or personal solicitation by our directors, executive officers and employees. No additional compensation will be paid to these individuals
for these services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of RadNet&#8217;s
common stock has one vote on each matter. Only &#8220;shareholders of record&#8221; as of the close of business on the Record Date are
entitled to vote at the Annual Meeting. As of the Record Date, there were 73,895,688 shares of RadNet&#8217;s common stock issued and
outstanding, held by 980 shareholders of record. In addition to shareholders of record of RadNet&#8217;s common stock, &#8220;beneficial
owners of shares held in street name&#8221; as of the Record Date can vote using the methods described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If your shares are registered
directly in your name with RadNet&#8217;s transfer agent, Equiniti Trust Company, LLC, you are the shareholder of record with respect
to those shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If your shares are held in
an account at a bank, broker, or other organization, then you are the &#8220;beneficial owner of shares held in street name.&#8221; As
a beneficial owner, you have the right to instruct the person or organization holding your shares how to vote your shares. Most individual
shareholders are beneficial owners of shares held in street name.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to Proposal No.
1 (the election of directors), stockholders may vote &#8220;FOR&#8221; all nominees, &#8220;WITHHOLD&#8221; authority for all nominees,
or vote &#8220;FOR&#8221; all except for those individual nominees for director for which the stockholder indicates it is withholding
authority. With respect to each other proposal, stockholders may vote &#8220;FOR&#8221; the proposal, &#8220;AGAINST&#8221; the proposal,
or abstain from voting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting Procedures</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are four ways to vote:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Online</b>. If you are
    a shareholder of record, you may vote by proxy by visiting <i>www.proxyvote.com</i> and entering the control number found in the
    Notice of Availability. If you are the beneficial owner of shares in street name, the availability of online voting will depend on
    the voting procedures of the organization that holds your shares. Stockholders who submit a proxy online need not return a Proxy
    Card or the form forwarded by your broker, bank, trust or other holder of record.</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Phone</b>. If you are a shareholder of record and request printed copies of the proxy materials by mail, you will receive a Proxy Card or voting instruction form and you may vote by proxy by calling the toll-free number found on the card or form. If you are a beneficial owner of shares in street name, the availability of phone voting will depend on the voting procedures of the organization that holds your shares.&#160;&#160;Stockholders who submit a proxy by phone need not return a Proxy Card or the form forwarded by your broker, bank, trust or other holder of record.</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mail</b>. If you are a shareholder of record and request printed copies of the proxy materials by mail, you will receive a Proxy Card or voting instruction form and you may vote by proxy by completing, dating and signing the Proxy Card or voting instruction form and returning it in the envelope provided.</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In Person</b>. If you are a shareholder of record, you may vote in person at the Annual Meeting by requesting a ballot. If you beneficially hold shares in street name and wish to vote in person at the Annual Meeting, you must also obtain a &#8220;legal proxy&#8221; from the organization that holds your shares and bring it to the Annual Meeting. A legal proxy is a written document that authorizes you to vote your shares held in street name at the Annual Meeting. Please contact the organization that holds your shares for instructions regarding obtaining a legal proxy. In order for your vote to be counted, you must hand both the copy of the legal proxy and your completed ballot to a Company representative to be provided to the inspector of election.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All shares represented by
valid proxies received prior to the taking of the vote at the Annual Meeting will be voted and, where a stockholder specifies by means
of the proxy a choice with respect to any matter to be acted upon, the shares will be voted in accordance with the stockholder&#8217;s
instructions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changing your Vote</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may revoke your proxy
and change your vote at any time before the taking of the vote at the Annual Meeting, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Online</b>. You may change your vote using the online voting method described above, in which case only your latest online proxy submitted prior to the Annual Meeting will be counted.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Phone</b>. You may change your vote using the phone voting method described above, in which case only your latest telephone proxy submitted prior to the Annual Meeting will be counted.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mail</b>. You may revoke your proxy and change your vote by signing and returning a new Proxy Card or voting instruction form dated as of a later date, in which case only your latest Proxy Card or voting instruction form received prior to the Annual Meeting will be counted.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In Person</b>. You may revoke your proxy and change your vote by attending the Annual Meeting and voting in person. However, your attendance at the Annual Meeting will not automatically revoke your proxy unless you properly vote at the Annual Meeting or specifically request that your prior proxy be revoked by delivering a written notice of revocation prior to the Annual Meeting to RadNet&#8217;s Corporate Secretary.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>If you have already voted
and do not wish to change your vote, you do not need to take any further action and your shares will be voted as originally directed by
you.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vote Required to Approve a Proposal</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet&#8217;s bylaws provide
that, in an uncontested election of directors&#8212;one where the number of candidates for election does not exceed the number of directors
to be elected&#8212;the affirmative vote of a majority of the shares present or represented by proxy and entitled to vote at the Annual
Meeting is required to elect a director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, approval of Proposals
Nos. 1, 2 and 3 requires, in each case, the affirmative vote of a majority of the shares present or represented by proxy and entitled
to vote on the subject matter at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Routine and Non-Routine Proposals</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Banks, brokers and nominees
will vote shares in accordance with instructions from the beneficial owners. If the bank, broker or other nominee does not receive an
instruction, it has discretionary authority to vote on &#8220;routine&#8221; matters, but not on &#8220;non-routine&#8221; matters. The
following proposal is considered a routine matter:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal 2: The ratification of the appointment of Ernst &amp; Young LLP as RadNet&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following proposals are
considered non-routine matters:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal 1: Election of directors; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal 3: A non-binding advisory vote to approve the compensation &#160;paid to our Named Executive Officers.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You must instruct your bank,
broker or nominee on how to vote your shares for the non-routine matters of Proposal No. 1 and Proposal No. 3 in order for your vote to
count for those proposals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broker Non-Votes and Abstentions</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you hold your shares in
street name and the organization that holds your shares does not receive instructions from you on how to vote your shares on a non-routine
proposal, that organization will inform the inspector of election that it does not have the authority to vote on the matter with respect
to your shares. This is generally referred to as a &#8220;broker non-vote.&#8221; Broker non-votes may exist in connection with Proposal
No. 1 and Proposal No. 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker non-votes and abstentions
are counted for purposes of determining whether a quorum is present. Broker non-votes will not be counted as having voting power to vote
on the proposal in question and will have no effect on the proposal presented. Abstentions will have the effect of a vote of &#8220;AGAINST&#8221;
for a director in Proposal No. 1, and &#8220;AGAINST&#8221; Proposal Nos. 2 and 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uninstructed Shares</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a shareholder of
record and submit a valid proxy or voting instruction form but do not indicate your specific voting instructions on one or more of the
proposals, your shares will be voted as recommended by our Board of Directors on those proposals and as the proxyholders may determine
in their discretion with respect to any other matters properly presented for a vote at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a beneficial owner
of shares held in street name and do not provide the organization that holds your shares with specific voting instructions, then the organization
may generally vote your shares in their discretion on &#8220;routine&#8221; matters, but cannot vote on &#8220;non-routine&#8221; matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Confidentiality of Votes</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Proxy instructions, ballots,
and voting tabulations that identify individual stockholders are handled in a manner that protects your voting privacy. Your vote will
not be disclosed either within RadNet or to third parties, except: (1) as necessary to meet applicable legal requirements and (2) to allow
for the tabulation of votes and certification of the vote. Occasionally, stockholders include additional comments on their Proxy Card
or with their voting instruction form, which are then forwarded to our management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tabulation and Reporting of Voting Results</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Final voting results will
be tallied by the inspector of election after the taking of the vote at the Annual Meeting. RadNet will publish the final voting results
in a Current Report on Form 8-K filed with the SEC within four business days of the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director and Officer Interest in Matters
to be acted Upon at the Annual Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Members of the Board and executive
officers do not have an interest in Proposal 2. Our executive officers have an interest in Proposal 3 as the proposal relates to the compensation
of our Named Executive Officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_003"></span>ENVIRONMENTAL</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We seek to manage and evolve
our operations in ways to minimize our impact on the environment as part of our commitment to improving health in the communities we serve.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Healthcare imaging is dependent
on technologically advanced equipment, that uses significant energy in its operation. While we do not design or manufacture the equipment
that we install in our facilities, we take a number of actions aimed at reducing our overall energy consumption:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We seek to maximize the
    utilization of equipment at our facilities. Efficient patient scheduling and high utilization of our machines reduces the energy
    consumed during idle periods where equipment is not contributing to patient care. We also try to power down imaging
    equipment that can safely and efficiently be powered down when not in use during off-hours.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We monitor the air
    conditioning systems at our imaging facilities. We generally set thermostats in common areas to eco-friendly levels based on the
    particular geographical environment. We use window shades, or other coverings, to reduce our cooling
    requirements.&#160;&#160;We replace older HVAC systems with newer, more energy efficient models when warranted, and conduct
    preventative maintenance on the HVAC systems to assure operating efficiency.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lighting systems in many
    of our imaging centers are equipped with motion sensors, timers and dimmers, to reduce unnecessary use. We are also in the process
    of converting older conventional lighting systems to newer systems using lower wattage LED lights.</span><i></i></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our imaging centers in California are subject to California Title 24 Building Energy Efficiency Standards, a set of standards for energy consumption designed to ensure new and existing buildings achieve energy efficiency.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_004"></span>SOCIAL RESPONSIBILITY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our social responsibility
begins with our patients and extends to our employees and consultants and to the communities in which we operate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate imaging centers
to facilitate the diagnosis and treatment of diseases and disorders. Our services may reduce unnecessary invasive medical procedures,
improve patient care and reduce the cost and amount of care for patients in the communities that we serve. At our imaging centers, we
focus on providing standardized high quality imaging services, regardless of location, to ensure patients, physicians and payors consistency
in service and quality. To ensure the high quality of our services, we monitor patient satisfaction, timeliness of services to patients
and reports to physicians.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At our centers, we seek to
provide state of the art facilities, with multiple imaging modalities, access to newer equipment and a highly-trained staff. Although
currently small in scope, we are investing in Artificial Intelligence (AI) technologies which we believe have the potential to significantly
change the medical imaging industry. We are developing applications to aid radiologists in scan interpretation by quickly allowing comparison
to large imaging databases to enable pinpoint diagnosis in shorter time frames. In addition, AI methods can also keep track of individuals
needing procedures on a regular basis (i.e. mammograms, follow ups, etc.) and alert our staff to contact the patient and schedule appointments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The strength of our workforce
is critical to the success of our mission to provide comprehensive radiology solutions and change the future of healthcare. We are focused
on attracting, retaining, and developing the talent we need to deliver on our commitment to our patients and partners. At December 31,
2023, we had a total of 7,849 full-time, 1,201 part-time and 924 per diem employees. These numbers include 218 full-time and 86 part-time
physicians and 2,226 full-time, 702 part-time and 607 per-diem technologists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are keenly aware of the
value of a diverse workforce and are proud of our track record. Approximately 81% of our workforce at December 31, 2023 was female and
54% were from under-represented groups.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_005.jpg" alt="" style="height: 147px; width: 318px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our culture of diversity and
inclusion enables us to exceed the expectations of our patients and meet our growth strategy. Our success in inclusion and diversity objectives
are the result of strong leadership, transparency and accountability. While our workforce demographics clearly indicate our success in
achieving a highly diverse team, in order to foster even stronger understanding of diversity, equity and inclusion, we have developed
an internal education program to ensure all of our team are aware of our closely held values. Our initiatives include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate support and sponsorship of community outreach/enrichment programs for underserved populations such as our ongoing and flourishing relationship with JVS SoCal; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High School, Vocational School and Collegiate outreach.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We invest in our employees
to ensure their confidence and competence in their roles, as well as to provide a path for professional career development. We provide
a range of internal education and development programs and opportunities to support the advancement of our employees. RadNet offers a
Leadership Development and Operations Rotation Program, Management Training, Technical Scholarship, and various modality education and
training support programs. We offer both formal and informal programs to identify, foster and retain top talent. We maintain a Tuition
Reimbursement Program which encourages professional development for our incumbent team, and we also sponsor undergraduate and graduate
education and advanced technical training (RPA) for various incumbent team members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide compensation that
is competitive and consistent with employee positions, skill levels, and experience. We align our executives&#8217; and eligible non-executive
employees&#8217; long-term equity compensation with our stockholders&#8217; interests. Our employees are eligible for benefits that are
industry-leading, including PPO and HDHP medical plans with a company sponsored HSA, wellness plans that include financial incentives,
free radiology procedures for team and family, paid life insurance and AD&amp;D, dental, vision, Employee Assistance Plan with enhanced
mental health benefits, group paid long and short term disability plans, 401(k), tuition reimbursement, access to instant earned wages
through DailyPay, paid and unpaid leave, flexible working schedule, and a variety of voluntary benefits including Colonial, Supplemental
Life, Dependent Life and Commuter benefits and free flu vaccinations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_005"></span>CORPORATE GOVERNANCE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Role of the Board of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is managed under
the direction of our Board of Directors. Our Board of Directors provides oversight, strategic direction and counsel to our management.
In addition, our Board of Directors elects our officers, delegates responsibilities for the conduct of our operations to those officers,
and evaluates their performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors held
four meetings during 2023 and took action by written consent on seven occasions. Each of our directors serving in 2023 attended at least
75% of the total number of meetings of the Board of Directors and applicable committees that each director was eligible to attend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board Leadership Structure</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Chairman of the Board
of Directors, Dr. Berger, also serves as our Chief Executive Officer. Our Board of Directors has determined that this leadership structure
is appropriate and effective for RadNet at this time. This structure effectively utilizes Dr. Berger&#8217;s knowledge of RadNet and the
industry in which we operate, while fostering greater communication and producing a greater degree of transparency between management
and our directors. Dr. Berger co-founded RadNet in 1980 and has served as Chairman of the Board and Chief Executive Officer for nearly
40 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">David L. Swartz currently
serves as Lead Independent Director of the Board of Directors. In this capacity, Mr. Swartz serves as Chairman of meetings of the Board
of Directors in the absence of the Chairman of the Board, calls, sets the agenda, and chairs the executive sessions of the independent
directors, works collaboratively with the Chairman of the Compensation Committee to oversee the evaluation of our Chief Executive Officer
and serves as the liaison between the independent directors and the Chairman of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director Independence</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors annually
determines the independence of our directors in accordance with the independence requirements under the NASDAQ Stock Market LLC (&#8220;NASDAQ&#8221;)
and the SEC rules which require at least a majority of the directors to be independent. As a result of this review, our Board of Directors
has determined that Lawrence L. Levitt, Laura P. Jacobs, Gregory E. Spurlock and David L. Swartz each qualifies as an independent director
in accordance with the NASDAQ and the SEC rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of Howard G. Berger,
M.D., Christine N. Gordon and A. Gregory Sorensen, M.D. is an employee of RadNet and therefore does not qualify as an independent director
under the NASDAQ and the SEC rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Majority Voting for Election of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under our bylaws, directors
must be elected by a majority of the shares present and entitled to vote in elections for which the number of nominees for election does
not exceed the number of directors to be elected. A plurality vote standard applies to contested elections where the number of nominees
exceeds the number of directors to be elected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a Director
Resignation Policy that provides that any incumbent director who does not receive a majority of the votes cast in an uncontested election
is required to tender their resignation for consideration by the Nominating and Governance Committee. The Nominating and Governance Committee
will make a recommendation to the Board on whether to accept or reject the resignation, or take other action. The director who tenders
their resignation will not participate in the Nominating and Governance Committee or Board&#8217;s decision. In making its determination
the Board will consider (a) the underlying reason for the vote result, if known, (b) the director&#8217;s contributions to the Company
during his or her tenure, and (c) the director&#8217;s qualifications. The Board may accept the resignation, refuse the resignation, or
refuse the resignation subject to such conditions designed to cure the underlying cause as the Board may impose. Promptly following the
decision regarding the tendered resignation, the Company will file with the SEC a current report on Form 8-K disclosing the decision with
respect to the resignation, describing the deliberative process and, if applicable, the specific reasons for rejecting the tendered resignation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Diversity</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board believes that diversity
brings forward different perspectives and improves decision-making and governance. While we don&#8217;t have a formal diversity policy,
our Nominating and Governance Committee considers gender, ethnicity, age, sexual orientation, and other characteristics that contribute
to diverse viewpoints when identifying nominees for our Board of Directors. Our Board composition already complies with NASDAQ&#8217;s
Board Diversity Rule. Of our current seven person Board of Directors, two of the seven directors self-identify as female and two of the
seven members self-identify as LGBTQ+.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_006.jpg" alt="" style="height: 176px; width: 348px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director Continuing Education</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We support director education
initiatives throughout a director&#8217;s tenure on the Board. We host &#8220;teach-ins&#8221; where members of our management meet with
the Board to review industry trends and the Company&#8217;s operations in a number of subject areas. Recent teach in sessions have covered
topic such as:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>Cyber Security</td>
</tr>
<tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>Human Capital, including Talent Acquisition, Employee Engagement,
Recruiting and Retention</td>
</tr>
<tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>Revenue Cycle &#8211; Billing &amp; Collections, Credit Balances</td>
</tr>
<tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>Regulatory Compliance</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We encourage all directors
to attend continuing education programs and to share information and observations from those programs with other directors. We reimburse
directors for reasonable expenses incurred in attending continuing education programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Committees of the Board of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors has
three standing committees: the Audit Committee, the Compensation Committee and the Nominating and Governance Committee. The committees
are comprised entirely of independent directors. Each committee operates under a written charter adopted by the Board of Directors, which
is available at&#160;<i>www.radnet.com</i>&#160;under Investor Relations &#8211; Corporate Governance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The current composition of
the committees is as set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit Committee</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation <br/>
Committee</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating and <br/>
Governance <br/>
Committee</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence L. Levitt</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laura P. Jacobs</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory E. Spurlock</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David L. Swartz</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>________________________&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8220;C&#8221; denotes chair of committee</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee&#8217;s
responsibilities include, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing the engagement, qualifications, independence, compensation, retention and performance of the Company&#8217;s independent auditors and the conduct of the annual independent audit of the Company&#8217;s financial statements; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing the integrity of the Company&#8217;s financial statements and other financial information provided by the Company to its stockholders, any governmental or regulatory body and others;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring the auditing, accounting and financial reporting processes and systems of internal control that are conducted by the Company&#8217;s independent auditors, internal audit function and the Company&#8217;s financial and senior management; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preparing the report of the Audit Committee required by the rules of the SEC to be included in the Company&#8217;s annual proxy statement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors has
determined that each of Mr. Swartz and Mr. Levitt qualifies as an &#8220;audit committee financial expert&#8221; as defined under the
applicable SEC rules and that each member of the Audit Committee meets the additional criteria for independence of Audit Committee members
under Rule 10A-3(b)(1) of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee held four
meetings and took action by written consent on two occasions in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Compensation Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee&#8217;s
responsibilities include, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting the Board in developing and reviewing compensation programs and strategy applicable to the Company&#8217;s directors and senior executives, and overseeing the Company&#8217;s overall compensation philosophy;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">making recommendations to the Board with respect to incentive compensation plans and equity-based plans, and interpreting and administering such plans;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and discussing with the Company&#8217;s management the tables and narrative discussion and analysis regarding executive officer and director compensation policies and practices to be included in the Company&#8217;s public filings, including its annual proxy statement and annual report on Form 10-K; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preparing the Compensation Committee Report to be included in the Company&#8217;s proxy statement and annual report on Form 10-K, in accordance with the rules and regulations of the SEC. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
held two meetings and took action by written consent on four occasions in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nominating and Governance Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Nominating and Governance Committee&#8217;s
responsibilities include, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">independently overseeing the director nomination process and procedures;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying, evaluating and recommending to the Board for election and/or appointment qualified candidates for membership on the Board or its committees;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing, reviewing, and recommending to the Board corporate governance policies, procedures and guidelines and otherwise shaping the Company&#8217;s corporate governance;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investigating and approving related party transactions, establishing and maintaining director conflicts of interest policies, and making recommendations to the Board with respect to the &#8220;independence&#8221; of directors; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring and overseeing evaluation of the Board and its committees, management&#8217;s performance, and succession planning for executive management.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Governance
Committee held one meeting and took action by written consent on two occasions in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Retention of Outside Advisors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board and all of its committees
have authority to retain outside advisors and consultants that they consider necessary or appropriate in carrying out their respective
responsibilities. Our independent registered public accounting firm is retained by, and reports directly to, the Audit Committee. Similarly,
the Compensation Committee retains a compensation consultant to assist in evaluating executive compensation which reports directly to
that committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board Role in Risk Oversight</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors performs
an oversight role in managing RadNet&#8217;s risk. In reviewing our strategy, business plan, budgets and historical and anticipated future
major transactions, the Board of Directors considers, among other factors, the risks RadNet faces and how such risks can be appropriately
managed. While our Board of Directors oversees risk management strategy, our management is responsible for implementing and supervising
day to day risk management processes. Our senior management regularly reports to the Board of Directors on areas of material risk, including
operational, financial, legal and strategic risks, which enables the Board of Directors to understand management&#8217;s views and strategies
regarding risk identification, risk management and risk mitigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the oversight
role assumed by the full Board of Directors, various committees of the Board of Directors also have responsibility for risk management.
The Director of Internal Audit reports directly to our Audit Committee on areas of material financial risk, including internal controls,
and the Audit Committee reports to the full Board of Directors on risks identified by the Director of Internal Audit that the Audit Committee
believes to be material. In addition, the Compensation Committee oversees the risks associated with our compensation policies and practices
to ensure that the compensation programs and incentives do not encourage short term risk taking at the expense of long term results or
create risks that may have a material adverse effect on RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corporate Governance Guidelines</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has adopted Corporate
Governance Guidelines to formalize certain policies and provide guidance in the exercise of its governance responsibilities. The Corporate
Governance Guidelines cover areas such as:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>The Role of the Board of Directors</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Board Size and Composition</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Terms for Director Service</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Meetings and procedures</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Board Committees</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Communications to and From Directors</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Director Compensation</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Performance Evaluation</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Management Review</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td>Succession Planning</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Governance
Committee is responsible for reviewing and making recommendations for amendment of the Corporate Governance Guidelines from time to time.
The Corporate Governance Guidelines are available at on our website at: <i>www.radnet.com/investor-relations </i>under Corporate Governance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Code of Financial Ethics</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a written
Code of Financial Ethics that is applicable to our directors, officers and employees and is designed to deter wrongdoing and to promote:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">honest and ethical conduct;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in other public communications;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with applicable laws, rules and regulations, including insider trading compliance; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accountability for adherence to the code and prompt internal reporting of violations of the code, including illegal or unethical behavior regarding accounting or auditing practices.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may obtain a copy of our
Code of Financial Ethics on our website at&#160;<i>www.radnet.com</i>/<i>investor-relations </i>under Corporate Governance. The Board
of Directors has designated the Audit Committee with the responsibility for reviewing the Code of Financial Ethics and making any appropriate
updates or amendments. We intend to disclose any changes in this code or waivers from this code that apply to our principal executive
officer, principal financial officer, or principal accounting officer by posting such information to our website or by filing with the
SEC a Current Report on Form 8-K, in each case if such disclosure is required by SEC or Nasdaq rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Review and Approval of Related Party Transactions</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under its current charter,
our Nominating and Governance Committee reviews and determines whether or not to approve any transaction between RadNet and its directors,
director nominees, executive officers and greater than 5% beneficial owners and each of their respective immediate family members where
the amount involved in the transaction exceeds or is expected to exceed $120,000 in a single year and the related party has or will have
a direct or indirect interest in the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Howard G. Berger, M.D., is
our President and Chief Executive Officer, a Chairman of our Board of Directors, and also owns, indirectly, 99% of the equity interests
in Beverly Radiology Medical Group III (&#8220;BRMG&#8221;). BRMG is responsible for the professional medical services at nearly all of
our facilities located in California and Arizona under a management agreement with us, and employs physicians or contracts with various
other independent physicians and physician groups to provide the professional medical services at most of our California and Arizona facilities.
We generally obtain professional medical services from BRMG in California and Arizona, rather than provide such services directly or through
subsidiaries. We have a management agreement with BRMG which automatically renewed for a 10-year period on January 1, 2024. Under our
management agreement, BRMG pays us, as compensation for the use of our facilities and equipment and for our services, a percentage of
the gross amounts collected for the professional services it renders. The percentage, which was 81% at December 31, 2023, is adjusted,
if necessary, to ensure that the parties receive fair value for the services they render. In operation and historically, the annual revenue
of BRMG from all sources closely approximates its expenses, including Dr. Berger&#8217;s compensation, fees payable to us and amounts
payable to third parties. In 2023, Dr. Berger received $500,000 of his salary and his entire cash bonus payment of $2.0 million from BRMG.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 1, 2022 we entered
into a lease agreement with HFB Heirs Trust II, the holder of approximately 7.2% of our outstanding common stock, with respect to a residential
unit located in New York, New York. Under the lease agreement we have agreed to pay rent of $15,000 per month to HFB Heirs Trust II. The
lease agreement is for a term of 24 months, subject to automatic renewal for successive three month periods on the same terms and conditions.
Our Audit Committee reviewed and approved the terms of the lease agreement. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board Evaluations</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors engages
in an annual self-assessment process, which is designed to elicit feedback on areas where the Board is performing well, and areas where
it could improve. Under the terms of their respective charters, each of our Committees engages in an annual review of their performance.
The Nominating and Governance Committee has responsibility for overseeing the self-evaluation process for the Board of Directors and its
committees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Every other year, we engage
Nasdaq Boardvantage to assist with our self-assessment process. In connection with that process, each director completes a separate detailed
assessment to evaluate the Board and each committee on which they serve. The assessment covers areas such as Board and committee size,
strategy and oversight, communication, meeting procedures and content, and effectiveness. The Chief Legal Officer coordinates delivery
of the responses to the Lead Independent Director and the chair of each committee. Each committee chair meets separately with each of
its members to discuss the results of that committee&#8217;s assessment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Succession Planning</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors, together
with the Nominating and Governance Committee, shares responsibility for succession planning for our CEO and executive management team.
As part of its role, our Nominating and Governance Committee reviews management development and succession planning to ensure that there
are adequate identified and qualified candidates who can assume top management positions without undue interruption. This process is designed
to prepare the Company for both expected successions, such as those arising from anticipated retirements, as well as those occurring when
executives leave unexpectedly, or due to death, disability, or other unforeseen events. We maintain emergency succession plans for the
CEO and other executive committee members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In developing its succession
plans, and assessing possible CEO and other senior leadership candidates, our Nominating and Governance Committee identifies the skills,
experiences, and attributes they believe are required to be an effective leader in light of the Company&#8217;s business strategies, opportunities,
and challenges. Members of our Nominating and Governance Committee have direct access to members of our senior management team. Members
of senior management are invited regularly to make presentations at Board and committee meetings and meet with directors in informal settings
to allow the directors to form a more complete understanding of the executives&#8217; skills and character. Succession reviews and planning
for executive roles includes an assessment of internal candidates as well as external talent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board Attendance at Annual Meetings of Stockholders</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We, as a matter of policy,
encourage our directors to attend meetings of stockholders but we do not require attendance. One of our directors attended the 2023 Annual
Meeting of Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholder Engagement</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board values an open dialogue
with shareholders, believing that regular communication is a critical part of the Company&#8217;s long-term success. Through these activities,
the Board discusses the Company&#8217;s corporate governance, executive compensation programs, and other topics of interest to shareholders.
We also closely monitor policy statements and areas of focus for shareholders. These engagement efforts allow the Board to better understand
the Company&#8217;s shareholders&#8217; priorities and perspectives and provide the Board with useful input concerning the Company&#8217;s
compensation, corporate governance, and other practices. In addition, our Chief Financial Officer regularly engages with existing and
prospective stockholders, as well as the Company&#8217;s lenders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have undertaken a number
of actions based on the recommendations of our stockholders to strengthen our governance practices and disclosure. We have voluntarily
implemented a majority voting standard in uncontested director elections and added the Director Skills and Demographic Information matrix
to this Proxy Statement to describe each director&#8217;s qualifications.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Communication with our Board of Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders and other interested
parties may communicate with our Board of Directors through the Corporate Secretary by writing to the following address: Board of Directors,
c/o Corporate Secretary, RadNet, Inc., 1510 Cotner Avenue, Los Angeles, CA 90025. The envelope containing such communication should contain
a clear notation that the letter is &#8220;Stockholder-Board Communication&#8221; or &#8220;Stockholder-Director Communication&#8221;
or a similar statement to indicate it is intended for the Board of Directors. All such communications must clearly indicate the author
as a stockholder and state whether the intended recipients are all members of the Board of Directors or certain specified directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_006"></span>DIRECTORS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nomination Process</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Nominating and Governance
Committee recommends nominees to the Board of Directors for election after carefully considering all candidates, taking into account the
qualifications set forth in the Nominating and Governance Committee Charter and all factors the Nominating and Governance Committee considers
appropriate, which may include career specialization, relevant technical, leadership or governance skills, or financial acumen, industry
knowledge, other board service, and diversity of viewpoint (including diversity of race, ethnicity, gender, age, education, cultural background,
and professional experience).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Nominating and Governance
Committee Charter contains our policy with regard to the consideration of diversity in the identification of director nominees. As part
of its evaluation of Board composition, the Nominating and Governance Committee considers the diversity of candidates to ensure that our
Board of Directors is comprised of individuals with a broad range of experiences, skills and backgrounds who can contribute to the Board&#8217;s
overall effectiveness in carrying out its responsibilities and can represent diverse viewpoints on our Board of Directors. The Nominating
and Governance Committee assesses the effectiveness of these efforts when evaluating the composition of the Board of Directors as part
of the annual nomination process.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Governance
Committee considers stockholder nominees made in accordance with our bylaws, and evaluates candidates recommended by stockholders in the
same manner as all other candidates brought to the attention of the Nominating and Governance Committee. Stockholder recommendations may
be submitted to the Nominating and Governance Committee in care of the Corporate Secretary at the address set forth under &#8220;Communication
with our Board of Directors.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nominees for Election</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The names of the director
nominees, their ages as of March 31, 2024, and other information about them are set forth below. All nominees currently serve on the Board
of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Director Nominee</b></span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 60%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our<br/>
Director Since</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard G. Berger, M.D.</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board, Chief Executive Officer and President</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1992</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine N. Gordon</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, Senior Vice President of Operations, Northern California</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. Gregory Sorensen, M.D.</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, Chief Science Officer</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laura P. Jacobs</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence L. Levitt</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2005</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory E. Spurlock</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director </span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David L. Swartz</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2004</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following biographies
describe the skills, qualities, attributes, and experience of the nominees that led the Board of Directors and the Nominating and Governance
Committee to determine that it is appropriate to nominate these directors for election to the Board of Directors.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Howard G. Berger, M.D.</i>&#160;has
served as President and Chief Executive Officer of RadNet and its predecessor entities since 1987. Dr. Berger received his M.D. at the
University of Illinois Medical School, is Board Certified in Nuclear Medicine and trained in an Internal Medicine residency, as well as
in a master&#8217;s program in medical physics in the University of California system. Dr. Berger is also the president or co-president
of the entities that own Beverly Radiology Medical Group III (&#8220;BRMG&#8221;). Dr.&#160;Berger brings senior business leadership skills
to our Board of Directors and deep industry knowledge derived from his nearly 40 years of experience in the development and management
of RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Christine N. Gordon</i>
currently serves as the Senior Vice President of Operations for RadNet&#8217;s Northern California Operations and has served as a director
since 2021. Ms. Gordon began her career in radiology in 1984 as a multi-modality technologist, then quickly transitioned into a role in
Practice Management for an Orange County, California based radiology group specializing in hospital-based and out-patient imaging. Ms.
Gordon joined RadNet in 1994, bringing her diverse skill set and expertise to multi-site, multi-modality operations and personnel management,
physician and site credentialing, reimbursement operations, payer contracting, acquisitions, and project and asset management. Ms. Gordon
has extensive operational experience with more than 40 years of broad-based experience in the field of medical imaging.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>A. Gregory Sorensen, M.D.</i>
was appointed as our Chief Science Officer and as a director in August 2023. Dr. Sorensen has served as the Chief Executive Officer of
our DeepHealth, Inc. (&#8220;DeepHealth&#8221;) subsidiary of the Company that is focused on using artificial intelligence and deep learning
methods to advance medical care with a special emphasis on breast cancer imaging. The Company acquired DeepHealth in June 2020. Dr. Sorensen
served as the President and Chief Executive Officer of Siemens Healthcare North America from 2011 to 2015. Prior to that, he served as
a Professor at Harvard Medical School and as a neuroradiologist at Massachusetts General Hospital, where he worked from 1990 to 2011.&#160;Dr.
Sorensen currently serves as: the Executive Chairman of the board of directors of IMRIS, Deerfield Imaging, Inc., which is focused on
the integration of imaging technologies in a neurosurgical setting; a member of the board of directors for RealmIDX, Inc., an integrated
diagnostics company wholly owned by KonicaMinolta; and a member of the Supervisory Board for Fresenius Medical Care AG &amp; Co KGaA,
a provider of products and services for people with chronic kidney failure. Dr. Sorensen served as a Supervisory Board Member at Siemens
Healthineers from 2018 to 2023. Dr. Sorensen holds a B.S. in biology from the California Institute of Technology, an M.S. in computer
science from Brigham Young University, and an M.D. degree from Harvard Medical School. Dr. Sorensen brings broad-based expertise on the
development and potential impact of new technologies, including artificial intelligence and machine learning, on imaging services and
healthcare.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Laura P. Jacobs</i>&#160;has
been a member of our Audit Committee, our Nominating and Governance Committee and our Compensation Committee since 2020. Ms. Jacobs retired
from her position as managing principal of GE Healthcare Partners in 2020, where she worked since 1990. Ms. Jacobs led the firm&#8217;s
US healthcare management consulting business from 2015 to 2019 and was a founding principal and executive leader of its predecessor consulting
firm, The Camden Group. She is currently a part-time Senior Advisor for Sg2, a consulting division of Vizient. She is a national expert
on healthcare trends and their impact on providers and has been involved in healthcare management for the past 40 years, including the
30 years with GE Healthcare Partners/The Camden Group, advising healthcare providers regarding strategies, operations and financial performance
improvement initiatives. Ms. Jacobs has advised physician organizations, complex health systems and other healthcare entities on strategies
for growth, technology adoption and financial performance improvement. Ms. Jacobs has led strategic, financial and operational redesign
of health systems, including transforming the framework for decision-making and care delivery. Ms. Jacobs has led the organizational and
compensation redesign for provider organizations to achieve greater integration and aligned incentives. She is a published author and
speaker regarding current trends in healthcare, payer strategies, risk-based payment models, consumer expectations, clinical integration,
governance and performance optimization. She currently serves as vice-chair for Front Porch, a nonprofit organization that owns and manages
retirement and affordable housing communities. Ms. Jacobs brings to our Board a wealth of experience in operating, managing and growing
healthcare companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Lawrence L. Levitt</i>&#160;has
been a member of our Audit Committee since March 2005 and a member of our Nominating and Governance Committee since 2011. Mr. Levitt has
served as Chair of our Compensation Committee since 2007. Mr. Levitt is a certified public accountant and received his MBA in Accounting
from the University of California Los Angeles. Since 1987, Mr. Levitt has been the President, Chief Financial Officer of Canyon Management
Company, a company which manages a privately held investment fund. Mr. Levitt brings to our Board of Directors extensive financial accounting
experience and is an audit committee financial expert under the SEC rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Gregory E. Spurlock</i>&#160;has
been a member of our Compensation Committee and our Nominating and Governance Committee since 2021. Mr. Spurlock is currently a Senior
Advisor to LLR Partners, a Philadelphia-based private equity fund with a focus on health care, and to Global Medical Response, a KKR company
with over 38,000 employees that provides emergency response to the ill and injured. He retired in 2019 as President of Alliance Healthcare
Services, where he directed operations for their professional, technical, and global hospital-based services, encompassing 40 centers
across 19 states. Mr. Spurlock helped lead U.S. Radiosurgery, LLC, through its acquisition by Alliance HealthCare Services in 2011. As
a member of the senior executive team, he led Alliance Healthcare&#8217;s transition from publicly traded to international privately-owned
in 2017. Previous leadership includes work as the Director of the Tennessee Orthopaedic Alliance in Nashville and Executive Director of
the Kerlan-Jobe Orthopedic Clinic in Los Angeles. Mr. Spurlock has served on a number of boards, including the CyberKnife Coalition, the
Corporate Advisory Council of the American Society for Radiation Oncology, and the Board of Directors of the American Association of Orthopaedic
Executives. He holds a Bachelor of Science degree from Virginia Tech. Mr. Spurlock brings extensive operational, management and industry
experience to our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>David L. Swartz</i>&#160;has
been Chair of our Audit Committee since 2004, has been a member of our Nominating and Governance Committee since 2007, a member of our
Compensation Committee since 2007 and was appointed as Lead Independent Director in 2011. Mr. Swartz is a certified public accountant
(retired) with experience providing accounting and advisory services to clients. Since 2010, Mr. Swartz has owned and continues to operate
his own consulting services firm. Mr. Swartz served as a member of the Board of Directors of the California State Board of Accountancy
until November 2012 and previously served as its president. From 2008 to 2010, Mr. Swartz served as a partner at J.H. Cohn LLP. Between
1990 and 2008, Mr. Swartz served as the managing partner of Good, Swartz, Brown &amp; Berns LLP which was acquired by J.H. Cohn LLP in
2008. Prior to 1988, Mr. Swartz served as managing partner and was on the national Board of Directors of a 50 office international accounting
firm. Mr. Swartz brings to our Board of Directors extensive public financial accounting experience and is an audit committee financial
expert under the SEC rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>Director Skills and Demographic
Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following matrix highlights
the mix of key skills, qualities, attributes, and experiences of the nominees that, among other factors, led the Board and the Nominating
Committee to recommend these nominees for election to the Board. The matrix is intended to depict notable areas of focus for each director.
This&#160;matrix&#160;is intended as a high-level summary and not an exhaustive list of each director&#8217;s&#160;skills&#160;or contributions
to the Board. Not having a mark does not mean that a particular director does not possess that qualification or skill. The demographic
information presented below is based on voluntary self-identification by each nominee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-right: #DADADA 1pt solid; padding-bottom: 1pt; width: 23%; text-align: left">&#160;</td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: Black 1pt solid; text-align: left; width: 11%"><p style="text-align: left; margin-top: 0; margin-bottom: 0">Howard G.</p>
                                                                                <p style="text-align: left; margin-top: 0; margin-bottom: 0">Berger, M.D.</p></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: Black 1pt solid; text-align: left; width: 11%"><p style="text-align: left; margin-top: 0; margin-bottom: 0">Christine N.</p>
                                                                                <p style="text-align: left; margin-top: 0; margin-bottom: 0">Gordon</p></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: Black 1pt solid; text-align: left; width: 11%"><p style="text-align: left; margin-top: 0; margin-bottom: 0">Laura P.</p>
                                                                                <p style="text-align: left; margin-top: 0; margin-bottom: 0">Jacobs</p></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: Black 1pt solid; text-align: left; width: 11%"><p style="text-align: left; margin-top: 0; margin-bottom: 0">Lawrence L.</p>
                                                                                <p style="text-align: left; margin-top: 0; margin-bottom: 0">Levitt</p></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. Gregory Sorensen, M.D.</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: Black 1pt solid; text-align: left; width: 11%"><p style="text-align: left; margin-top: 0; margin-bottom: 0">Gregory E.</p>
                                                                                <p style="text-align: left; margin-top: 0; margin-bottom: 0">Spurlock</p></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: Black 1pt solid; text-align: left; width: 11%"><p style="text-align: left; margin-top: 0; margin-bottom: 0">David L.</p>
                                                                                <p style="text-align: left; margin-top: 0; margin-bottom: 0">Swartz</p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify">&#160;</td>
    <td colspan="7" style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid"><b>Knowledge,&#160;Skills&#160;&amp; Experience</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Governance</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid">&#160;</td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid">&#160;</td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Operations</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human Capital </span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry Knowledge</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Management</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid">&#160;</td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: #DADADA 1pt solid; text-align: justify">&#160;</td>
    <td colspan="7" style="border-right: #DADADA 1pt solid"><b>Diversity</b> </td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-right: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gender</span></td>
    <td style="border-right: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Male</span></td>
    <td style="border-right: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Female</span></td>
    <td style="border-right: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Female</span></td>
    <td style="border-right: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Male</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Male</span></td>
    <td style="border-right: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Male</span></td>
    <td style="border-right: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Male</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LGBTQ+</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Race/Ethnicity</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
    <td style="border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
    <td style="border-right: #DADADA 1pt solid; border-bottom: #DADADA 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_007"></span>COMPENSATION OF DIRECTORS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overview of Director Compensation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use cash and stock based
incentive compensation to attract and retain qualified candidates to serve on our Board of Directors. In setting director compensation,
we consider the significant amount of time that our directors expend in fulfilling their duties to RadNet as well as the skill level required
by the members of our Board of Directors. The Compensation Committee considers and evaluates compensation arrangements and makes recommendations
to the Board of Directors, which has ultimate authority to approve such compensation. In addition, our certificate of incorporation and
bylaws include indemnification provisions for our directors and executive officers and we maintain liability insurance for our directors
and executive officers. Employee directors do not receive any compensation for their service as a director. In accordance with provisions
contained in our stockholder-approved Equity Incentive Plan, as amended (the &#8220;Equity Incentive Plan&#8221;), the maximum total compensation
that can be paid to any non-employee director in a calendar year is $500,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Annual Compensation for Non-Employee Directors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the recommendation
of the Compensation Committee&#8217;s independent compensation consultant Pearl Meyer &amp; Partners LLC (&#8220;Pearl Meyer&#8221;) and
a review of peer group data, the Compensation Committee and the Board of Directors determined that there would be no changes to non-employee
director compensation for fiscal year 2023, such that all elements of non-employee director compensation were the same as in fiscal year
2022, as set forth in the table below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: justify">Annual cash compensation retainer</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">75,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Audit Committee Chair annual cash compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Compensation Committee Chair annual cash compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Nominating and Governance Committee Chair annual cash compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Lead Independent Director annual cash compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Committee Meeting Attendance (per meeting)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Annual equity compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on data and advice from
Pearl Meyer, in January 2024 the Compensation Committee recommended and the Board of Directors approved the following changes to non-employee
director compensation effective January 1, 2024 (with all other compensation elements for the non-employee directors remaining unchanged
from 2023).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Changes to Non-Employee Director Compensation</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Increase in Amount</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">New Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Annual cash compensation retainer</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">10,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">85,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Compensation Committee Chair annual cash compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Lead Independent Director cash compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Annual equity compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">160,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below reflects which
persons received the above additional non-employee director compensation for service during fiscal 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 73%; font-weight: bold; text-align: justify; padding-bottom: 1pt">Additional Annual Retainers</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 26%; font-weight: bold; text-align: center; padding-bottom: 1pt">Name</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Lead Independent Director</td><td>&#160;</td>
    <td style="text-align: center">David Swartz</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Audit Committee Chair</td><td>&#160;</td>
    <td style="text-align: center">David Swartz</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Compensation Committee Chair</td><td>&#160;</td>
    <td style="text-align: center">Lawrence Levitt</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Nominating and Governance Committee Chair</td><td>&#160;</td>
    <td style="text-align: center">Laura Jacobs</td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity Compensation Awarded in 2023</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 7, 2023, each of the
non-employee directors received a restricted stock award of 4,066 shares of common stock under our Equity Incentive Plan, with a grant
date value of approximately $125,000 based on the grant date $30.74 per-share closing price of RadNet&#8217;s common stock. Subject to
continued service, vesting of this stock grant will occur at the end of each non-employee director&#8217;s current term which coincides
with the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nonqualified Deferred Compensation Arrangements</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Non-employee directors are
eligible to participate in our Deferred Compensation Plans (as defined below). None of our non-employee directors elected to defer any
portion of their 2023 compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director Compensation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below summarizes
the compensation received by our non-employee directors for the fiscal year ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Fees Earned <br/>
or Paid
    in Cash<br/>
 ($)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Stock Awards <br/>
($)(1)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>All Other
    Compensation ($)</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Total
    ($)</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 36%; text-align: left">Lawrence L. Levitt</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">124,989</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">224,989</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Laura P. Jacobs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,989</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">222,489</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Gregory E. Spurlock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,989</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207,489</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">David L. Swartz</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,989</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">244,989</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(1)</td><td style="text-align: justify">Reflects the restricted stock awards described above in &#8220;Equity
Compensation&#8221; awarded in 2023. In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock
awards granted in 2023 computed in accordance with FASB ASC Topic 718, calculated by multiplying the number of shares subject to the
award by the closing price of RadNet&#8217;s common stock on the grant date. These are not amounts actually paid to or necessarily realized
by the grantee. As of December 31, 2023, each of the above non-employee directors held 4,066 shares of unvested restricted stock and
no stock options.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below summarizes
the compensation received by our directors who also served as employees (i.e. Dr. Berger, Dr. Sorensen, Ms. Gordon, Ms. Wilson) for the
year ended December 31, 2023. These employee directors do not receive any additional compensation for their services as directors. Dr.
Berger&#8217;s 2023 compensation is shown below in the Summary Compensation Table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Fees Earned<br/>
    or Paid in Cash<br/>
    ($)</b></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Stock Awards<br/>
    ($)</b></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>All Other</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>Compensation ($)<sup>(1)</sup></b></p></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Total ($)</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 36%; text-align: left">Christine N. Gordon<sup>(2)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">379,519</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">163,510</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">21,952</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">564,981</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Ruth V. Wilson<sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,024,011</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,037,473</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">A. Gregory Sorensen, M.D.<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,188,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,288</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,805,935</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(1)</td><td style="text-align: justify">Ms. Gordon, Ms. Wilson and Dr. Sorensen received certain of the
following items of other compensation as specified in the below table: (a) an automobile allowance; (b) RadNet paid premiums for coverage
under RadNet&#8217;s split dollar life insurance plans; (c) a 401(k) retirement plan match from RadNet; (d) RadNet paid premiums for
group health insurance (medical, dental and vision) plans; (e) RadNet paid premiums for life insurance and long-term disability coverage
under RadNet&#8217;s group life insurance plans; and (f) for Ms. Wilson, payments and benefits provided under the Wilson Agreement as
described in footnote (3).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Christine Gordon</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ruth Wilson</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">A. Gregory <br/>
Sorensen, M.D.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left; padding-left: 2.7pt">Auto Allowance</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">8,400</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 17%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 17%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.7pt">Split Dollar Life</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.5pt">401(k) Matching Contribution</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,300</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.5pt">Life/Disability Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">481</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.5pt">Group Health Insurance/COBRA</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,203</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,507</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 2.7pt">Wellness</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; padding-left: 2.7pt">Severance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 2.55pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,952</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,024,011</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,288</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(2)</td><td style="text-align: justify">Ms. Gordon was an employee (but was not an executive officer)
during 2023 and the amounts reported in the table reflect amounts paid to Ms. Gordon for her services as an employee. On January 3, 2023,
the Company granted Ms. Gordon 8,772 shares of Company common stock and the closing price of a Company common share as reported on Nasdaq
on such date was $18.64. Subject to Ms. Gordon&#8217;s continued service, these shares vest in three equal annual installments with one-third
vesting on each of March 10<sup>th</sup> of 2023, 2024, and 2025. Ms. Gordon and RadNet Management, Inc., a Delaware corporation and
wholly owned subsidiary of the Company, (&#8220;RMI&#8221;) are parties to an Amended and Restated Severance Agreement, dated February
24, 2022. Under this agreement, upon any termination of Ms. Gordon&#8217;s employment (other than due to her death), Ms. Gordon will
receive a lump sum payment (which can be paid partly in Company shares) equal to 200% of her then current annual base salary (which currently
is $400,000), with payment occurring within 60 days of termination of employment, and RMI will pay the monthly cost of Ms. Gordon&#8217;s
group medical insurance under federal/California COBRA (as applicable) for up to two years after termination of employment. These post-employment
payments are conditioned on Ms. Gordon providing a general release of all claims. As of December 31, 2023, Ms. Gordon held 4,386 shares
of unvested restricted stock and no stock options.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(3)</td><td style="text-align: justify">Ms. Wilson decided to not stand for re-election to the Board at
the Company&#8217;s Annual Meeting of Stockholders held in June 2023 and ceased to serve on the Board as of the conclusion of the 2023
Annual Meeting. Ms. Wilson was an employee (but was not an executive officer) until termination of her employment on February 3, 2023
and the amounts reported in the Fees Earned or Paid in Cash column reflect amounts paid to Ms. Wilson for her services as an employee.
Ms. Wilson and RMI were parties to an Amended and Restated Severance Agreement, dated January 26, 2022 (&#8220;Wilson Agreement&#8221;).
Under the Wilson Agreement, Ms. Wilson received an annual base salary of $100,000 for services as a part-time employee commencing as
of January 29, 2022. Upon termination of Ms. Wilson&#8217;s employment, Ms. Wilson was entitled to receive a lump sum payment (which
could be paid partly in Company shares) equal to $1,000,000 (with payment occurring within 15 days after effectiveness of a release of
claims) and RMI was also obligated to pay the monthly cost of Ms. Wilson&#8217;s group medical insurance under federal COBRA for up to
18 months after January 28, 2022. These post-employment payments were conditioned on Ms. Wilson providing a general release of all claims.
The amounts reported in the All Other Compensation column reflect the foregoing post-employment payments provided by the Wilson Agreement.
As of the end of her service on the Board, Ms. Wilson held no shares of unvested restricted stock and no stock options.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(4)</td><td style="text-align: justify">Dr. Sorensen was appointed to the Board (and also then became
a Company executive officer) on August 8, 2023. On June 1, 2020, Dr. Sorensen entered into an employment agreement (with a five year
term) with RMI. This employment agreement provides for an annual base salary of $600,000 (which is still his current base salary) and,
subject to approval by the Compensation Committee, an annual restricted stock grant (&#8220;Restricted Stock Award&#8221;), pursuant
to the Company&#8217;s Equity Incentive Plan, with the number of granted shares determined by dividing Dr. Sorensen&#8217;s annual base
salary by the grant per share value of such shares. Subject to Dr. Sorensen&#8217;s continuous service, each annual Restricted Stock
Award incrementally vest by one third (1/3) on each of the first three anniversaries of the applicable Restricted Stock Award grant date.
All options, warrants and any other deferred equity compensation then held by Dr. Sorensen which are unvested at the date of the Change
in Control will then vest on an accelerated basis. If the Company terminates Dr. Sorensen&#8217;s employment without Cause or Dr. Sorensen
resigns his employment for Good Reason, then Dr. Sorensen is eligible to receive severance in an aggregate amount equal to his annual
base salary. The severance is conditioned upon Dr. Sorensen executing and not revoking a general release of claims and will be paid in
substantially equal installments over a twelve month period after termination except that the severance will be made in a single lump
sum payment if a Change in Control occurred during the twelve month period preceding Dr. Sorensen&#8217;s termination date. On January
3, 2023, the Company granted Dr. Sorensen 31,579 shares of Company common stock and the closing price of a Company common share as reported
on Nasdaq on such date was $18.64. Subject to Dr. Sorensen&#8217;s continued service, these shares vest in three equal annual installments
with one-third vesting on each of March 10<sup>th</sup> of 2023, 2024, and 2025. On June 1, 2023, the Company granted Dr. Sorensen 20,155
shares of Company common stock and the closing price of a Company common share as reported on Nasdaq on such date was $29.77. Subject
to Dr. Sorensen&#8217;s continued service, these shares vest in three equal annual installments with one-third vesting on each of June
1st of 2024, 2025, and 2026. As of December 31, 2023, Dr. Sorensen held 62,936 shares of unvested restricted stock and stock options
to acquire 62,964 shares.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following definitions are contained
in Dr. Sorensen&#8217;s employment agreement and are summarized below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Adverse Change in Duties</i>: means
an action or series of actions taken by RMI, without Dr. Sorensen&#8217;s prior written consent, which results in the below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">A change in Dr. Sorensen&#8217;s reporting structure, titles,
job duties or job functions which results in a material diminution of his status, control, authority or level of responsibility;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The assignment to Dr. Sorensen of any positions, duties or responsibilities
which are materially inconsistent with Dr. Sorensen&#8217;s positions, duties and responsibilities or status with RMI;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">A requirement by RMI that Dr. Sorensen be based or perform his
duties anywhere other than (i) where they are currently performed (or within a 25 mile radius of that location), or (ii) at RMI&#8217;s
corporate office location on the date of the employment agreement; or</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>A reduction by RMI in Dr. Sorensen&#8217;s base salary.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Change in Control</i>: has the meaning
provided to such term in the Company&#8217;s Equity Incentive Plan and it is presently defined as the occurrence of any of the following.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">any merger or consolidation in which the Company shall not be
the surviving entity (or survives only as a subsidiary of another entity whose stockholders did not own all or substantially all of the
common stock in substantially the same proportions as immediately before such transaction);</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td>the sale of all or substantially all of the Company&#8217;s assets
to any other person or entity (other than a wholly-owned subsidiary of the Company);</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>the acquisition of beneficial ownership of a controlling interest
(including power to vote) in the outstanding shares by any person or entity (including a &#8220;group&#8221; as defined by or under Section
13(d)(3) of the Securities Exchange Act of 1934);</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>the dissolution or liquidation of the Company; or</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">a contested election of directors, as a result of which or in
connection with which the persons who were directors before such election or their nominees cease to constitute a majority of the Board.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Cause</i>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Dr. Sorensen&#8217;s conviction of (or plea of guilty or nolo
contendere to) (A) any felony or (B) any misdemeanor involving fraud or dishonesty in connection with the performance of his duties hereunder
or moral turpitude;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the willful and continued failure of Dr. Sorensen for a total
of 10 days (which need not be consecutive days) to substantially perform his duties with the Company (other than any such failure resulting
from illness or Disability) after a written demand for substantial performance from the Company is delivered to Dr. Sorensen, which demand
specifically identifies the manner in which it is claimed Dr. Sorensen has not substantially performed his duties, or</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>Dr. Sorensen has willfully engaged in misconduct which has, or
can reasonably be expected to have, a direct and material adverse monetary effect on RMI.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Disability</i>: shall mean that for
a period of at least 120 days during any twelve consecutive month period on account of a mental or physical condition, Dr. Sorensen is
unable to perform the essential functions of his job for RMI, with or without reasonable accommodation. The determination of Dr. Sorensen&#8217;s
Disability shall be made (a) by a medical physician selected or agreed to by RMI or (b) upon mutual agreement of RMI and Dr. Sorensen
or his personal representative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Good Reason</i>: means that Dr. Sorensen
voluntarily terminates his employment due to either (i) a material default by RMI in the performance of any of its obligations under the
employment agreement, or (ii) an Adverse Change in Duties (as defined above), which default or Adverse Change in Duties remains unremedied
by RMI for a period of thirty days following its receipt of written notice thereof from Dr. Sorensen (which notice must be provided to
the Company within 45 days of the initial existence of the applicable event and which reasonably describes the facts claimed by Dr. Sorensen
to constitute the default or Adverse Change in Duties) (the reasons described in items (i) and (ii) of this paragraph being referred to
herein as "Good Reason") and such Good Reason termination is consummated by Dr. Sorensen within 30 business days after the expiration
of the Company's 30 day remedy period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_008"></span>EXECUTIVE OFFICERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The names of our current executive
officers, their ages as of March 31, 2024, and their positions are shown below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 25%; font-weight: bold; text-align: center">Name of Executive Officer</td>
    <td style="width: 1%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 4%; text-align: center; font-weight: bold">Age</td>
    <td style="width: 1%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 60%; text-align: center; font-weight: bold">Position</td>
    <td style="width: 1%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center; font-weight: bold">Executive Officer Since</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Howard G. Berger, M.D.</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">79</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">President, Chief Executive Officer and Chairman of the Board</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">1992</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">Stephen M. Forthuber</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">63</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">President and Chief Operating Officer - Eastern Operations</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">2006</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Norman R. Hames</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">68</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">President and Chief Operating Officer- Western Operations</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">1996</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">Mark D. Stolper</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">52</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Executive Vice President and Chief Financial Officer</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">2004</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Mital Patel</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">38</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">2016</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">Michael M. Murdock</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">69</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Executive Vice President, Mergers and Acquisitions</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">2007</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify">David J. Katz</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">60</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Executive Vice President, Chief Legal Officer and Corporate Secretary</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">2020</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">Ranjan Jayanathan</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">68</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Executive Vice President, Chief Information Officer</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">2021</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify">A. Gregory Sorensen, M.D. </td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">62</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Executive Vice President, Chief Science Officer</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">2023</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Biographical summaries of
each of our executive officers who are not also members of our Board of Directors are included below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stephen M. Forthuber </i>has
served as an executive officer of RadNet since our acquisition of Radiologix, Inc. in 2006 and currently serves as our President and Chief
Operating Officer-Eastern Operations. He joined Radiologix in January 2000, serving as Regional Director of Operations, Northeast, Regional
Vice President of Operations, Northeast, Senior Vice President and Chief Development Officer, and ultimately Chief Operating Officer of
Radiologix at the time of the sale to RadNet. Prior to working at Radiologix, Mr. Forthuber was employed from 1982 until 1999 by Per-Se
Technologies, Inc. and its predecessor companies, where he had significant physician practice management and radiology operations responsibilities.
Mr. Forthuber received a B.A. in Business Administration from the College of William and Mary in Virginia.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Norman R. Hames </i>has
served as an executive officer of RadNet since 1996 and currently serves as our President and Chief Operating Officer-Western Operations.
Mr. Hames served on RadNet&#8217;s Board of Directors from 2000 until his resignation in 2019. Applying his more than 30 years of experience
in the industry, Mr. Hames oversees all aspects of our California and Arizona facility operations. Prior to joining RadNet, Mr. Hames
was President and Chief Executive Officer of his own company, Diagnostic Imaging Services, Inc., which owned and operated 14 multi modality
imaging facilities throughout Southern California prior to its sale to RadNet. Mr. Hames gained his initial experience in operating imaging
centers for American Medical international, or AMI, and was responsible for the development of AMl&#8217;s single and multi-modality imaging
centers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Mark D. Stolper </i>has
served as our Executive Vice President and Chief Financial Officer since July 2004 and prior to that was an independent member of our
Board of Directors. Prior to joining RadNet, Mr. Stolper had diverse experiences in investment banking, private equity, venture capital
investing and operations. Mr. Stolper began his career as a member of the corporate finance group at Dillon, Read and Co., Inc., executing
mergers and acquisitions, public and private financings, and private equity investments with Saratoga Partners LLP, an affiliated principal
investment group of Dillon Read. After Dillon Read, Mr. Stolper joined Archon Capital Partners, which made private equity investments
in media and entertainment companies. Mr. Stolper also worked for Eastman Kodak, where he was responsible for business development for
Kodak&#8217;s Entertainment Imaging subsidiary ($1.5 billion in sales). Mr. Stolper was also co-founder of Broadstream Capital Partners,
a Los Angeles based investment banking firm focused on advising middle market companies engaged in financing and merger and acquisition
transactions. Mr. Stolper has been a member of the board of directors of Surgalign Holdings, Inc. (NASDAQ: SRGA) since March 2017 and
Coherus BioSciences, Inc. (NASDAQ: CHRS) since January 2021. He was a member of the board of directors and audit committee for On Track
Innovations, Ltd. (NASDAQ: OTIV) from December 2012 until December 2016. He was also previously a member of the board of directors and
audit committee for Metropolitan Health Networks, Inc. (NYSE: MDF) from April 2010 until its sale in December 2012, was a member of the
board of directors for a privately held entertainment company providing discount ticketing services and branded event merchandising and
was Chairman of the board for a private telemedicine and eHealth provider. Mr. Stolper graduated with a liberal arts degree from the University
of Pennsylvania and a finance degree from the Wharton School. Additionally, Mr. Stolper earned a postgraduate Award in Accounting from
the University of California, Los Angeles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Mital Patel </i>has served
as our Executive Vice President of Financial Planning and Analysis since 2016 and Chief Administrative Officer since 2021. Mr. Patel directs
national budgets and finance, provides counsel regarding corporate acquisitions, and identifies opportunities for the company to deliver
cost-effective medical services. His background, experience and insight provide a critical and effective connection between our business
units and management team. Mr. Patel began his career at RadNet in 2010. Prior to that time, Mr. Patel served as part of the management
team at Truxtun Radiology before its acquisition by RadNet. Mr. Patel earned a B.A. degree in Business Administration, with a concentration
Management and Marketing, from California State University in Bakersfield.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Michael Murdock </i>has
served as our Executive Vice President, Mergers and Acquisitions since 2021. Michael Murdock joined RadNet in November of 2006 upon the
acquisition of Radiologix by RadNet. Mr. Murdock was Senior Vice President and Chief Financial Officer of Radiologix since January 2005.
Mr. Murdock has spent the majority of his career in senior financial positions with health care companies, including positions with American
Medical International and its successor American Medical Holdings, Inc., a $2.4 billion in revenue publicly traded owner and operator
of acute care facilities that was acquired by National Medical Enterprises, now Tenet Healthcare. Mr. Murdock also served as Chief Financial
Officer of Physician Reliance Network, Inc., a $398 million in revenue publicly traded physician practice management company, specializing
in oncology. In 1999, PRN merged with American Oncology, Inc. to become U.S. Oncology, Inc., the nation&#8217;s largest healthcare network
dedicated to cancer treatment and research. From 1999 through 2004, Mr. Murdock served as CFO of Dental One, a venture capital-backed
owner and operator of 48 dental practices in Texas, Arizona, Colorado, and Utah. Mr. Murdock began his career in 1978 as an auditor with
Arthur Andersen after receiving a B.S. degree from California State University, Northridge.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>David J. Katz </i>has served
as our Executive Vice President and Chief Legal Officer since March 2020. Mr. Katz has served as our Corporate Secretary since April 2021.
Mr. Katz joined RadNet from the international law firm Perkins Coie LLP, where he was a partner for 20 years. Mr. Katz was in private
practice for 30 years before joining RadNet. Mr. Katz is responsible for overseeing all of RadNet&#8217;s legal matters including, without
limitation, mergers, acquisitions, securities and joint ventures. Mr. Katz has also served as a Los Angeles County Sheriff Reserve Deputy
since 1990, and is a two-time Medal of Valor recipient from the Los Angeles County Sheriff&#8217;s Department.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Ranjan Jayanathan </i>currently
serves as our Executive Vice President and Chief Information Officer, and also serves as General Manager of eRAD, the Company&#8217;s
information technology division. Mr. Jayanathan joined RadNet in 2010 from Voyant Health, where he was the General Manager of American
operations. Prior to Voyant, he was a member of the executive management team of Dynamic Imaging. During his nine year tenure at Dynamic
Imaging, Mr. Jayanathan managed sales, client services, and solutions architecture. He assisted with Dynamic Imaging&#8217;s sale to General
Electric in 2007 and its integration into GE&#8217;s operations. Prior to Dynamic Imaging, he held various Chief Information Officer and
Research and Development positions at Advanced Radiology, Reynolds and Reynolds, and National Medical Computer Services. Mr. Jayanathan
earned a degree in electrical engineering from the Massachusetts Institute of Technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our executive officers are
appointed by and serve at the discretion of the Board of Directors. There are no family relationships among any of our executive officers
and directors. There have been no material proceedings to which any director, executive officer or affiliate of the Company, any owner
of record or beneficially of more than five percent of any class of voting securities of the Company, or any associate of any such director,
executive officer, affiliate of the Company, or security holder is a party adverse to the Company or any of its subsidiaries or has a
material interest adverse to the Company or any of its subsidiaries. There are no arrangements or understandings with another person pursuant
to which any of our executive officers or directors were selected as an executive officer or director. None of our current directors or
executive officers have been, during the past 10 years, involved in any legal proceedings required to be disclosed pursuant to Item 401(t)
of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_009"></span>COMPENSATION DISCUSSION AND ANALYSIS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Compensation Discussion
and Analysis explains the guiding principles and practices upon which our executive compensation program is based and the compensation
paid to our fiscal year 2023 named executive officers (who consist of our principal executive officer, principal financial officer and
our next three most highly compensated executive officers in fiscal year 2023 and such persons are referred to as our &#8220;Named Executive
Officers&#8221;):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Howard G. Berger, M.D. - President and
Chief Executive Officer (our principal executive officer)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Mark D. Stolper- Executive Vice President
and Chief Financial Officer (our principal financial officer)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Stephen M. Forthuber - President and
Chief Operating Officer - Eastern Operations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Norman R. Hames - President and Chief
Operating Officer - Western Operations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Mital Patel - Executive Vice President
of Financial Planning and Analysis and Chief Administrative Officer</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our executive compensation
program is designed to attract, retain and motivate talented executive officers who are capable of providing leadership, vision and execution
necessary to achieve our business objectives. We actively seek to align the interests of our Named Executive Officers with the creation
of stockholder value through our equity compensation program. We believe the compensation paid to our Named Executive Officers for the
year ended December 31, 2023 appropriately reflects and rewards their contribution to our performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our 2022 revenue of $1.43
billion was a 7.8% increase over 2021 and income from operations was $46.4 million. In addition, in 2022, through the efforts of our executive
management team, we continued to invest and position the Company for future growth, adding a net of 10 new radiology centers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2023, we finished the
year with revenue of $1.62 billion an increase of 13.1% over 2022. Income from operations increased by 112.7% to $98.7 million. In addition,
the Company took a number of steps to position itself for future growth, including completion of a secondary public offering raising net
proceeds of $245.8 million and continuing its investment in AI technologies and product development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Compensation Philosophy</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following principles influence
and guide the compensation decisions of the Compensation Committee:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Our Management Team is Integral to our Success. </i>At the
core of our compensation philosophy is the guiding belief that our management team is an integral component to RadNet&#8217;s continued
success. Equity compensation and cash bonuses are generally determined near the end of the calendar year and are paid at the beginning
of the fiscal year with the goal of continuing to retain and incentivize our Named Executive Officers to achieve or exceed the strategic
initiatives set for the upcoming year.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Compensation Decisions Should Promote the Interests of Stockholders.
</i>Compensation should create incentives for management to achieve strong short-term (annual) performance in a manner that supports
and ensures our long-term success and profitability. The Compensation Committee believes that performance-based equity incentive awards,
stock option and/or restricted stock awards (or restricted stock units (&#8220;RSUs&#8221;)) create long-term incentives that align the
interests of management with the long-term interests of stockholders.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Compensation Should Reflect Position and Responsibility. </i>Total
compensation and accountability should generally increase with position and responsibility. Consistent with this philosophy: (a) total
compensation is higher for individuals with greater responsibility and greater ability to influence RadNet&#8217;s achievement of targeted
results and strategic initiatives; and (b) equity-based compensation is higher for persons with higher levels of responsibility, making
a significant portion of their total compensation dependent on long-term stock appreciation.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Internal Pay Equity. </i>We have not established a formal
policy regarding the ratio of total compensation of the Chief Executive Officer to that of the other officers, but the Compensation Committee
believes that internal pay equity is an important factor to be considered in establishing compensation for our Named Executive Officers,
and reviews compensation levels to ensure that appropriate pay equity exists.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Compensation Should be Reasonable and Responsible. </i>It
is essential that our overall compensation levels be sufficiently competitive to attract and retain talented leaders and motivate those
leaders to achieve superior results. At the same time, we believe that compensation should be set at responsible levels and the Compensation
Committee periodically reviews market information from external sources or advisors to determine appropriate levels. Our executive compensation
programs are intended to be consistent with our focus on controlling costs.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Compensation Disclosures Should be Clear and Complete. </i>The
Compensation Committee and management believe that all aspects of executive compensation should be clear, comprehensible and promptly
disclosed in plain English. The Compensation Committee and management believe that compensation disclosures should provide all of the
information necessary to permit stockholders to understand our compensation philosophy, our compensation-setting process and how much
our Names Executive Officers are paid.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board and Committee Process</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Role of the Compensation Committee</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors has
delegated to the Compensation Committee the authority to approve all compensation and awards to Named Executive Officers. With respect
to equity compensation awarded to the Named Executive Officers and others, the Compensation Committee acts as the administrator under
the Equity Incentive Plan, and has the authority under that plan to grant equity compensation awards, including restricted stock, RSUs
and stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation Committee
meets as often as necessary to perform its duties and responsibilities. The Committee meets with its compensation consultant and, as applicable,
executive management, including our Chief Executive Officer. The Compensation Committee meets in executive session each year to: (a) evaluate
the performance of the Named Executive Officers, (b) set the annual compensation of the Named Executive Officers, and (c) consider and
approve any grants of equity incentive compensation to the Named Executive Officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
has ultimate authority, including delegated authority over all aspects of Named Executive Officer compensation, including the base salary
for each Named Executive Officer and the overall compensation of the Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Role of Management in the Compensation-Setting
Process</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management&#8217;s role in
the compensation-setting process, includes the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">establishing the operating budget approved by the Board of Directors,
which forms the basis for evaluating corporate achievements and the achievements of the divisions our Named Executive Officers manage
that are taken into consideration when evaluating compensation levels for Named Executive Officers;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">making recommendations to the Compensation Committee on salary
levels and performance-based equity incentive awards, stock option and restricted stock awards (or RSUs); and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">allocating the amount of cash bonus, restricted stock (or RSUs)
and stock option amounts to be awarded to our Named Executive Officers.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management also prepares information
for Compensation Committee meetings. Our Chief Executive Officer (or other executive officers) also participate in committee meetings
at the request of the Compensation Committee to provide, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td>background information regarding RadNet&#8217;s strategic objectives;
and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">his evaluation of the performance of the other Named Executive
Officers, including accomplishments, and areas of strength and weakness.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Role of the Compensation Consultant</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under its charter, the Compensation
Committee is granted the authority to retain outside advisors and compensation consultants. The Compensation Committee has retained Pearl
Meyer to serve as its independent outside compensation consultant and provide compensation analysis and advice since 2016. Pearl Meyer
provides the following services with respect to compensation determinations:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Executive compensation benchmarking and framework;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Assessment of market trends of non-employee director compensation;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Review of market compensation practices and trends;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Annual incentive plan and equity award design;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Advice on merit increases, target bonuses and equity award levels;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Assessment of employment and Change in Control agreement provisions;
and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Legislative and regulatory updates.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pearl Meyer attends certain
Compensation Committee meetings in person or by telephone, including executive sessions as requested, and consults with the Compensation
Committee Chair. Pearl Meyer also reviewed and commented on this executive compensation disclosure and the Named Executive Officer and
director compensation tables contained in this Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the selection and
retention process, the Compensation Committee analyzes the independence of Pearl Meyer under SEC and Nasdaq Rules. Pearl Meyer reports
directly to the Compensation Committee and performs no other work for RadNet besides rendering compensation consulting services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with its charter,
the Compensation Committee analyzed whether the work of Pearl Meyer as a compensation consultant has raised any conflict of interest,
taking into consideration the following factors: (a) the provision of other services to RadNet by Pearl Meyer; (b) the amount of fees
from RadNet paid to Pearl Meyer as a percentage of the firm&#8217;s total revenue; (c) Pearl Meyer&#8217;s policies and procedures that
are designed to prevent conflicts of interest; (d) any business or personal relationship of Pearl Meyer or the individual compensation
advisors employed by the firm with an executive officer of RadNet; (e) any business or personal relationship of the individual compensation
advisors with any member of the Compensation Committee; and (f) any stock of RadNet owned by Pearl Meyer or the individual compensation
advisors employed by the firm. The Compensation Committee has determined, based on its analysis of the above factors, that the work of
Pearl Meyer and the individual compensation advisors employed by Pearl Meyer as compensation consultants to RadNet has not created a conflict
of interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Role of Peer Companies and Benchmarking</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
reviews a peer group of companies (&#8220;Peer Group&#8221;) recommended by Pearl Meyer in order to assess the competitiveness of our
executive officer compensation level and structure. The composition of the Peer Group is reviewed periodically. In December 2022, with
input from Pearl Meyer, the Compensation Committee determined to keep the Peer Group for 2023 the same as what was utilized in 2022, as
reflected in the following list:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="width: 30%; text-align: justify">Acadia Healthcare Company, Inc.</td>
    <td style="width: 32%; text-align: justify">AdaptHealth Corp</td>
    <td style="width: 38%; text-align: justify">Addus HomeCare Corporation</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">Apria, Inc.</td>
    <td style="text-align: justify">Aveanna Healthcare Holdings Inc.</td>
    <td style="text-align: justify">Cano Health, Inc.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Fulgent Genetics, Inc.</td>
    <td style="text-align: justify">Hanger, Inc.</td>
    <td style="text-align: justify">InnovAge Holding Corp.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">LHC Group, Inc.</td>
    <td style="text-align: justify">ModivCare Inc.</td>
    <td style="text-align: justify">Pediatrix Medical Group, Inc.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Surgery Partners, Inc.</td>
    <td style="text-align: justify">The Ensign Group, Inc.</td>
    <td style="text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following selection criteria
was established to identify companies for inclusion in the Peer Group:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">U.S. publicly traded companies with annual revenue approximately
one-third to twice RadNet&#8217;s annual revenue; and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">primary operations in the healthcare facility and services industry.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Elements of Executive Compensation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Base Salary</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We seek to establish a base
salary compensation level that appropriately recognizes each Named Executive Officer&#8217;s achievements and contributions. Base salary
also provides executives with a secure level of income that is not at risk, and our Compensation Committee believes that this gives our
Named Executive Officers the ability to focus on the longer term and avoid the urgency that could otherwise encourage a Named Executive
Officer to take unnecessary risks. In determining base salaries, our Compensation Committee considers the Named Executive Officer&#8217;s
qualifications and experience, scope of responsibilities and future potential, the executive&#8217;s ability to influence RadNet&#8217;s
achievements of targeted results and strategic initiatives, the goals and objectives established for the Named Executive Officer, the
Named Executive Officer&#8217;s past performance, the general pay practices at other companies in our Peer Group, internal pay equity
and the tax deductibility of base salary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Discretionary Cash Bonuses</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent years, the Compensation
Committee has elected to supplement base salary and equity-based compensation with discretionary cash bonus awards generally paid in the
beginning of the fiscal year. These discretionary cash bonuses are awarded with the goal of continuing to retain and incentivize our Named
Executive Officers to achieve or exceed the strategic initiatives set for the upcoming year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity Based Compensation</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that equity compensation
is the most effective means of aligning the interests of our officers and other key management personnel with gains realized by our stockholders.
The Compensation Committee uses equity awards, including performance-based equity incentive awards, restricted stock, RSUs and stock options,
as a long-term incentive vehicle because:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">performance-based equity incentive awards align the interests
of executives with those of our stockholders while encouraging objective strategic goals established by the Compensation Committee;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">restricted stock, RSUs and/or stock options align the interests
of executives with those of our stockholders, support a pay-for-performance culture, foster employee stock ownership and focus the management
team on increasing value for our stockholders; and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the vesting period encourages executive retention and the creation
of stockholder value.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use a mix of performance-based
equity awards, restricted stock, RSUs and/or stock options for equity compensation grants to the Named Executive Officers. In determining
the maximum number of performance-based equity awards shares of restricted stock, RSUs and stock options to be granted to Named Executive
Officers, the Compensation Committee considers the individual&#8217;s position, scope of responsibility, ability to affect profits and
stockholder value and the individual&#8217;s historic and recent performance, the value of the equity awards in relation to other elements
of total compensation, internal pay equity and market competitiveness. While there is no formal policy about the timing and frequency
of equity compensation awards, the Compensation Committee has historically issued annual equity grants to the named executive officers
during the first two weeks of January. The Chief Executive Officer considers similar factors when allocating the number of shares of performance-based
equity awards, restricted stock, RSUs and stock options to be granted to the senior executive officers, within the limitations set by
the Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Equity Incentive Plan
was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023. Unless terminated earlier, the Equity
Incentive Plan will terminate on April 26, 2033. The Equity Incentive Plan permits the discretionary award of incentive stock options
(&#8220;ISOs&#8221;), nonqualified stock options (&#8220;NSOs&#8221;), stock appreciation rights (&#8220;SARs&#8221;), restricted stock,
and RSUs. Directors, officers, employees and consultants of RadNet and certain of our affiliated companies are eligible to receive awards
under the Equity Incentive Plan. Certain other key features of the Equity Incentive Plan are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Up to a maximum aggregate of 20,100,000 common shares may be
issued under the Equity Incentive Plan. As of December 31, 2023, 4,069,349 common shares were available for potential future issuance.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The aggregate value of compensation, including awards granted
to any individual non-employee director during any calendar year, may not exceed $500,000.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The Equity Incentive Plan will generally be administered by a
committee comprised solely of independent members of the Board, such as the Compensation Committee (the &#8220;Plan Administrator&#8221;).
The Board or Plan Administrator may designate a Company officer to make awards (within parameters established by the Board) to employees
who are not officers subject to the reporting requirements of Section 16 of the Exchange Act or are not Code Section 162(m) Covered Employees.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The Plan Administrator has the discretion to determine (a) who
shall receive any Plan awards, and (b) the terms and conditions of such awards.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Stock options and stock appreciation rights may not be granted
at a per share exercise price below the fair market value of a share of our common stock on the date of grant.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Stock options and stock appreciation rights may not be repriced
or exchanged without stockholder approval. The maximum exercisable term of stock options and stock appreciation rights may not exceed
ten years.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Awards are subject to recoupment of compensation policies (referred
to as clawback policies) which have been adopted (including without limitation, the Company&#8217;s Policy on Recovery of Erroneously
Awarded Compensation as adopted by the Board on November 8, 2023 and as may be amended from time to time by the Company) or which may
be adopted by the Company in the future.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional Benefits</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our executive officers, including
our Named Executive Officers, participate in other employee benefit plans generally available to all employees on the same terms as similarly
situated employees. Perquisites to our Named Executive Officers are not a material element of our compensation program. We pay the premiums
for our Named Executive Officers&#8217; coverages under our health and life insurance plans and all of our Named Executive Officers are
provided either an automobile allowance, the use of a Company-provided automobile or Company reimbursement for certain automobile expenses.
We also maintain a Split Dollar Life Insurance Plan pursuant to which we have corporate owned life insurance (&#8220;COLI&#8221;) policies
on our key management employees including our Named Executive Officers. These COLI policies would, upon the insured&#8217;s death, pay
death benefits proceeds to the insured&#8217;s beneficiaries while RadNet would then receive any excess death benefit proceeds along with
any remaining cash surrender value of the COLI policy. Each Named Executive Officer has executed a participation agreement with RadNet
under the Split Dollar Life Insurance Plan, which agreement specifies the amount of death benefit proceeds and the beneficiaries of this
life insurance arrangement. Additionally, we have historically provided matching 40l(k) contributions for our employee participants, which
we suspended in 2020 but commenced providing again in 2021 and continued to provide in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Change in Control and Severance Arrangements</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described in the &#8220;Employment
Agreements&#8221; section below, as an inducement to attract and retain qualified executive officers, certain benefits are provided if
the Named Executive Officer&#8217;s employment is terminated under certain circumstances. None of our Named Executive Officers are eligible
for gross-up payments to cover excise taxes in connection with a change in control transaction. There is full acceleration of time-based
vesting for all then-unvested shares underlying equity compensation awards issued under the Equity Incentive Plan and the Deferred Compensation
Plans upon termination of a participant&#8217;s service due to his/her death or disability. Such accelerated vesting is also provided
to the Named Executive Officers upon a change in control or upon a qualifying involuntary termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nonqualified Deferred Compensation Arrangements</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a Nonqualified
Deferred Compensation Plan (the &#8220;NDC Plan&#8221;) and a RadNet Deferred Compensation Plan (2016) (the &#8220;Excess Plan&#8221;
and together with the NDC Plan, the &#8220;Deferred Compensation Plans&#8221;) which are administered by the Compensation Committee. The
NDC Plan is used for the deferral of equity compensation and the Excess Plan is used for the deferral of cash compensation. The Named
Executive Officers, the members of the Board of Directors, and other executives or highly compensated employees of RadNet or designated
affiliated entities (collectively, &#8220;participants&#8221;) who are selected by the Compensation Committee are eligible to participate
in the Deferred Compensation Plans. Participants have the opportunity to voluntarily elect to defer the timing of payment of base salary,
incentive compensation and/or stock awards. The Compensation Committee determines which forms of compensation are eligible for deferral
and can prescribe limits on the amount of deferrals. It may also, in its discretion, credit a participant&#8217;s account with a contribution
amount from RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash-based deferrals may also
accrue notional investment returns based on the performance of one or more measurement funds selected by RadNet and in which the participant
may elect to have portions of his/her cash account hypothetically invested. RadNet stock grant deferrals will be settled on a one-for-one
basis with RadNet common shares (or their cash equivalent). The Deferred Compensation Plans are not funded; payments are made out of RadNet&#8217;s
general assets and participants are unsecured general creditors of RadNet with respect to deferred amounts. However, as expressly permitted
under the Deferred Compensation Plans and applicable tax laws, RadNet has established a &#8220;rabbi trust&#8221; to provide a source
of funds for meeting its financial obligations under the Deferred Compensation Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Participants generally must
submit their elections to defer compensation before the calendar year in which compensation is earned (except that participants can make
a deferral election within 30 days of their initial eligibility to participate in the Deferred Compensation Plans). Settlement of deferred
amounts will be affected in accordance with the Deferred Compensation Plans and the applicable deferral election and generally will be
paid in either a lump sum or a series of annual installments after the applicable distribution date. Deferred compensation amounts can
be paid out on an accelerated basis under certain circumstances including a change in control of RadNet. The aggregate amount that could
potentially be paid out under the Deferred Compensation Plans is presently indeterminable and will depend on the amounts and types of
deferrals along with the performance of the hypothetical investments and RadNet stock value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Deferred Compensation
Plans are each intended to be a &#8220;top-hat&#8221; plan and are governed by the laws of the state of Delaware except to the extent
preempted by The Employee Retirement Income Security Act of 1974. It is intended that the Deferred Compensation Plans and any payments
thereunder comply with Internal Revenue Code (&#8220;Code&#8221;) Section 409A, which governs the federal income taxation of nonqualified
deferred compensation. The Deferred Compensation Plans will remain in effect until terminated by RadNet, but deferred amounts may still,
in certain circumstances, remain outstanding in accordance with the applicable deferral elections after termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Policy Prohibiting Hedging and Pledging</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our insider trading policy
prohibits employees, advisors, officers, directors and consultants of the Company, members of their immediate families, and corporations,
partnerships or similar entities which such persons influence or control (collectively, &#8220;Covered Persons&#8221;) from entering into
hedging or derivative transactions, including purchasing financial instruments (such as prepaid variable forward contracts, equity swaps,
collars, and exchange funds), or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease
in the market value of the Company&#8217;s securities. Our Chief Legal Officer, who serves as chief compliance officer under the policy,
has the authority to grant exceptions to the prohibition against pledges where a Covered Person wishes to pledge Company securities as
collateral for a loan (not including margin debt) and clearly demonstrates the financial capacity to repay the loan without resort to
the pledged securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Year 2023 Compensation Determinations</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2022, Pearl Meyer
provided the Compensation Committee with a compensation benchmarking report on the Company&#8217;s Peer Group (which Peer Group was unchanged
from the one used above for 2022 compensation determinations). Based in part on this report and also on advice from Pearl Meyer, the Compensation
Committee elected to (a) not modify base salaries for the Named Executive Officers so that salaries remain unchanged from 2022 and (b)
make other compensation decisions set forth below for 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 3, 2023, in order
to retain and further motivate the Named Executive Officers and align their interests with Company stockholder interests, the Compensation
Committee determined to provide the Named Executive Officers with the cash bonuses which were paid in January 2023 in the amount of $2,000,000,
$287,500, $325,000, $325,000, and $287,500 for Messrs. Berger, Stolper, Hames, Forthuber and Patel, respectively. The bonuses paid to
the Named Executive Officers (other than the Chief Executive Officer) were equal to 50% of 2022 base salaries. Dr. Berger&#8217;s cash
bonus amount was paid by BRMG.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
also then determined to provide the Named Executive Officers with (a) grants of stock units (for those Named Executive Officers deferring
receipt of the underlying shares) or restricted shares (either &#8220;RSG Shares&#8221;) with a grant date value approximately equal to
50% of the 2022 base salaries for the Named Executive Officers, and (b) grants of stock options (&#8220;Options&#8221;) with a grant date
value approximately equal to the Black Scholes option pricing value of 50% of 2022 base salaries. The table below reflects these awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date Value of each of RSGs and of Option Award</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of RSG</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Shares(1) </p></td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Option  Shares(2) </td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 49%; text-align: justify; padding-left: 2.7pt">Howard Berger</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 14%; text-align: right">1,000,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 14%; text-align: right">53,648</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 14%; text-align: right">103,969</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 2.7pt">Mark Stolper</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">287,500</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">15,423</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">29,891</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-left: 2.5pt">Norman Hames</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">325,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">17,435</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">33,789</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 2.5pt">Stephen Forthuber</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">325,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">17,435</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">33,789</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 2.7pt">Mital Patel</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">287,500</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">15,423</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">29,891</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify; padding-left: 2.55pt">Total</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">2,225,000</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">134,787</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">231,329</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(1)</td><td style="text-align: justify">The number of RSG Shares is equal to the whole number (rounded
down to the nearest integer) that is the quotient of the grant dollar value shown above divided by the closing price of a Company common
share as reported on Nasdaq for January 3, 2023 which was $18.64.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(2)</td><td style="text-align: justify">The number of Option shares is equal to the whole number (rounded
down to the nearest integer) utilizing the Black-Scholes option pricing model for the grant dollar value shown above and applying the
closing price of a Company common share as reported on Nasdaq for January 3, 2023 which was $18.64. The per share exercise price for
the Options is also $18.64.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the Named Executive
Officer&#8217;s continued service, the RSG Shares vest in two equal annual installments with one-half vesting on March 10, 2023 and one-half
vesting on March 10, 2024. Subject to the Named Executive Officer&#8217;s continued service, the Option shares vest in three equal annual
installments with one-third vesting on each of March 10, 2023, March 10, 2024 and March 10, 2025, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, on January 3,
2023, the Compensation Committee approved the award to each Named Executive Officer of performance-based options (&#8220;PSOs&#8221;)
and performance-based restricted stock units (&#8220;PSUs&#8221;). The performance vesting conditions are based on attainment of Company
Adjusted earnings before Interest, Taxes, Depreciation, and Amortization (&#8220;AEBITDA&#8221;) goals established (and adjusted as needed)
by the Compensation Committee for calendar year 2023. The Compensation Committee has determined that AEBITDA is the financial performance
measure that, in the Compensation Committee&#8217;s assessment, represents the most important performance measure used by the Company
to link compensation actually paid to the Named Executive Officers to Company performance. The maximum number of shares subject to these
PSOs have an aggregate grant date value approximately equal to the Black-Scholes option value of approximately 50% of the 2022 base salaries.
The target number of shares subject to these PSUs have an aggregate grant date value approximately equal to 25% of the 2022 base salaries.
The maximum number of PSUs that can vest is equal to 200% of the target number. The closing price of a common share on the grant date
of January 3, 2023 was $18.64. The portion of the PSOs and PSUs that satisfy the EBITDA performance vesting conditions will also be subject
to continued service vesting conditions. 50% of those PSUs will incrementally vest on each of March 10th of 2025 and 2026. One-third of
those PSOs will incrementally vest on each of March 10th of 2025, 2026 and 2027. The PSOs have a per share exercise price of $18.64.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2023 target AEBITDA was
established at $214,874,252 which was higher than both the approximately $201.9 million AEBITDA target established for the PSOs/PSUs granted
in 2022 and the actual 2022 achieved AEBITDA of approximately $192.5 million. The ratio of actual AEBITDA divided by target AEBITDA determines
the amount of PSOs/PSUs that become vested as shown in the table below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 35%; text-align: center; font-weight: bold"><b>FY 2023
    AEBITDA<br/> Achieved vs. Target</b></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 32%; vertical-align: bottom"><b>Shares Performance Vested<br/>

    As % of Maximum PSO Shares </b></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 31%; vertical-align: bottom"><b>Shares Performance Vested <br/>

    As % of Target PSU Shares </b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">Less than or equal to 92.5%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">0%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">93.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">5%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">10%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">94.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">15%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">30%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">95.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">25%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">50%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">96.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">30%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">60%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">97.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">35%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">70%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">98.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">40%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">80%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">99.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">45%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">90%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">100.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">50%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">100%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">101.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">55%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">110%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">102.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">60%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">120%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">103.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">65%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">130%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">104.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">70%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">140%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">105.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">75%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">150%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">106.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">85%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">170%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: right">107.0%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">95%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">190%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: right">Greater than or equal to 107.5%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">100%</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">200%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 1, 2024, based on
2023 financial data provided by Company management showing that actual AEBITDA was $237,324,127, the Compensation Committee determined
that a 110.4% performance level of AEBITDA performance was attained for 2023 and therefore that 100% of the PSOs became performance-based
vested and 200% of the PSUs became performance-based vested. No portion of the PSOs/PSUs were forfeited as a result of the performance
vesting conditions. The tables below summarize these 2023 performance-based awards and the far right column in each table shows how many
shares underlying the 2023 performance-based awards remain outstanding and eligible to become vested if/when the time-based service vesting
conditions are attained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Name</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Grant Date</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Threshold  PSUs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Target PSUs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Maximum PSUs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Performance Period</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Actual Date Performance
    Achievement was Determined</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Number of
    Performance Vested PSUs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; width: 23%; text-align: left; padding-left: 2.7pt">Howard Berger</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 10%; text-align: center">1/3/23</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">2,012</td><td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="text-align: right; width: 1%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">20,118</td><td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="text-align: right; width: 1%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">40,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right">1/1/23 to 12/31/23</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 10%; text-align: right">3/1/24</td><td style="text-align: right; width: 1%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">40,236</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.7pt; vertical-align: top">Mark Stolper(1)</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-left: 0.1pt">1/3/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">771</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">7,711</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">15,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/1/23 to 12/31/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">3/1/24</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">15,422</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: left; padding-left: 2.5pt">Norman Hames</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">1/3/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">872</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">8,717</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">17,434</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/1/23 to 12/31/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">3/1/24</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">17,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left; padding-left: 2.5pt">Stephen Forthuber</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center">1/3/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">872</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">8,717</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">17,434</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/1/23 to 12/31/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">3/1/24</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">17,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1pt; padding-left: 2.7pt">Mital Patel</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1pt; padding-left: 0.1pt">1/3/23</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">771</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">7,711</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">15,422</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">1/1/23 to 12/31/23</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; padding-bottom: 1pt">3/1/24</td><td style="text-align: right; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">15,422</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 2.55pt; vertical-align: middle">Total</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">5,298</td><td style="padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">52,974</td><td style="padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">105,948</td><td style="vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">105,948</td><td style="vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Name</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Grant Date</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Threshold<br/>
  PSOs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Target<br/>
  PSOs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Maximum<br/>
  PSOs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Performance Period</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Actual Date Performance
    Achievement was Determined</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Number of
    Performance Vested PSOs (#)</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; width: 23%; text-align: left; padding-left: 2.7pt">Howard Berger</td><td style="text-align: center; width: 1%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 10%; text-align: center">1/3/23</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">3,899</td><td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="text-align: right; width: 1%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">38,898</td><td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="text-align: right; width: 1%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">77,976</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right">1/1/23 to 12/31/23</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 10%; text-align: right">3/1/24</td><td style="text-align: right; width: 1%; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: right">&#160;</td><td style="vertical-align: top; width: 8%; text-align: right">77,976</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.7pt; vertical-align: top">Mark Stolper(1)</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-left: 0.1pt">1/3/23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">1,495</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">14,946</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">29,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/1/23 to 12/31/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">3/1/24</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">29,891</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: left; padding-left: 2.5pt">Norman Hames</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">1/3/23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">1,690</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">16,895</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/1/23 to 12/31/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">3/1/24</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">33,789</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left; padding-left: 2.5pt">Stephen Forthuber</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">1/3/23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: right">1,690</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">16,895</td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/1/23 to 12/31/23</td><td>&#160;</td>
    <td style="vertical-align: top; text-align: right">3/1/24</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right">33,789</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1pt; padding-left: 2.7pt">Mital Patel</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1pt; padding-left: 0.1pt">1/3/23</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">1,495</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">14,946</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">29,891</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">1/1/23 to 12/31/23</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; padding-bottom: 1pt">3/1/24</td><td style="text-align: right; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">29,891</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 2.55pt; vertical-align: middle">Total</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">10,269</td><td style="padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">102,580</td><td style="padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">205,336</td><td style="vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="text-align: right; padding-bottom: 2.5pt; vertical-align: middle">&#160;</td>
    <td style="padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right; vertical-align: middle">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; vertical-align: middle; text-align: right">&#160;</td><td style="border-bottom: Black 2.5pt double; vertical-align: middle; text-align: right">205,336</td><td style="vertical-align: middle; padding-bottom: 2.5pt; text-align: right">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify"><span style="font-weight: normal">(1)</span></td><td><span style="font-weight: normal">Reflects amounts before transfer
of a portion of the award to Mr. Stolper&#8217;s former spouse pursuant to a domestic relations order.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholder Advisory Votes on Executive Compensation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2022, over 95% of
the stockholder votes (excluding abstained and broker non-votes) were cast &#8220;FOR&#8221; the stockholder advisory vote regarding our
Named Executive Officers&#8217; compensation. In June 2023, approximately 88% of the stockholder votes (excluding abstained and broker
non-votes) were cast &#8220;FOR&#8221; the stockholder advisory vote regarding our Named Executive Officers&#8217; compensation. The Compensation
Committee carefully considered these results and a variety of other information, including the most recent competitive market assessment
of pay, in determining compensation structure and amounts for each of 2023 and 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Year 2024 Compensation Determinations</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2023, Pearl Meyer
provided the Compensation Committee with a compensation benchmarking report on the Company&#8217;s Peer Group along with a recommended
new Peer Group for fiscal year 2024 after review of U.S. publicly traded companies with annual revenue, EBITDA, Net Income, market capitalization,
and enterprise value approximately one-third to twice RadNet&#8217;s annual revenue whose primary operations are in the healthcare facility
and services industry. The Compensation Committee approved the proposed new Peer Group which consists of the following companies:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; width: 33%; text-align: left">Acadia Healthcare Company, Inc.</td>
    <td style="vertical-align: top; width: 34%; text-align: left">AdaptHealth Corp</td>
    <td style="vertical-align: top; width: 33%; text-align: left">Addus HomeCare Corporation</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-align: left">Amedisys, Inc.</td>
    <td style="vertical-align: top; text-align: left">Astrana Health, Inc.</td>
    <td style="vertical-align: top; text-align: left">Aveanna Healthcare Holdings Inc.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: left">InnovAge Holding Corp.</td>
    <td style="vertical-align: top; text-align: left">ModivCare Inc.</td>
    <td style="vertical-align: top; text-align: left">Option Care Health, Inc.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-align: left">Pediatrix Medical Group, Inc. (fka MEDNAX, Inc.).</td>
    <td style="text-align: left; vertical-align: top">Select Medical Holdings Corporation</td>
    <td style="vertical-align: top; text-align: left">Surgery Partners, Inc.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: left">The Ensign Group, Inc.</td>
    <td style="vertical-align: top; text-align: left">U.S. Physical Therapy, Inc.</td>
    <td style="vertical-align: top; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based in part on this report,
and after considering each executive&#8217;s contribution to the Company&#8217;s growth and record AEBITDA performance, the Compensation
Committee elected to (a) modify base salaries for the Named Executive Officers as shown in the below table and (b) make certain other
compensation decisions set forth below for 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Increase in</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Base Salary</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Base Salary as of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">January 1, 2024</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-left: 2.7pt">Howard Berger</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 2.7pt">Mark Stolper</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-left: 2.5pt">Norman Hames</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">800,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 2.5pt">Stephen Forthuber</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">800,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-left: 2.7pt">Mital Patel</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">175,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">750,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The increases in base salary
are reflective of the continuing superior Company performance especially evident in the fiscal year 2023 financial results. In the case
of the Chief Executive Officer, the increase in base salary was in part to compensate him for the many years in which he received no equity
compensation and in which his total compensation was below the median of chief executive officers in our peer group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 9, 2024, in order
to retain and further motivate the Named Executive Officers and align their interests with Company stockholder interests, the Compensation
Committee determined to provide the Named Executive Officers with the cash bonuses which were paid in January 2024 in the amount of $4,000,000,
$575,000, $650,000, $650,000, and $575,000 for Messrs. Berger, Stolper, Hames, Forthuber and Patel, respectively. The bonuses paid to
the Named Executive Officers (other than the Chief Executive Officer) were equal to 100% of 2023 base salaries. Dr. Berger&#8217;s cash
bonus amount was paid by BRMG. In addition, the Compensation Committee determined to eliminate the portion of long-term incentives previously
granted in stock options, PSOs and PSUs after a careful review of which equity vehicle would best motivate executives to achieve the strategic
plan and encourage a rapid and effective response given the Company&#8217;s opportunities for growth. The Compensation Committee determined
to provide the Named Executive Officers with grants of stock units (for those Named Executive Officers deferring receipt of the underlying
shares) or restricted shares (for those Named Executive Officers who are not deferring receipt of the underlying shares) (either &#8220;RSG
Shares&#8221;) with a grant date value approximately equal to 100% of the 2023 base salaries for the Named Executive Officers (other than
for the Chief Executive Officer). These amounts compare to the 2023 equity award values for the Named Executive Officers (other than for
the Chief Executive Officer) of 175% of salary as outlined above. Moreover, the grant date values of the 2024 equity compensation awards
to each Named Executive Officer is materially lower than the grant date values of their 2023 equity compensation awards. The table below
reflects the 2024 awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Grant Date
    Value of RSGs</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Number of RSG<br/>
  Shares(1)</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify; padding-left: 2.7pt">Howard Berger</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">55,494</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 2.7pt">Mark Stolper</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,954</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-left: 2.5pt">Norman Hames</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,036</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 2.5pt">Stephen Forthuber</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,036</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 2.7pt">Mital Patel</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">575,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,954</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify; padding-left: 2.55pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,450,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">123,474</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(1)</td><td style="text-align: justify">The number of RSG Shares is equal to the whole number (rounded
to the nearest integer) that is the quotient of the grant dollar value shown above divided by the closing price of a Company common share
as reported on Nasdaq for January 9, 2024 which was $36.04. Subject to the Named Executive Officer&#8217;s continued service, the RSG
Shares vest in three equal annual installments with one-third vesting on each of March 10, 2024, March 10, 2025 and March 10, 2026.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Taxes, Risks and other Considerations</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tax Deductibility of Compensation</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 162(m) of the Internal
Revenue Code generally places a $1 million limit on the amount of compensation a publicly held company can deduct in any tax year on compensation
paid to &#8220;covered employees.&#8221; The Compensation Committee considers tax deductibility as one of many factors in determining
executive compensation, including the impact of these tax law changes. However, the Compensation Committee believes that in certain circumstances
factors other than tax deductibility take precedence when determining the forms and levels of executive compensation most appropriate
and in our best interest and the best interest of our stockholders. Thus, executive compensation arrangements may not be tax deductible
or, if initially intended to be tax deductible, may not actually receive this treatment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risk Considerations in Our Compensation
Programs</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation Committee
reviews the concept of risk as it relates to our compensation program and does not believe our compensation program encourages excessive
or inappropriate risk taking. The Compensation Committee believes our compensation programs strike a balance between providing secure
compensation (base salaries) as well as appropriate short- and long-term incentives, such that our executive officers are not encouraged
to take unnecessary or excessive risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock Ownership</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We structure our pay to consist
of primarily fixed compensation with base salary in cash, bonuses and non-cash long-term incentive programs. Although we do not have requirements
or guidelines specifying amounts of ownership of RadNet common stock for our Named Executive Officers, we do promote and encourage the
aligning of their interests with those of our stockholders by providing them with significant equity awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recoupment of Erroneously Awarded Compensation
Policy</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2023, our Board
of Directors adopted a Policy on Recovery of Erroneously Awarded Compensation or &#8220;Clawback Policy&#8221; that is intended to deter
both financial/accounting irregularities with respect to RadNet&#8217;s financial statements and also misconduct by senior executives.
The Clawback Policy is intended to comply with the listing rules of the Nasdaq Stock Market LLC and SEC Exchange Act Rule 10D-1. The Clawback
Policy is generally administered by the Compensation Committee although the Board of Directors may administer the policy or designate
another committee to serve in such role, and may also act in conjunction with the Audit Committee. The policy applies to RadNet&#8217;s
officers and other designated key employees (collectively, &#8220;Senior Executives&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Clawback Policy,
if RadNet is required to restate any financial statements (other than due to a change in accounting policy), then the Compensation Committee
(or other designated committee) can take certain actions to recoup performance-based compensation from the Senior Executives that exceeded
the amount that would have been paid under the restated financial results, including the cancellation of equity compensation awards. Performance-based
compensation that was paid, vested or earned in the three most recent completed fiscal years prior to (a) the date the Board, a committee
of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or
reasonably should have concluded, that the Company is required to prepare an accounting restatement or (b) the date a court, regulator
or other legally authorized body directs the Company to prepare an accounting restatement, in each case regardless of if or when the restated
financial statements are filed is generally subject to recoupment. A Senior Executive that is determined to have committed &#8220;Misconduct&#8221;
(as defined under the Clawback Policy) is subject to additional measures including recoupment or cancellation or reimbursement of incentive
compensation, adjustment of future compensation, and/or disciplinary actions including termination of employment.<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_010"></span>COMPENSATION COMMITTEE REPORT*</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
has reviewed and discussed with RadNet&#8217;s management the &#8220;Compensation Discussion and Analysis&#8221; included above and unanimously
recommended to the Board of Directors that the &#8220;Compensation Discussion and Analysis&#8221; be included in this Proxy Statement
and the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Submitted by the Compensation
Committee:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lawrence L. Levitt, Chair</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Laura P. Jacobs</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gregory E. Spurlock</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David L. Swartz</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The material in this report is not &#8220;soliciting
material,&#8221; is not deemed filed with the SEC and is not to be incorporated by reference into any of our filings under the Securities
Act or the Exchange Act whether made before or after the date of this Proxy Statement and irrespective of any general incorporation language
therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Compensation Committee Interlocks and Insider
Participation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The members of our Compensation
Committee are Lawrence L. Levitt, Laura P. Jacobs, Gregory E. Spurlock, and David L. Swartz. None of our executive officers serve or have
served on the board of directors or compensation committee of another company that also has an executive officer that serves on our board
of directors or our Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_011"></span>EXECUTIVE COMPENSATION TABLES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Summary Compensation Table</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table, footnotes
and related narrative summarizes the total compensation paid to or earned by each of our Named Executive Officers for fiscal years 2023,
2022, and 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Name and Principal Position</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Stock</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Awards</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($) (1)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Option Awards</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($) (1)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other Compensation ($)(2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 31%; text-align: left; padding-left: 0.25pt">Howard G. Berger, M.D.</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 6%; text-align: right">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">1,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">2,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">1,375,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">1,750,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">75,183</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">6,700,183</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.25pt">President and Chief Executive Officer</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,555,517</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">(principal executive officer)(3)</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,308,654</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,568</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,567,222</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25pt">Mark D. Stolper</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">431,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,900,704</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><p style="margin-top: 0; margin-bottom: 0">Executive Vice President and</p>
                                 <p style="margin-top: 0; margin-bottom: 0">Chief Financial Officer</p></td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">525,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">681,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">825,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,637,463</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">(principal financial officer)</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">525,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">393,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">460,882</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,466</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,408,098</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.05pt">Stephen M. Forthuber</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">487,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,065</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,160,565</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.25pt">President and Chief Operating</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">775,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">937,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,009,758</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.05pt">Officer - Eastern Operations</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">450,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">526,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,265</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,613,986</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5pt">Norman R. Hames</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">487,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,142,960</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.25pt">President and Chief Operating</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">775,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">937,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,989,277</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.05pt">Officer - Western Operations</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">450,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">526,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,375</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,593,096</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.25pt">Mital Patel</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">431,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,918,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.1pt"><p style="margin-top: 0; margin-bottom: 0">Executive Vice President of</p>
                                                      <p style="margin-top: 0; margin-bottom: 0">Financial Planning and Analysis and</p></td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">525,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">681,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">825,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,799</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,657,049</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.1pt">Chief Administrative Officer</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">524,038</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">375,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,153,939</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,091,873</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(1)</td><td style="text-align: justify">The value for the stock awards is based on the number of shares
granted multiplied by the closing share price of our common stock on the date of grant. These are not amounts actually paid to or realized
by the Named Executive Officer. In accordance with SEC rules, the grant date fair value for stock options is calculated based on a Black
Scholes valuation of each award determined under FASB ASC 718 incorporating the following assumptions: expected life 6 years; weighted
average volatility 49.32%; risk free interest rate 3.8%; and expected dividend yield 0%. We used historical stock prices as the basis
for the volatility assumptions. The risk free interest rate was based on U.S. Treasury rates in effect at the time of grant.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(2)</td><td style="text-align: justify">For 2023, the Named Executive Officers received certain of the
following items of other compensation as specified in the following table: (a) an automobile allowance; (b) RadNet paid premiums for
coverage under RadNet&#8217;s split dollar life insurance plans; (c) a 401(k) retirement plan match from RadNet; (d) RadNet paid premiums
for group health insurance (medical, dental and vision) plans; and (e) RadNet paid premiums for life insurance and long-term disability
coverage under RadNet&#8217;s group life insurance plans.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">In 2023, Dr. Berger
and Mr. Hames utilized RadNet-provided automobiles for which it was estimated that thirty percent was used for personal purposes and RadNet
also paid for automobile insurance costs. The below figures reflect the estimated incremental cost incurred by RadNet for the personal
usage by Dr. Berger and Mr. Hames of such RadNet-provided automobiles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in">
  <tr style="vertical-align: top">
    <td style="width: 27%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; text-align: center; font-weight: bold"><span style="font-size: 10pt">Howard Berger</span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; text-align: center; font-weight: bold"><span style="font-size: 10pt">Mark Stolper</span></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: center; font-weight: bold"><span style="font-size: 10pt">Stephen Forthuber</span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; text-align: center; font-weight: bold"><span style="font-size: 10pt">Norman Hames</span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; text-align: center; font-weight: bold"><span style="font-size: 10pt">Mital Patel</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 2.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auto Allowance</span></td>
    <td style="text-align: right">&#8211;&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$9,600</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$15,000</span></td>
    <td style="text-align: right">&#8211;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$18,000</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 2.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company-provided Automobile</span></td>
    <td style="padding-left: 0.1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$13,668</span></td>
    <td style="text-align: right">&#8211;</td>
    <td style="text-align: right">&#8211;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5,460</span></td>
    <td style="text-align: right">&#8211;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 2.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Split Dollar Life</span></td>
    <td style="padding-left: 0.1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$50,835</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$924</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,120</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,313</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$440</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">401(k) Matching Contribution</span></td>
    <td style="text-align: right">&#8211;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,300</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,300</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,300</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,300</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Group Health Insurance</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10,199</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$17,649</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$27,164</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$17,906</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$27,164</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 2.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life/Disability Insurance</span></td>
    <td style="border-bottom: Black 1pt solid; padding-left: 0.1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$481</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$481</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$481</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$481</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$481</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; padding-left: 2.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$75,183</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$31,954</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$48,065</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$30,460</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$49,385</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(3)</td><td>$500,000 of the base salary and all of the cash bonus compensation
paid to Dr. Berger in each year was paid by BRMG.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Grants of Plan-Based Awards in 2023</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below sets forth
certain information with respect to grants of awards to our Named Executive Officers under the Equity Incentive Plan during 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Estimated Future Payouts Under<br/>
Equity Incentive Plan Awards</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Name/Award Type</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Grant <br/>
Date</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Threshold (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Target (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Maximum (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>All Other Stock Awards; Number
    of Shares of Stock or Units (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>All Other Option Awards: Number
    of Securities Underlying Options (#)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Exercise or Base Price of Option
    Awards ($/Sh)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Grant Date Fair Value of Stock
    and Option Awards ($) (4)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Howard G. Berger, M.D.</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; text-align: justify">-Performance based RSUs (2)</td><td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: center">1.3.23</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">20,118</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">40,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">375,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">--Time-based RSUs (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,648</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">-Performance-based Option (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">750,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">--Time-based Option (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,969</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">Mark D. Stolper (3)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">-Performance based RSUs (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">--Time-based RSUs (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">-Performance-based Option (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">--Time-based Option (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Stephen M. Forthuber</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">-Performance based RSUs (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">872</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,434</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">--Time-based RSUs (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">-Performance-based Option (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,690</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">--Time-based Option (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">Norman R. Hames</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">-Performance based RSUs (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">872</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,434</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">--Time-based RSUs (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">-Performance-based Option (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,690</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">--Time-based Option (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Mital Patel</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">-Performance based RSUs (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">--Time-based RSUs (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">-Performance-based Option (2)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">--Time-based Option (1)</td><td>&#160;</td>
    <td style="text-align: center">1.3.23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,500</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(1)</td><td style="text-align: justify">Subject to the Named Executive Officer&#8217;s continued service,
the restricted shares/RSUs vest in two equal annual installments on March 10th of 2023 and 2024. One-third of the stock options vested
on the date of grant. Subject to the Named Executive Officer&#8217;s continued service, the remaining two-thirds of the Options will
vest in two equal annual installments on March 10th of 2024 and 2025. The time-based vesting of unvested outstanding awards fully accelerates
earlier upon: (a) termination of the Named Executive Officer&#8217;s service due to his death or Disability (as defined below) or (b)
termination of the Named Executive Officer&#8217;s service either by RadNet without Cause (as defined below) or by the Named Executive
Officer for Good Reason (as defined below) or (c) a change in control of RadNet.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(2)</td><td style="text-align: justify">These awards have both time-based and performance-based vesting
conditions. The performance vesting conditions were based on attainment of AEBITDA goals established by the Compensation Committee for
calendar year 2023. These goals are more fully described above in the Fiscal Year 2023 Compensation Determinations section and the actual
level of performance achievement was 110.4% of the target AEBITDA. The maximum number of shares subject to these PSOs have an aggregate
grant date value approximately equal to the Black-Scholes option value of approximately 50% of the 2022 base salaries. The target number
of shares subject to these PSUs have an aggregate grant date value approximately equal to 25% of the 2022 base salaries. The maximum
number of PSUs that can vest is equal to 200% of the target number. The closing price of a common share on the grant date of January
3, 2023 was $18.64. The portion of the PSOs and PSUs that satisfied the AEBITDA performance vesting conditions will also be subject to
continued service vesting conditions. 50% of those performance-vested PSUs can incrementally vest on each of March 10th of 2025 and 2026.
One-third of those performance-vested PSOs can incrementally vest on each of March 10th of 2025, 2026 and 2027.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0pt"/><td style="width: 20pt; text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(3)</td><td style="text-align: justify">The equity award numbers listed above reflect the gross numbers
granted and, for Mr. Stolper, include the portions of such awards that were transferred to Mr. Stolper&#8217;s former spouse pursuant
to a domestic relations order.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0pt"/><td style="width: 20pt; text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(4)</td><td style="text-align: justify">For discussion regarding the valuation model and assumptions used
to calculate the grant date fair value of these stock and option awards, see footnote (1) to the Summary Compensation Table.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Outstanding Equity Awards at Fiscal Year End</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below summarizes
outstanding equity awards held by our Named Executive Officers at December 31, 2023. All of the below awards were issued under the Equity
Incentive Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>OPTION AWARDS</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>STOCK AWARDS</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Name</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Number of  Securities    Underlying Unexercised Options(#) Exercisable (1)(3)(6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Number of  Securities
     Underlying  Unexercised Options(#) Unexercisable (1)(3)(6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Equity  incentive
    plan  awards:  number of  securities  underlying  unexercised  unearned  options
    (#) (6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Option  Exercise
    Price($)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Option  Expiration  Date</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Number of  Shares or
     Units of  Stock That  Have Not  Vested(#)  (2)(3)(6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Market  Value of
    Shares or  Units of  Stock That  Have Not  Vested($)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that
    have Not Vested (#) (6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Equity  Incentive
    Plan  Awards:  Market or  Payout  Value  of  Unearned  Shares,  Units or  Other
     Rights That Have  Not  Vested ($) (7)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.75pt">Howard G. Berger, M.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; text-align: left; padding-left: 2.75pt">January 3, 2023 PSUs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: justify">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">40,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">1,399,006</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.75pt">January 3, 2023 PSO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.75pt">January 3, 2023 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">932,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.75pt">January 3, 2023 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69,312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.75pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.75pt">Mark D. Stolper (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2016 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.07</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/26</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 6, 2017 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/6/27</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 2, 2018 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,564</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/2/28</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.5pt">January 7, 2019 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,828</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/7/29</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 6, 2020 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/6/30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSUs(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,227</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">77,433</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,068</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">141,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSO(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,854</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,772</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,818</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 Option (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 PSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">489,283</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 PSO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,036</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">244,642</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,092</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>OPTION AWARDS</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>STOCK AWARDS</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Name</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Number of  Securities    Underlying Unexercised Options(#) Exercisable (1)(3)(6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Number of  Securities
     Underlying  Unexercised Options(#) Unexercisable (1)(3)(6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Equity  incentive
    plan  awards:  number of  securities  underlying  unexercised  unearned  options
    (#) (6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Option  Exercise
    Price($)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Option  Expiration  Date</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Number of  Shares or
     Units of  Stock That  Have Not  Vested(#)  (2)(3)(6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Market  Value of
    Shares or  Units of  Stock That  Have Not  Vested($)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that
    have Not Vested (#) (6)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Equity  Incentive
    Plan  Awards:  Market or  Payout  Value  of  Unearned  Shares,  Units or  Other
     Rights That Have  Not  Vested ($) (7)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b></b></td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.7pt; width: 28%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 7%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.65pt">Stephen M. Forthuber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2016 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.07</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/26</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 6, 2017 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,698</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/6/27</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.5pt">January 2, 2018 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,363</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/2/28</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 7, 2019 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,158</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/7/29</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.5pt">January 6, 2020 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,461</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/6/30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSUs(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">95,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,095</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">177,153</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSO(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,013</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,499</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 Option (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 PSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,434</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">606,180</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 PSO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">303,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.75pt">Norman R. Hames</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 2, 2018 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,194</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/2/28</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.5pt">January 7, 2019 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/7/29</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 6, 2020 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,461</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/6/30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSUs(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">95,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,095</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">177,153</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSO(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,013</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,499</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 Option (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 PSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,434</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">606,180</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 PSO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">303,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 2.75pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.75pt">Mital Patel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 6, 2017 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,762</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/6/27</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 2, 2018 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/2/28</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 7, 2019 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/7/29</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 6, 2020 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,401</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/6/30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSUs(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,441</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">84,874</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,458</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">155,005</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 4, 2022 PSO(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.5pt">January 4, 2022 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,952</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.5pt">January 4, 2022 Option (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/4/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.5pt">January 3, 2023 PSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">536,223</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 PSO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">268,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 2.7pt">January 3, 2023 Option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,927</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: justify; padding-left: 1.9pt">1/3/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(1)</td><td style="text-align: justify">For options granted between 2016 and 2018, one-third of the options
vest on the second anniversary of the date of grant and the remaining portion of the options vest in equal increments on the third and
fourth anniversaries of the date of grant. For options granted in 2019 and 2020, one-third of the options incrementally vest on each
of the first three anniversaries of the date of grant.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(2)</td><td style="text-align: justify">For stock/RSU awards granted before 2022, one-third of the stock/RSU
awards are fully-vested as of the date of grant and the remaining portion of the stock/RSU awards vest in equal increments on the first
and second anniversaries of the date of grant.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(3)</td><td style="text-align: justify">One-third of the restricted shares/RSUs granted in 2022 vested
on the date of grant. Subject to the Named Executive Officer&#8217;s continued service, the remaining restricted shares/RSUs vested in
two equal annual installments on January 3rd of 2023 and 2024. One-third of the stock options granted in 2022 vested on the date of grant.
Subject to the Named Executive Officer&#8217;s continued service, the remaining two-thirds of these options vest in three equal annual
installments on January 2nd of 2023, 2024 and 2025. The time-based vesting of unvested outstanding awards fully accelerates earlier upon:
(i) termination of the Named Executive Officer&#8217;s service due to his death or Disability or (ii) termination of the Named Executive
Officer&#8217;s service either by RadNet without Cause or by the Named Executive Officer for Good Reason or (iii) a change in control
of RadNet.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(4)</td><td style="text-align: justify">These stock options vested on January 4, 2023.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(5)</td><td style="text-align: justify">Performance awards granted in 2022 have both time-based and performance-based
vesting conditions. The performance vesting conditions were based on attainment of AEBITDA goals established by the Compensation Committee
for calendar year 2022. The actual level of performance achievement was 95% of the target AEBITDA. The maximum number of shares subject
to these PSOs had an aggregate grant date value approximately equal to the Black-Scholes option value of approximately 50% of the 2022
base salaries. The target number of shares subject to these PSUs have an aggregate grant date value approximately equal to 25% of the
2022 base salaries. The maximum number of PSUs that could vest was equal to 200% of the target number. The closing price of a common
share on the grant date of January 4, 2022 was $29.44. The portion of the PSOs and PSUs that satisfied the AEBITDA performance vesting
conditions (which figures are reflected in the above table) are also subject to continued service vesting conditions. 50% of those performance-vested
PSUs can incrementally vest on each of January 4th of 2024 and 2025. One-third of those performance-vested PSOs can incrementally vest
on each of January 4th of 2024, 2025 and 2026.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(6)</td><td style="text-align: justify">For awards granted in 2023, see footnotes (1) through (3) to the
above Grants of Plan-Based Awards Table. All options have a maximum ten-year term from their date of grant. The time-based vesting of
unvested outstanding awards fully accelerates earlier than the above scheduled vesting upon: (a) termination of the Named Executive Officer&#8217;s
service due to his death or Disability or (b) termination of the Named Executive Officer&#8217;s service either by RadNet without Cause
or by the Named Executive Officer for Good Reason or (c) a change in control of RadNet. The figures reflected in the above table for
the PSUs granted in 2023 reflect the maximum possible number of PSUs that could become performance vested.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(7)</td><td style="text-align: justify">The aggregate market value is determined by multiplying the number
of shares that have not vested by $34.77 per share, the last closing price of our common stock as of December 29, 2023.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(8)</td><td style="text-align: justify">The equity award numbers listed above are net of the portions
transferred to Mr. Stolper&#8217;s former spouse pursuant to a domestic relations order.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Option Exercises and Stock Vested During
2023</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information for the Named Executive Officers regarding the value realized during 2023 pursuant to the vesting of restricted stock, or
RSUs, and exercised stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">OPTION AWARDS</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">STOCK</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">AWARDS</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares Acquired on Exercise (#)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Value Realized on Exercise ($)<sup>(1)</sup></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares Acquired on Vesting (#)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Value Realized on Vesting ($)<sup>(3)</sup></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: justify; padding-left: 0.25pt">Howard G. Berger, M.D.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">26,824</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">627,413</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.25pt">Mark D. Stolper</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,998</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">445,427</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-left: 0.05pt">Stephen M. Forthuber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">554,517</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman R. Hames<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,306</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,413,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">554,517</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-left: 0.25pt">Mital Patel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,772</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">481,820</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(1)</td><td style="text-align: justify">The value realized on option exercise is equal to the product
of the number of shares that were exercised multiplied by the difference between the per share closing price of our common stock on the
exercise date and the option&#8217;s per share exercise price.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(2)</td><td style="text-align: justify">On June 2, 2023, Mr. Hames exercised a stock option, with a $6.07
per share exercise price, and acquired 39,127 shares. On June 2, 2023, Mr. Hames exercised another stock option, with a $6.30 per share
exercise price, and acquired 19,179 shares. The closing share price of our common stock on June 2, 2023 was $30.38.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(3)</td><td style="text-align: justify">The value realized on vesting is equal to the product of the number
of shares that became vested multiplied by the per share closing price of our common stock on the vesting date. The below table shows
the details of the figures reported in the above table. The figures shown for Mr. Stolper are net of the portions of his equity compensation
awards that were transferred to his former spouse pursuant to a domestic relations order.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Grant Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Vesting Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Closing Share Price on Vesting Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Number of Shares Vesting (#)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Value Realized on Vesting Date ($)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 40%; text-align: left; padding-left: 0.25pt">Howard G. Berger, M.D.</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">1/3/23</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">3/10/23</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">$23.39</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">26,824</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">627,413</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.05pt">Mark D. Stolper</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">$18.64</td><td>&#160;</td>
    <td style="text-align: right">4,068</td><td>&#160;</td>
    <td style="text-align: right">75,828</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 0.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/21</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">6,439</td><td>&#160;</td>
    <td style="text-align: right">121,182</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 0.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">4,455</td><td>&#160;</td>
    <td style="text-align: right">83,843</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 0.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">3/10/23</td><td>&#160;</td>
    <td style="text-align: right">$23.39</td><td>&#160;</td>
    <td style="text-align: right">7,036</td><td>&#160;</td>
    <td style="text-align: right">164,572</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.05pt">Stephen M. Forthuber</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">$18.64</td><td>&#160;</td>
    <td style="text-align: right">5,095</td><td>&#160;</td>
    <td style="text-align: right">94,971</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/21</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">8,064</td><td>&#160;</td>
    <td style="text-align: right">151,764</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">5,519</td><td>&#160;</td>
    <td style="text-align: right">103,868</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">3/10/23</td><td>&#160;</td>
    <td style="text-align: right">$23.39</td><td>&#160;</td>
    <td style="text-align: right">8,718</td><td>&#160;</td>
    <td style="text-align: right">203,914</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 0.25pt">Norman R. Hames</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">$18.64</td><td>&#160;</td>
    <td style="text-align: right">5,095</td><td>&#160;</td>
    <td style="text-align: right">94,971</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 0.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/21</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">8,064</td><td>&#160;</td>
    <td style="text-align: right">151,764</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 0.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">5,519</td><td>&#160;</td>
    <td style="text-align: right">103,868</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 0.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">3/10/23</td><td>&#160;</td>
    <td style="text-align: right">$23.39</td><td>&#160;</td>
    <td style="text-align: right">8,718</td><td>&#160;</td>
    <td style="text-align: right">203,914</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.25pt">Mital Patel</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">$18.64</td><td>&#160;</td>
    <td style="text-align: right">4,458</td><td>&#160;</td>
    <td style="text-align: right">83,097</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/21</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">6,720</td><td>&#160;</td>
    <td style="text-align: right">126,470</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/4/22</td><td>&#160;</td>
    <td style="text-align: right">1/4/23</td><td>&#160;</td>
    <td style="text-align: right">$18.82</td><td>&#160;</td>
    <td style="text-align: right">4,882</td><td>&#160;</td>
    <td style="text-align: right">91,879</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/3/23</td><td>&#160;</td>
    <td style="text-align: right">3/10/23</td><td>&#160;</td>
    <td style="text-align: right">$23.39</td><td>&#160;</td>
    <td style="text-align: right">7,712</td><td>&#160;</td>
    <td style="text-align: right">180,383</td></tr>
  </table>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pension Benefits and Nonqualified Deferred
Compensation Plans</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not have any tax-qualified
defined benefit plans or supplemental executive retirement plans that provide for payments or other benefits to our Named Executive Officers
in connection with their retirement. However, we do have the Deferred Compensation Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The employment arrangements
of three of our Named Executive Officers include a required payment of deferred compensation upon termination of employment in certain
situations. The following table shows the contributions, earnings and distributions of nonqualified deferred compensation during the fiscal
year ended December&#160;31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nonqualified Deferred Compensation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Name</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Executive
    Contributions in Last Fiscal Year ($)</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Registrant
    Contributions in Last Fiscal Year ($)</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Aggregate Earnings in Last
    Fiscal Year ($)(3)</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Aggregate
    Withdrawals/<br/>
Distributions ($)</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>Aggregate
    Balance at Last Fiscal Year End ($)(6)</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: justify">Howard G. Berger, M.D. (1)(4)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,749,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,514,349</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,764,347</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Mark D. Stolper (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">524,641</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,764,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,394,739</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Norman R. Hames (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,039,958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">851,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,011,252</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(1)</td><td style="text-align: justify">In 2023, Dr. Berger elected to defer receipt of his 2023 stock
grants, resulting in his receipt of 93,884 RSUs/PSUs (with the number of PSUs reflecting the maximum possible number of PSUs that could
become vested) from two grants on January 3, 2023. On the date of grant of these RSUs/PSUs, the Company share price was $18.64. On December
29, 2023 the Company share price was $34.77. For Dr. Berger, $1,375,000 has been reported as compensation in the Summary Compensation
Table for 2023. As of December 29, 2023, Dr. Berger was holding a total of 93,884 RSUs/PSUs.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(2)</td><td style="text-align: justify">In 2023, Mr. Stolper elected to defer receipt of his 2023 stock
grants (net of shares transferred to his former spouse pursuant to a domestic relations order), resulting in his receipt of 28,146 RSUs/PSUs
(with the number of PSUs reflecting the maximum possible number of PSUs that could become vested) from two grants on January 3, 2023.
On the date of grant of these RSUs/PSUs, the Company share price was $18.64. On December 29, 2023 the Company share price was $34.77.
For Mr. Stolper, $431,250 has been reported as compensation in the Summary Compensation Table for 2023, which represents the value of
these RSU/PSU grants prior to the transfer of shares to his former spouse in accordance with a domestic relations order. As of December
29, 2023, Mr. Stolper was holding a total of 155,155 RSUs/PSUs.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(3)</td><td style="text-align: justify">Amount represents stock price appreciation in 2023 on all RSUs/PSUs
and gains on notional investments made under the Excess Plan. No portion of any such appreciation or depreciation has been reported as
compensation in the Summary Compensation Table for 2023.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(4)</td><td style="text-align: justify">Pursuant to the Management Consulting Agreement dated as of January
1, 1994, as amended, between Dr. Berger and BRMG, upon Dr. Berger&#8217;s resignation or RadNet&#8217;s termination of his employment
without cause by the Company, Dr. Berger is entitled to receive an amount equal to five times his 2010 base salary paid by BRMG (and
$2,500,000 is included in the Aggregate Balance column). Upon termination of his employment by the Company for cause, Dr. Berger is entitled
to an amount equal to his 2010 base salary paid by BRMG. Dr. Berger&#8217;s 2010 base salary as paid by BRMG was $500,000. Such post-employment
payment is subject to post-termination covenants intended to protect RadNet&#8217;s business.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(5)</td><td style="text-align: justify">In 2023, Mr. Hames elected to defer receipt of his 2023 stock
grants, resulting in his receipt of 34,869 RSUs/PSUs (with the number of PSUs reflecting the maximum possible number of PSUs that could
become vested) from two grants on January 3, 2023. On the date of grant of these RSUs/PSUs, the Company share price was $18.64. On December
29, 2023 the Company share price was $34.77. Pursuant to the Employment Agreement dated as of September 1, 2022, upon Mr. Hames&#8217;
resignation or RadNet&#8217;s termination of employment without cause, Mr. Hames is entitled to receive an amount equal to three times
his 2010 base salary (and $1,050,000 is included the Aggregate Balance column). Upon termination of his employment by the Company for
cause, Mr. Hames is entitled to an amount equal to his 2010 base salary. Mr. Hames&#8217; 2010 base salary was $350,000. Such post-employment
payment is subject to post-termination covenants intended to protect RadNet&#8217;s business. Mr. Hames&#8217; balance under the Excess
Plan as of December 31, 2023 was $1,748,857. For Mr. Hames, $877,500 has been reported as compensation in the Summary Compensation Table
for 2023. As of December 29, 2023, Mr. Hames was holding a total of 34,869 RSUs/PSUs.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: justify">(6)</td><td style="text-align: justify">Of the $5,764,347 reported for Dr. Berger, $1,375,000 is reported
in the Summary Compensation Table for 2023 and a total of $0 was reported for Dr. Berger in the Summary Compensation Table for prior
years. Of the $5,394,739 reported for Mr. Stolper, $431,250 is reported in the Summary Compensation Table for 2023 and a total of $1,575,543
was reported for Mr. Stolper in the Summary Compensation Table for prior years. Of the $4,011,252 reported for Mr. Hames, $877,500 is
reported in the Summary Compensation Table for 2023 and a total of $1,209,615 was reported for Mr. Hames in the Summary Compensation
Table for prior years.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employment Agreements</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 1, 2022, RMI
entered into new executive employment agreements (each an &#8220;Agreement&#8221; and together the &#8220;Agreements&#8221;) with our
Named Executive Officers other than Dr. Berger (whose Agreement with RMI was executed on April 20, 2023), pursuant to which each such
Named Executive Officer will continue to be employed by RMI under the terms and conditions of the Agreements. Under the Agreements, employment
is &#8220;at will&#8221; and may be terminated by either RMI or the Named Executive Officer at any time. The Agreements generally have
uniform terms and conditions and they replace and supersede all existing employment agreements although certain individual-specific legacy
provisions from the former agreements are retained in the Agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Agreements, each
Named Executive Officer is eligible to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(a)</td><td style="text-align: justify">receive an annual base salary (subject to adjustment in the discretion
of our Board of Directors or its compensation committee);</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(b)</td><td style="text-align: justify">participate in bonus and incentive compensation plans (Dr. Berger&#8217;s
bonuses are paid by BRMG);</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(c)</td><td style="text-align: justify">receive full vesting of the time-based vesting portions of their
outstanding equity compensation awards upon a &#8220;change in control&#8221; of the Company (which term is defined in the Equity Incentive
Plan);</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(d)</td><td style="text-align: justify">receive reimbursement for all reasonable business expenses and
be covered under directors and officers liability insurance coverage;</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(e)</td><td style="text-align: justify">receive six weeks annual paid vacation in accordance with RMI&#8217;s
vacation policy for employees and receive medical, disability and life insurance coverage and such sick leave and holiday benefits, if
any, and any other benefits as are made available to executive officers generally; and</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(f)</td><td style="text-align: justify">receive transportation assistance in the form of either a RMI
provided automobile or in the form of a monthly automobile allowance.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon termination of employment
for any reason RMI shall pay or provide to the Named Executive Officer, or the Named Executive Officer&#8217;s estate, the annual base
salary, prorated through the date of termination. Unless his employment is terminated due to his death or disability, Mr. Hames will (on
his termination date) also receive a lump sum payment of $1,050,000 (the &#8220;Hames Termination Payment&#8221;) (or $350,000 if his
employment was terminated for Cause (as defined in his Agreement)).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Named
Executive Officer&#8217;s employment by RMI is terminated due to the Named Executive Officer&#8217;s death, then:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(a)</td><td style="text-align: justify">the Named Executive Officer&#8217;s representative shall have
up until the first anniversary of the termination of employment (or the applicable expiration date if earlier) to exercise the Named
Executive Officer&#8217;s vested stock options; and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(b)</td><td style="text-align: justify">the Named Executive Officer shall receive full vesting of the
time-based vesting portions of the Named Executive Officer&#8217;s outstanding equity compensation awards.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Named
Executive Officer&#8217;s employment by RMI is terminated due to the Named Executive Officer&#8217;s Disability, then:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(a)</td><td style="text-align: justify">the Named Executive Officer shall receive the same benefits provided
above in the case of the Named Executive Officer&#8217;s death; and</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(b)</td><td style="text-align: justify">the Named Executive Officer shall receive a lump sum payment
(within 15 days after the effectiveness of the required release of claims) in an amount equal to the sum of the Named Executive Officer&#8217;s
then annual base salary plus the greater of the Named Executive Officer&#8217;s prior year annual cash bonus or the average of the Named
Executive Officer&#8217;s prior three years annual cash bonus (the greater of such two bonuses is the &#8220;Severance Bonus&#8221;).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Named
Executive Officer&#8217;s employment by RMI is terminated either by RMI without Cause, or by the Named Executive Officer for Good Reason
(either a &#8220;Qualifying Termination&#8221;), then:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(a)</td><td style="text-align: justify">the Named Executive Officer shall receive severance in an amount
equal to the Severance Pay (defined below);</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(b)</td><td style="text-align: justify">the Named Executive Officer shall receive full vesting of the
time-based vesting portions of the Named Executive Officer&#8217;s outstanding equity compensation awards; and</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(c)</td><td style="text-align: justify">RMI shall (l) pay the cost of the premium for the Named Executive
Officer to receive continuation coverage (as defined in the Consolidation Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;))
under RMI&#8217;s (or the Company&#8217;s) group medical plan until the earlier of (i) the second anniversary of the termination date
or (ii) the maximum time for which COBRA continuation coverage is permitted under applicable law or (iii) the date on which the Named
Executive Officer obtains substantially equivalent benefits from another party and (2) continue to provide the Named Executive Officer
with life insurance coverage in accordance with RMI&#8217;s (or the Company&#8217;s) benefits program until the earlier of (i) the second
anniversary of the termination date or (ii) the date on which the Named Executive Officer obtains substantially equivalent benefits from
another party. If the Named Executive Officer was not then covered under the applicable benefit plan at the time of termination then
RMI shall pay the Named Executive Officer the cash equivalent for such benefit.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the above,
&#8220;Severance Pay&#8221; means a dollar amount that is equal to: (a) if the number of the Named Executive Officer&#8217;s years of
service with RMI is less than five, the Named Executive Officer&#8217;s then annual base salary, (b) if the number of the Named Executive
Officer&#8217;s years of service with RMI is at least five but less than ten, the sum of the Named Executive Officer&#8217;s then annual
base salary plus the Severance Bonus, or (c) if the number of the Named Executive Officer&#8217;s years of service with RMI is at least
ten, the sum of 200% of the Named Executive Officer&#8217;s then annual base salary plus 200% of the Severance Bonus. In the case of Dr.
Berger, Severance Pay would be reduced by $2,500,000 (which is an amount he would be paid under his Management Consulting Agreement with
BRMG). In the case of Mr. Hames, Severance Pay would be reduced by the Hames Termination Payment. All of the Named Executive Officers
presently have accumulated more than ten years of service with RMI. The Severance Pay would generally be paid out in equal installments
over the twenty-four months after termination except that for Mr. Forthuber it would be paid in a single lump sum within 15 days after
the effectiveness of the required release of claims if the termination occurred within one year after a change in control and Mr. Stolper
it would be paid in a single lump sum within 15 days after the effectiveness of the required release of claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to receive any of
the above post termination compensation and benefits for a Qualifying Termination or termination due to death or disability, the Named
Executive Officer or his representative must timely sign and not revoke a complete and general release of claims in a form to be reasonably
determined by RMI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below are summaries of certain
definitions contained in the Agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>Cause</i>&#8221;
shall generally mean any one or more of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(i)</td><td style="text-align: justify">the Named Executive Officer&#8217;s conviction of (or plea of
guilty or nolo contendere to) (A) any felony or (B) any misdemeanor involving fraud or dishonesty in connection with the performance
of his duties hereunder or moral turpitude;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(ii)</td><td style="text-align: justify">the willful and continued failure of the Named Executive Officer
to substantially perform his duties with RMI (other than any such failure resulting from illness or Disability) after a written demand
for substantial performance from the Named Executive Officer is delivered to the Named Executive Officer, which demand identifies the
manner in which it is claimed the Named Executive Officer has not substantially performed his duties;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(iii)</td><td style="text-align: justify">the Named Executive Officer has willfully engaged in misconduct
which has, or can reasonably be expected to have, a material adverse effect on the Group; or</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(iv)</td><td style="text-align: justify">the Named Executive Officer material breach of the Agreement
or any other written agreement with the Group.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No act or failure to act on
the Named Executive Officer&#8217;s part shall be considered &#8220;willful&#8221; unless the Named Executive Officer acted in bad faith
or without a reasonable belief that the Named Executive Officer&#8217;s action or omission was in the best interest of the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Solely to the extent that
our Board of Directors determines in its reasonable discretion that the Cause conduct is curable, the Named Executive Officer shall have
ten (10) business days after receipt of notice that the Group believes it has grounds to terminate the Named Executive Officer&#8217;s
employment for Cause to entirely cure the Cause conduct under subsections (ii) through (iv) above and its consequences to the satisfaction
of our Board of Directors and thereby avoid termination of the Named Executive Officer&#8217;s employment for Cause if so determined by
our Board of Directors in its sole discretion. During any time period when the Group believes that (or is in the process of investigating
whether) the Named Executive Officer may have committed an act of Cause (or has committed an act which could result in constituting Cause
under any of the above subsection), RMI may in its discretion place the Named Executive Officer on a leave of absence and/or preclude
the Named Executive Officer from utilizing Group resources or having access to Group premises. If after the Named Executive Officer&#8217;s
termination date which occurred due to a reason other than termination by RMI for Cause, the Group discovers that the Named Executive
Officer&#8217;s employment could have been terminated for Cause, then the Group may in its discretion recharacterize such termination
as a termination for Cause.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>Disability</i>&#8221;
generally means that for a period of at least 120 days during any twelve (12) consecutive month period on account of a mental or physical
condition, the Named Executive Officer is unable to perform the essential functions of his job for RMI, with or without reasonable accommodation.
The determination of the Named Executive Officer&#8217;s Disability shall be made by a medical physician selected or agreed to by the
Group unless there is mutual agreement of RMI and the Named Executive Officer or his personal representative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>Group</i>&#8221;
means the Company and its affiliated entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>Good Reason</i>&#8221;
generally means any one or more of the following have occurred without the Named Executive Officer&#8217;s prior written consent:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(i)</td><td style="text-align: justify">RMI&#8217;s material breach of the Agreement or any other written
agreement between the Company and the Named Executive Officer; or</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(ii)</td><td style="text-align: justify">an Adverse Change in Duties.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the above
clause (ii), &#8220;Adverse Change in Duties&#8221; generally means an action or series of actions taken by RMI and/or its board of directors
or the Company Board of Directors, without the Named Executive Officer&#8217;s prior written consent, which results in any one or more
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(i)</td><td style="text-align: justify">a change in the Named Executive Officer&#8217;s reporting structure,
positions, titles, job duties or job functions which results in a material diminution of his status, control, authority or level of responsibility;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(ii)</td><td style="text-align: justify">a requirement by RMI that Employee be based or perform his duties
more than ten miles away from his primary work location;</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(iii)</td><td style="text-align: justify">a reduction by RMI in the Named Executive Officer&#8217;s base
compensation; or</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">(iv)</td><td style="text-align: justify">for each of the first two complete fiscal years immediately following
the fiscal year in which a change in control of RadNet occurs, the Named Executive Officer&#8217;s post change in control annual incentive
compensation is less than a calculated annual incentive compensation threshold. This threshold is the lesser of $1 million or 50% of
a specified pre change in control annual paid incentive compensation amount.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order for the Named Executive
Officer to resign his employment for Good Reason, the Named Executive Officer must provide written notice to the Company within ninety
(90) days of the initial existence of the alleged Good Reason event and such notice must reasonably describe the facts claimed by the
Named Executive Officer to constitute Good Reason and the alleged Good Reason event remains unremedied by the Company for a period of
sixty (60) days following the Company&#8217;s receipt of such written notice and the Named Executive Officer must resign his employment
for Good Reason within sixty (60) business days after the expiration of the Company&#8217;s sixty (60) day remedy period in which the
Company did not cure or remedy the Good Reason event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Agreements also contain
provisions regarding, among other things, confidential information, governing law, dispute resolutions and covenants governing the Named
Executive Officer&#8217;s conduct.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Agreements were each amended
as of January 1, 2024 solely to reflect the adjustments to base salary (as described above). All other terms of the Agreements remained
unchanged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The below summarizes the employment
agreement for the Chief Executive Officer which was operative for some of fiscal year 2023 but which was superseded by his Agreement as
described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Dr. Berger<b>. </b></i>Dr.
Berger has a Management Consulting Agreement with BRMG dated January 1, 1994 and had an employment agreement with us dated as of June
12, 1992, as amended. The terms of this now superseded employment agreement provided for a base salary which was subsequently amended
from time to time and, which as of January 1, 2023, was $1,500,000. Under the terms of the Management Consulting Agreement, in the event
of termination (other than due to death or disability) or voluntary resignation &#8220;without cause,&#8221; upon his termination date
Dr. Berger is entitled to receive a severance payment in an amount equal to five times his 2010 BRMG annual compensation, or $2,500,000,
such amount also payable in certain other circumstances as set forth under the &#8220;Nonqualified Deferred Compensation&#8221; section
above. Separately, in the event of termination &#8220;for cause&#8221; by BRMG, Dr. Berger is entitled to receive compensation in an amount
equal to his 20l0 annual base compensation from an affiliate of BRMG, or $500,000. BRMG may terminate Dr. Berger&#8217;s consulting services
&#8220;for cause&#8221; if (1) there is a material breach by Dr. Berger of the agreement which persists for more than thirty (30) days
after notice of such breach has been provided, (2) Dr. Berger willfully breaches or habitually neglects his duties, (3) Dr. Berger commits
any acts of a criminal nature, fraud, dishonest misrepresentations or any acts of moral turpitude, (4) Dr. Berger&#8217;s professional
license is suspended, revoked or terminated or (5) Dr. Berger is convicted of a felony or of fraud involving payments or charges for professional
medical services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Potential Payments Upon Termination or Change
in Control</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payments Made Upon Termination</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regardless of the manner in
which the employment of a Named Executive Officer is terminated, he is entitled to receive vested amounts that were earned during his
term of employment. Such amounts include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">non-equity incentive compensation earned, to the extent vested;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">equity awarded pursuant to our Equity Incentive Plan, to the
extent vested, including without limitation amounts accrued under the Deferred Compensation Plans; and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">unused vacation pay.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing items will be
provided in connection with any termination of employment. In addition, except if termination of employment was due to death, Dr. Berger
and Mr. Hames will also receive certain termination payments specified above in the Employment Agreements section.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payments Made Upon Death or Disability</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of the death
of a Named Executive Officer resulting in termination of employment, the Named Executive Officer&#8217;s beneficiaries will receive life
insurance proceeds: (a) the COLI policy death benefit proceeds payable would be $5 million for Dr. Berger and $1 million for each of the
other Named Executive Officers and (b) the group life insurance plans death benefit proceeds payable would be $20,000 for Dr. Berger and
$100,000 for each of the other Named Executive Officers. In the event of the Disability of a Named Executive Officer (other than the Chief
Executive Officer) resulting in termination of employment the Named Executive Officer shall receive a lump sum payment in an amount equal
to the sum of the Named Executive Officer&#8217;s then annual base salary plus the greater of the Named Executive Officer&#8217;s prior
year annual cash bonus or the average of the Named Executive Officer&#8217;s prior three years annual cash bonus. Tn the event of either
the death or Disability of a Named Executive Officer resulting in termination of employment, the time vesting portions of all of the Named
Executive Officer&#8217;s outstanding unvested equity compensation awards will become vested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Severance and Change in Control Arrangements</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our employment
agreements with our Named Executive Officers, we have severance obligations to the Named Executive Officers upon certain terminations
of employment as discussed above under the heading &#8220;Employment Agreements.&#8221; Additionally, the employment agreements provide
for full vesting of time-based vesting conditions of outstanding equity compensation awards upon a change in control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quantitative Estimates</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
numerical estimates of potential payments upon termination of service or a change in control and assumes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The applicable triggering event occurred on December 31, 2023.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The price per share used to calculate the value of equity compensation
awards was $34.77 which was our last closing price per share as of December 29, 2023 which was the last trading day for fiscal year 2023.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The value of a share underlying equity compensation awards is
assumed to be the difference between $34.77 minus any applicable purchase or exercise price.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">All unvested equity compensation awards are assumed to become
vested upon a (a) Qualifying Termination or (b) change in control with performance awards vesting at their maximum levels.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The unused vacation pay has been estimated using the maximum
permitted accrual amount for each Named Executive Officer under the applicable vacation policy. These maximum limits are as follows:
Dr. Berger &#8211; 160 hours; Messrs. Stolper and Hames &#8211; 320 hours each; Messrs. Forthuber and Patel &#8211; 400 hours each.</td>
</tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The estimated premium for each Named Executive Officer to receive
(a) COBRA continuation coverage under RMI&#8217;s (or the Company&#8217;s) group medical plan until the second anniversary of the officer&#8217;s
termination date and (b) continued life insurance coverage in accordance with RMI&#8217;s (or the Company&#8217;s) benefits program until
the second anniversary of the officer&#8217;s termination date are provided in the below table:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">COBRA Continuation($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life Insurance($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 64%; text-align: left">Howard G. Berger, M.D.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">21,464</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">101,669</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Mark D. Stolper</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,151</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,847</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Stephen M. Forthuber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,240</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Norman R. Hames</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,767</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,626</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Mital Patel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67,353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">880</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The below dollar amounts are estimates only for a particular
point in time and do not necessarily reflect the actual amounts that would be paid to a Named Executive Officer upon a triggering event.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Resignation<br/> without Good Reason ($)</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Termination<br/> for Cause<br/> ($)</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Termination<br/> due to Death<br/> ($)</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Termination Due to Disability</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Resignation for Good Reason or Termination without Cause <br/> ($)</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change in<br/> Control<br/> ($)</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Howard G. Berger, M.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 28%; text-align: left">Cash Separation Payments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,020,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Excess Plan Deferred Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Continuation of Health/Life Insurance Benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">123,133</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued Unused Vacation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">173,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">173,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">173,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">173,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">173,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Previously Vested RSU/Option Awards</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">559,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">559,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">559,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">559,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">559,017</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Acceleration of Vesting of RSU/Option Awards</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,707,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,707,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,707,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,707,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,232,094</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">673,077</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">10,459,526</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,439,526</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">14,062,659</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,266,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 28%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 9%">&#160;</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Mark D. Stolper</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash Separation Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Excess Plan Deferred Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Continuation of Health/Life Insurance Benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">39,998</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued Unused Vacation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Previously Vested RSU/Option Awards</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,880,944</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,441,937</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,880,944</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,880,944</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,880,944</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,880,944</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Acceleration of Vesting of RSU/Option Awards</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,334,972</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,334,972</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,334,972</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,334,972</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">7,969,406</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,530,399</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">10,404,378</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">10,404,378</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,544,375</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">9,215,916</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Stephen M. Forthuber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash Separation Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Excess Plan Deferred Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Continuation of Health/Life Insurance Benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">69,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued Unused Vacation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Previously Vested RSU/Option Awards</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,009,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,009,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,009,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,009,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,009,783</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Acceleration of Vesting of RSU/Option Awards</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,745,231</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,745,231</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,745,231</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,745,231</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,134,783</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">125,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,980,014</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">7,130,014</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">8,449,254</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,755,014</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Norman R. Hames</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash Separation Payments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,050,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">350,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Excess Plan Deferred Compensation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,748,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,748,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,748,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,748,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,748,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,748,857</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Continuation of Health/Life Insurance Benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">51,393</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued Unused Vacation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Previously Vested RSU/Option Awards</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,044,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,007</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,044,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,044,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,044,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,044,040</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Acceleration of Vesting of RSU/Option Awards</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,656,672</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,656,672</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,656,672</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,656,672</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,942,897</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,228,864</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,649,569</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,799,569</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">7,100,962</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,449,569</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Mital Patel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash Separation Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Excess Plan Deferred Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Continuation of Health/Life Insurance Benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">68,233</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued Unused Vacation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">110,577</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">110,577</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">110,577</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">110,577</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">110,577</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Previously Vested RSU/Option Awards</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,170,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,170,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,170,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,170,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,170,313</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Acceleration of Vesting of RSU/Option Awards</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,463,020</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,463,020</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,463,020</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,463,020</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,280,890</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">110,577</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,843,909</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,843,909</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,012,143</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,633,332</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pay Ratio Disclosure</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under SEC rules we are required
to disclose the ratio of our median employee&#8217;s total annual compensation to the total annual compensation of Dr. Berger, our principal
executive officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the median
employee, we prepared a list of all employees as of December 31, 2023. We excluded 90 employees based in our international locations (Canada-31,
the Netherlands-41, the United Kingdom-8, Germany-3, Romania-2, Spain-2, Bulgaria-1 Finland-1 and Portugal-1) because they represented
less than 1% of our total employees and their exclusion did not have a material effect on the median calculation. We do not grant equity
compensation awards widely to our employees, and consequently determined that annual gross wages is an appropriate compensation metric
to utilize. We selected our median employee based on the annual gross wages reflected in our payroll records in 2023, which includes part-time,
temporary and international employees (we do not have any seasonal employees).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2023, the pay ratio calculation
is as follows, showing that for 2023, the PEO&#8217;s total annual compensation was 160 times that of the median of the total annual compensation
of all employees other than the PEO:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top; background-color: rgb(238,238,238)">
  <td style="width: 80%">Median Employee Annual Total Compensation </td>
  <td style="text-align: right; width: 20%">$41,909</td></tr>

<tr style="vertical-align: top; background-color: White">
  <td style="width: 80%">Dr. Berger (&#8220;PEO&#8221;) Annual Total Compensation</td>
  <td style="text-align: right; width: 20%">$6,700,183</td></tr>

<tr style="vertical-align: top; background-color: rgb(238,238,238)">
  <td style="width: 80%">Ratio of PEO to Median Employee Compensation</td>
  <td style="text-align: right; width: 20%">160:1</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the SEC rules for
identifying the median employee and calculating the pay ratio based on that employee&#8217;s total annual compensation allow companies
to use a variety of methodologies, to apply certain exclusions and to make reasonable estimates and assumptions that reflect their employee
populations and compensation practices, the pay ratio reported by other companies may not be comparable to our pay ratio, as other companies
may utilize different methodologies, exclusions, estimates and assumptions in calculating their pay ratios. These companies may also operate
in different industries and different geographic locations, be of a different size, have different revenues, earnings and market capitalization
and be subject to different regulations than RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pay Versus Performance</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As required by Section 953(a)
of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information
about the relationship between executive compensation actually paid and certain financial performance of the Company. The disclosures
included in this section are prescribed by SEC rules and do not necessarily align with how the Company, our Board, or the Compensation
Committee view the link between the Company&#8217;s performance and Named Executive Officer pay, and neither the Board nor the Compensation
Committee uses compensation actually paid as the basis for making compensation decisions. The tabular disclosure and the following graphs
were calculated in accordance with SEC rules and do not fully represent the actual final amount of compensation earned by or actually
paid to our Named Executive Officers during the applicable fiscal years. For further information concerning the Company&#8217;s pay-for-performance
philosophy and how the Company&#8217;s aligns executive compensation with the Company&#8217;s performance, refer to the above Compensation
Discussion and Analysis section.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pay Versus Performance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000013" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_883_eecd--PvpTableTextBlock_zmy4QvebPoVl" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of Initial Fixed $100 Investment Based On:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Summary Compensation Table Total for PEO<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>1</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Compensation Actually Paid to PEO<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>2</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Average Summary Compensation Table Total for Non-PEO Named Executive Officers<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>3</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Average Compensation Actually Paid to Non-PEO Named Executive Officers<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>4</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Total Shareholder Return<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>5</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Peer Group Total Shareholder Return<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>6</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Net Income (millions)<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>7</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Adjusted EBITDA (millions)<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>8</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">(a)</td><td>&#160;</td>
    <td style="text-align: center">(b)</td><td>&#160;</td>
    <td style="text-align: center">(c)</td><td>&#160;</td>
    <td style="text-align: center">(d)</td><td>&#160;</td>
    <td style="text-align: center">(e)</td><td>&#160;</td>
    <td style="text-align: center">(f)</td><td>&#160;</td>
    <td style="text-align: center">(g)</td><td>&#160;</td>
    <td style="text-align: center">(h)</td><td>&#160;</td>
    <td style="text-align: center">(i)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 11%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zb1gN72bmHNj" title="Summary Compensation Table Total for PEO" style="width: 11%; text-align: center">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,700,183</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDIp_zKs14lVHgZGa" title="Compensation Actually Paid to PEO" style="width: 10%; text-align: center">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,101,435</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zk8oeLWwT7ud" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="width: 10%; text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,030,591</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zt44keS1CCqk" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="width: 10%; text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,585,219</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_zUlvVwmlSPs2" title="Total Shareholder Return Amount" style="width: 10%; text-align: center">$<ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000023" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">171.28</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDYp_zHYIHrtNeLE6" title="Peer Group Total Shareholder Return Amount" style="width: 10%; text-align: center">$<ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000025" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">143.18</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn4n6_c20230101__20231231_fKDcp_zQL9SVC32p33" title="Net Income" style="width: 10%; text-align: center">$<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000027" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">3.04</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20230101__20231231_fKDgp_zD40Bp0NYvWb" title="Adjusted EBITDA" style="width: 10%; text-align: center">$<ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000029" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">232.30</ix:nonFraction></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zUxbvD7yG4Hk" title="Summary Compensation Table Total for PEO" style="text-align: center">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,555,517</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDIp_zR7MzXVMR3Wi" title="Compensation Actually Paid to PEO" style="text-align: center">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,555,517</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_zsvFZxwDVSeg" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,823,387</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zTurpzCsPDUf" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,962,193</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_z8UPVaEUytf7" title="Total Shareholder Return Amount" style="text-align: center">$<ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000039" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">92.76</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_982_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDYp_zKWukHhwKXEf" title="Peer Group Total Shareholder Return Amount" style="text-align: center">$<ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000041" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">140.29</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn4n6_c20220101__20221231_fKDcp_z3f4AREKD3yc" title="Net Income" style="text-align: center">$<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000043" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">10.65</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_98F_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20220101__20221231_fKDgp_zbV4LlTmAU2" title="Adjusted EBITDA" style="text-align: center">$<ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="From2022-01-012022-12-31" id="Fact000045" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">191.28</ix:nonFraction></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td id="xdx_980_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zaqyBA2AEc81" title="Summary Compensation Table Total for PEO" style="text-align: center">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,567,222</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_983_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKDIp_zBPgTkqBR1q3" title="Compensation Actually Paid to PEO" style="text-align: center">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,567,222</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDMp_zAm6l8VW29v6" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,676,763</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKDQp_zDJRqA6d65ij" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-01-012021-12-31" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,073,838</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_98B_eecd--TotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKDUp_zcQGnMltXDJ8" title="Total Shareholder Return Amount" style="text-align: center">$<ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2021-01-012021-12-31" id="Fact000055" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">148.33</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_988_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKDYp_zvSG8dL5ZrSh" title="Peer Group Total Shareholder Return Amount" style="text-align: center">$<ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="From2021-01-012021-12-31" id="Fact000057" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">143.09</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--NetIncomeLoss_pn4n6_c20210101__20211231_fKDcp_zKhM54jjWTcd" title="Net Income" style="text-align: center">$<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" id="Fact000059" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">24.73</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_98C_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20210101__20211231_fKDgp_zeaq4TRu8ix5" title="Adjusted EBITDA" style="text-align: center">$<ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="From2021-01-012021-12-31" id="Fact000061" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">211.94</ix:nonFraction></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2020</td><td>&#160;</td>
    <td id="xdx_98D_eecd--PeoTotalCompAmt_c20200101__20201231_fKDEp_zG72mIcCj0R7" title="Summary Compensation Table Total for PEO" style="text-align: center">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2020-01-012020-12-31" id="Fact000063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,835,761</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKDIp_zBpbghPBXKig" title="Compensation Actually Paid to PEO" style="text-align: center">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2020-01-012020-12-31" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,835,761</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_fKDMp_zPIkWRvBRZqg" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2020-01-012020-12-31" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,050,250</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20200101__20201231_fKDQp_z34o1uRgdzfj" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2020-01-012020-12-31" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,015,548</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_989_eecd--TotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKDUp_zNdrFJivLZl1" title="Total Shareholder Return Amount" style="text-align: center">$<ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2020-01-012020-12-31" id="Fact000071" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">96.40</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_98C_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKDYp_ztGOmNFRJHM2" title="Peer Group Total Shareholder Return Amount" style="text-align: center">$<ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="From2020-01-012020-12-31" id="Fact000073" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">113.45</ix:nonFraction></td><td>&#160;</td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_pn4n6_c20200101__20201231_fKDcp_zu2YnCaVwIml" title="Net Income" style="text-align: center">($<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" id="Fact000075" format="ixt:numdotdecimal" decimals="-4" scale="6" sign="-" unitRef="USD">14.84</ix:nonFraction>)</td><td>&#160;</td>
    <td id="xdx_981_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20200101__20201231_fKDgp_z00Ttz0pmaWc" title="Adjusted EBITDA" style="text-align: center">$<ix:nonFraction name="ecd:CoSelectedMeasureAmt" contextRef="From2020-01-012020-12-31" id="Fact000077" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">114.95</ix:nonFraction></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td id="xdx_F0F_zLt7gxVXdzkf" style="width: 0.5in; text-align: left">(1)</td><td id="xdx_F17_zixdsMWOCAbe" style="text-align: justify"><ix:footnote id="Footnote000078" xml:lang="en-US">The dollar amounts reported in column (b) are the amounts of total
compensation reported for <span id="xdx_90B_eecd--PeoName_c20230101__20231231_zbMEwARGj3R2"><span id="xdx_901_eecd--PeoName_c20220101__20221231_zeYebgkyielf"><span id="xdx_90A_eecd--PeoName_c20210101__20211231_zTdluKUxdXva"><span id="xdx_906_eecd--PeoName_c20200101__20201231_zZtDOpfVbuXh"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000079" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-12-31" id="Fact000080" name="ecd:PeoName"><ix:nonNumeric contextRef="From2021-01-012021-12-31" id="Fact000081" name="ecd:PeoName"><ix:nonNumeric contextRef="From2020-01-012020-12-31" id="Fact000082" name="ecd:PeoName">Dr. Berger</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span></span> (our Chief Executive Officer) for each corresponding year in the &#8220;Total&#8221; column of the
Summary Compensation Table. Refer to the above Summary Compensation Table.</ix:footnote></td>
</tr><tr style="display: none; vertical-align: top">
<td id="xdx_F0E_zNnBZT4ZWeb1" style="display: none; text-align: left">(2)</td><td id="xdx_F13_zMSoXF2EyPJ3" style="display: none; text-align: justify"><ix:footnote id="Footnote000083" xml:lang="en-US">The dollar amounts reported in column (c) represent the amount
of &#8220;compensation actually paid&#8221; to Dr. Berger, as computed in accordance with Item 402(v) of Regulation S-K. In accordance
with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Berger&#8217;s total compensation
for 2023 to determine the compensation actually paid:</ix:footnote></td>
</tr>
<tr style="display: none; vertical-align: top">
<td id="xdx_F01_zdPv5weu9cne" style="display: none; text-align: left">(3)</td><td id="xdx_F1A_zYMV4cSvFCJl" style="display: none"><ix:footnote id="Footnote000084" xml:lang="en-US">The dollar amounts reported in column (d) and (e) represent the
average of the amounts reported for the Named Executive Officers as a group (excluding Dr. Berger) in the &#8220;Total&#8221; column
of the Summary Compensation Table in 2023. The names of each of the Named Executive Officers (excluding Dr. Berger) included for purposes
of calculating the average amounts in each applicable year are Mark Stolper, Stephen Forthuber, Norman Hames, and Mital Patel.</ix:footnote></td>
</tr>
<tr style="display: none; vertical-align: top">
<td id="xdx_F04_zfczbg94vW91" style="display: none; text-align: left">(4)</td><td id="xdx_F1B_zAlempUENyAi" style="display: none; text-align: justify"><ix:footnote id="Footnote000085" xml:lang="en-US">The dollar amounts reported in column (e) represent the average
amount of &#8220;compensation actually paid&#8221; to the Named Executive Officers as a group (excluding Dr. Berger), as computed in
accordance with Item 402(v) of Regulation S-K. The dollar amounts do not necessarily reflect the actual average amount of compensation
earned by or paid to the Named Executive Officers as a group (excluding Dr. Berger) during the applicable year. In accordance with the
requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the Named Executive
Officers as a group (excluding Dr. Berger) for each year to determine the compensation actually paid, using the same methodology described
above in Note 2:</ix:footnote></td>
</tr>
<tr style="display: none; vertical-align: top">
<td id="xdx_F09_zXiyuJHmJK9l" style="display: none; text-align: left">(5)</td><td id="xdx_F14_zRqMXURxlnO4" style="display: none"><ix:footnote id="Footnote000086" xml:lang="en-US">Cumulative TSR is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share
price at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period.</ix:footnote></td>
</tr>
<tr style="display: none; vertical-align: top">
<td id="xdx_F01_zC7zMkOksYvf" style="display: none; text-align: left">(6)</td><td id="xdx_F10_zSN0iLiCXER9" style="display: none"><ix:footnote id="Footnote000087" xml:lang="en-US">Represents the weighted peer group TSR, weighted according to
the respective companies&#8217; stock market capitalization at the beginning of each period for which a return is indicated. The peer
group used for this purpose is the S&amp;P 500 &#8211; Healthcare Sector index.</ix:footnote></td>
</tr>
<tr style="display: none; vertical-align: top">
<td id="xdx_F06_zy67LI2dc3J9" style="display: none; text-align: left">(7)</td><td id="xdx_F15_zSF3sM8EyHM7" style="display: none"><ix:footnote id="Footnote000088" xml:lang="en-US">The dollar amounts reported represent the amount of net income
reflected in the Company&#8217;s audited financial statements for the applicable year.</ix:footnote></td>
</tr>
<tr style="display: none; vertical-align: top">
<td id="xdx_F06_zF2k6cHonC4g" style="display: none; text-align: left">(8)</td><td id="xdx_F1C_zwiab6kZqZBf" style="display: none; text-align: justify"><ix:footnote id="Footnote000089" xml:lang="en-US">Adjusted EBITDA is defined as earnings before interest, taxes,
depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other Financial Performance Measures
income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.
While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company&#8217;s
compensation programs, the Company has determined that Adjusted EBITDA is the financial performance measure that, in the Company&#8217;s
assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the
Company to link compensation actually paid to the Company&#8217;s Named Executive Officers, for the most recently completed fiscal year,
to Company performance.</ix:footnote></td>
</tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000091" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_84D_eecd--AdjToPeoCompFnTextBlock_dU_zPPEyF6K1ESb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(2)</td><td style="text-align: justify">The dollar amounts reported in column (c) represent the amount
of &#8220;compensation actually paid&#8221; to Dr. Berger, as computed in accordance with Item 402(v) of Regulation S-K. In accordance
with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Berger&#8217;s total compensation
for 2023 to determine the compensation actually paid:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Year</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Reported Summary Compensation Table Total
    for PEO</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Reported Value of Equity Awards</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Equity Award Adjustments<span style="font: normal 10pt Times New Roman, Times, Serif"><sup>(a)</sup></span></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Reported Change in the Actuarial Present
    Value of Pension Benefits<span style="font: normal 10pt Times New Roman, Times, Serif"><sup>(b)</sup></span></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Pension Benefit Adjustments<span style="font: normal 10pt Times New Roman, Times, Serif"><sup>(c)</sup></span></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Compensation Actually Paid to PEO</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 14%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_982_eecd--PeoTotalCompAmt_c20230101__20231231_z0dQEPMiizMj" title="Summary Compensation Table Total for PEO" style="width: 14%; text-align: center">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,700,183</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentTypeMember_z2UNbwxxQxj5" title="Reported Value of Equity Awards" style="width: 14%; text-align: center">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentTypeMember" id="Fact000095" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,125,000</ix:nonFraction>)</td><td style="width: 1%">&#160;</td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_fKGEp_zfvsN5JC9426" title="Equity Award Adjustments" style="width: 13%; text-align: center">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType1Member" id="Fact000097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,526,252</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_fKGIp_zhaAOX4bZm47" title="Reported Change in the Actuarial Present Value of Pension Benefits" style="width: 13%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType2Member" id="Fact000099" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_fKGMp_zoY99xcozWc" title="Pension Benefit Adjustments" style="width: 13%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType3Member" id="Fact000101" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zEaCvE0riG1h" title="Compensation Actually Paid to PEO" style="width: 13%; text-align: center">$<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,101,435</ix:nonFraction></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td id="xdx_F02_z4oAbMmkW3ak" style="width: 0.5in; text-align: left">(a)</td><td id="xdx_F1B_zmVP8Wrmrjte"><ix:footnote id="Footnote000104" xml:lang="en-US">The amounts deducted or added in calculating Dr. Berger&#8217;s
equity award adjustments are as follows:</ix:footnote></td>
</tr><tr style="display: none; vertical-align: top">
<td style="display: none"/><td id="xdx_F04_z2E9F8yTbAi2" style="display: none; text-align: left">(b)</td><td id="xdx_F13_za9C1x58h3cf" style="display: none; text-align: justify"><ix:footnote id="Footnote000105" xml:lang="en-US">The amounts included in this column are the amounts reported
in &#8220;Change in Pension and Nonqualified Deferred Compensation&#8221; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.</ix:footnote></td>
</tr>
<tr style="display: none; vertical-align: top">
<td style="display: none"/><td id="xdx_F00_zHttPbcGdJyk" style="display: none; text-align: left">(c)</td><td id="xdx_F1C_z4fdET60JgN" style="display: none; text-align: justify"><ix:footnote id="Footnote000106" xml:lang="en-US">The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#8220;service cost&#8221;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#8220;prior
service cost&#8221;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.</ix:footnote></td>
</tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year End Fair Value of Equity Awards Granted in the Current Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Outstanding and
    Unvested Equity Awards Granted in Prior Years</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value as of Vesting Date of Equity Awards Granted and Vested
    in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Equity Awards Granted
    in Prior Years that Vested in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value at the End of the Prior Year of Equity Awards that Failed
    to Meet Vesting Conditions in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Value of Dividends or other Earnings Paid on Stock or Option Awards
    not Otherwise Reflected in Fair Value or Total Compensation</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Total Equity Award Adjustments</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 12%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zMJBiUhXP198" title="Year End Fair Value of Equity Awards Granted in the Current Year" style="width: 12%; text-align: center">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType4Member_custom_HowardBergerMember" id="Fact000108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,590,692</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zWdrxWCfvwpk" title="Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years" style="width: 12%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType5Member_custom_HowardBergerMember" id="Fact000110" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zodWPY1WtSig" title="Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year" style="width: 12%; text-align: center">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType6Member_custom_HowardBergerMember" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">935,560</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_989_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zrhIGdOi9682" title="Year over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year" style="width: 12%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType7Member_custom_HowardBergerMember" id="Fact000114" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType8Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zpunzWCo5tRh" title="Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year" style="width: 11%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType8Member_custom_HowardBergerMember" id="Fact000116" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_984_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType9Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zB4Nci6AdQB6" title="Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation" style="width: 11%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType9Member_custom_HowardBergerMember" id="Fact000118" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType10Member__ecd--IndividualAxis__custom--HowardBergerMember_zW4pHjDZhk7j" title="Total Equity Award Adjustments" style="width: 11%; text-align: center">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType10Member_custom_HowardBergerMember" id="Fact000120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,526,252</ix:nonFraction></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -13.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left">(b)</td><td style="text-align: justify">The amounts included in this column are the amounts reported
in &#8220;Change in Pension and Nonqualified Deferred Compensation&#8221; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -13.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left">(c)</td><td style="text-align: justify">The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#8220;service cost&#8221;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#8220;prior
service cost&#8221;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_851_za886RgIBi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000122" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_841_eecd--NamedExecutiveOfficersFnTextBlock_dU_zRq5CA0huDUj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(3)</td><td>The dollar amounts reported in column (d) and (e) represent the
average of the amounts reported for the Named Executive Officers as a group (excluding Dr. Berger) in the &#8220;Total&#8221; column
of the Summary Compensation Table in 2023. The names of each of the Named Executive Officers (excluding Dr. Berger) included for purposes
of calculating the average amounts in each applicable year are Mark Stolper, Stephen Forthuber, Norman Hames, and Mital Patel.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_853_z6ro6qypJU72" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000124" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_ziKHkqFdLdp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(4)</td><td style="text-align: justify">The dollar amounts reported in column (e) represent the average
amount of &#8220;compensation actually paid&#8221; to the Named Executive Officers as a group (excluding Dr. Berger), as computed in
accordance with Item 402(v) of Regulation S-K. The dollar amounts do not necessarily reflect the actual average amount of compensation
earned by or paid to the Named Executive Officers as a group (excluding Dr. Berger) during the applicable year. In accordance with the
requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the Named Executive
Officers as a group (excluding Dr. Berger) for each year to determine the compensation actually paid, using the same methodology described
above in Note 2:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Reported Summary Compensation Table Total for Non-PEO Named
    Executive Officers</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Reported Value of Equity Awards</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Equity Award Adjustments<sup>(a)</sup></b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Reported Change in the Actuarial Present Value of Pension
    Benefits<sup>(b)</sup></b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Pension Benefit Adjustments<sup>(b)</sup></b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Compensation Actually Paid to Non-PEO Named Executive Officers</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 14%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zHXMp7EpxwSl" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="width: 14%; text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000126" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,030,591</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentTypeMember_zXQJFIoXteG1" title="Average Reported Value of Equity Awards" style="width: 14%; text-align: center">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentTypeMember" id="Fact000128" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,071,875</ix:nonFraction>)</td><td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: center">$2,626,503</td><td style="width: 1%">&#160;</td>
    <td id="xdx_980_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_fKGIp_zqqEB5qngIVb" title="Average Reported Change in the Actuarial Present Value of Pension Benefits" style="width: 13%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType2Member" id="Fact000130" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_983_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_fKGIp_zEgYq3jhyixh" title="Average Pension Benefit Adjustments" style="width: 13%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType3Member" id="Fact000132" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_z7XiMt22a3ek" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="width: 13%; text-align: center">$<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,585,219</ix:nonFraction></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td id="xdx_F0D_zR4MPK95I2e1" style="width: 0.5in; text-align: left">(a)</td><td id="xdx_F17_ztfk7wQERqE2" style="text-align: justify"><ix:footnote id="Footnote000135" xml:lang="en-US">The amounts deducted or added in calculating the total average
equity award adjustments are as follows:</ix:footnote></td>
</tr><tr style="display: none; vertical-align: top">
<td style="display: none"/><td id="xdx_F03_zThT4KNxr668" style="display: none; text-align: left">(b)</td><td id="xdx_F19_zrGeOFDuhcKe" style="display: none; text-align: justify"><ix:footnote id="Footnote000136" xml:lang="en-US">The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.</ix:footnote></td>
</tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Year End Fair Value of Equity Awards Granted in the Current
    Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Outstanding and
    Unvested Equity Awards Granted in Prior Years</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Fair Value as of Vesting Date of Equity Awards Granted
    and Vested in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Equity Awards Granted
    in Prior Years that Vested in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Fair Value at the End of the Prior Year of Equity Awards
    that Failed to Meet Vesting Conditions in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Value of Dividends or other Earnings Paid on Stock or Option
    Awards not Otherwise Reflected in Fair Value or Total Compensation</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Total Average Equity Award Adjustments</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 12%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zt9EU0iIYaa" title="Average Year End Fair Value of Equity Awards Granted in the Current Year" style="width: 12%; text-align: center">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType4Member" id="Fact000138" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,032,116</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zgPPGOpL7w0l" title="Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years" style="width: 12%; text-align: center">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType5Member" id="Fact000140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">309,243</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zjPJR3MKWsI4" title="Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year" style="width: 12%; text-align: center">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType6Member" id="Fact000142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">286,517</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zl3Tv4e6SuO6" title="Year over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year" style="width: 12%; text-align: center">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType7Member" id="Fact000144" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,373</ix:nonFraction>)</td><td style="width: 1%">&#160;</td>
    <td id="xdx_988_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType8Member_zTtCfNoUS4t" title="Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year" style="width: 11%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType8Member" id="Fact000146" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td id="xdx_98A_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType9Member_zecY8eyfSs0c" title="Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation" style="width: 11%; text-align: center"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType9Member" id="Fact000148" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">$2,626,503</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left">(b)</td><td style="text-align: justify">The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_85A_zpLo8ASvzpKa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(5)</td><td>Cumulative TSR is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share
price at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000150" name="ecd:PeerGroupIssuersFnTextBlock"><p id="xdx_848_eecd--PeerGroupIssuersFnTextBlock_dU_zM1PCq1mRRMi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(6)</td><td>Represents the weighted peer group TSR, weighted according to
the respective companies&#8217; stock market capitalization at the beginning of each period for which a return is indicated. The peer
group used for this purpose is the S&amp;P 500 &#8211; Healthcare Sector index.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_85C_zPovHpJLhto7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(7)</td><td>The dollar amounts reported represent the amount of net income
reflected in the Company&#8217;s audited financial statements for the applicable year.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(8)</td><td style="text-align: justify"><span id="xdx_90A_eecd--CoSelectedMeasureName_c20230101__20231231_zehOYkKokfs4" title="Company Selected Measure Name"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000152" name="ecd:CoSelectedMeasureName">Adjusted EBITDA</ix:nonNumeric></span> is defined as earnings before interest, taxes,
depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other Financial Performance Measures
income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.
While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company&#8217;s
compensation programs, the Company has determined that Adjusted EBITDA is the financial performance measure that, in the Company&#8217;s
assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the
Company to link compensation actually paid to the Company&#8217;s Named Executive Officers, for the most recently completed fiscal year,
to Company performance.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000154" name="ecd:TabularListTableTextBlock"><p id="xdx_849_eecd--TabularListTableTextBlock_dU_zrZ5NtElSywc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Financial Performance Measures</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described in greater detail
in the Compensation Discussion and Analysis section. the Company&#8217;s executive compensation program reflects a pay-for-performance
philosophy. The metrics that the Company uses for both our long-term and short- term incentive awards are selected based on an objective
of incentivizing our Named Executive Officers to increase the value of our enterprise for our shareholders. The most important financial
performance measures used by the Company to link executive compensation actually paid to the Company&#8217;s Named Executive Officers,
for the most recently completed fiscal year, to the Company&#8217;s performance are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">1.</td><td id="xdx_988_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__1_ziE6pWbjgSOg" title="Measure Name"><ix:nonNumeric contextRef="From2023-01-012023-12-31_1" id="Fact000156" name="ecd:MeasureName">Adjusted EBITDA</ix:nonNumeric></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">2.</td><td id="xdx_981_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__2_zG4A7oMPh7gc" title="Measure Name"><ix:nonNumeric contextRef="From2023-01-012023-12-31_2" id="Fact000158" name="ecd:MeasureName">Total Shareholder Return (via equity grants); and</ix:nonNumeric></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">3.</td><td id="xdx_987_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__3_zd6RhC7CX7se" title="Measure Name"><ix:nonNumeric contextRef="From2023-01-012023-12-31_3" id="Fact000160" name="ecd:MeasureName">Strategic Objectives (via discretionary bonus).</ix:nonNumeric></td>
</tr></table>

</ix:nonNumeric><p id="xdx_852_zHVSnWwd8er9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Analysis of the Information Presented in the Pay versus Performance
Table</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described in more detail
in the Compensation Discussion and Analysis section, the Company&#8217;s executive compensation program reflects a pay-for-performance
philosophy. While the Company utilizes several performance measures to align executive compensation with Company performance, all of those
Company measures are not presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term
performance, and therefore does not specifically align the Company&#8217;s performance measures with compensation that is actually paid
(as computed in accordance with Item 402(v) of Regulation S-K) for a particular year. In accordance with Item 402(v) of Regulation S-K,
the Company is providing the following descriptions of the relationships between information presented in the Pay versus Performance table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000162" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_846_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zuM1ingWbM4c" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Actually Paid and TSR</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="image_007.jpg" alt="" style="height: 4.66in; width: 6.14in"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><p id="xdx_855_z5XcpjqdQ7Ag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000164" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_846_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zDraBwHdCyL1" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Actually Paid and Net Income</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<img src="image_011.jpg" alt="" style="height: 4.43in; width: 5.81in"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><p id="xdx_85A_z96VC4Cnukcf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000166" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock"><p id="xdx_84B_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zXN5Cgs1Wl9k" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Actually Paid and Adjusted EBITDA</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<img src="image_012.jpg" alt="" style="height: 4.64in; width: 6.09in"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><p id="xdx_85A_zdoevcNLhG76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_012"></span>EQUITY COMPENSATION PLAN INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have one active equity
compensation plan, our Equity Incentive Plan. The Equity Incentive Plan provides for the grant of stock options (incentive and non-qualified),
stock awards (including RSUs), stock appreciation rights and cash awards. As of December 31, 2023, we have reserved an aggregate 20,100,000
shares of common stock for issuance under our Equity Incentive Plan, subject to adjustment for stock dividends, reorganizations, or other
changes in our capital structure and 4,069,349 common shares remained available for potential future issuance. Shares underlying any portion
of an award that is cancelled, terminates, expires, or lapses for any reason are generally returned to the available pool under the Equity
Incentive Plan. Shares attributable to (a) shares of common stock upon the exercise of incentive stock options that are subsequently forfeited
or repurchased, or (b) awards transferred under any award transfer program, shall not again be available for grant under the Equity Incentive
Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with our acquisition
of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan and its then-outstanding stock options held
to acquire DeepHealth, Inc. stock. After giving effect to subsequent exercises, at December 31, 2023 these assumed stock options were
exercisable for up to 72,219 shares of RadNet common stock. No additional awards will be granted under the DeepHealth Inc. 2017 Stock
Incentive Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the number of shares of common stock subject to outstanding options, RSUs, warrants and other convertible securities into share rights,
the weighted-average exercise price of outstanding options, and the number of shares remaining available for future award grants as of
December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Plan Category</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>(A)<br/> Number of Shares to Be Issued Upon Exercise of Outstanding Options, Warrants and<br/> Rights (#)<sup>(1)(2)</sup></b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(B)<br/> Weighted Average Exercise Price of Outstanding Options, Warrants and<br/> Rights ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(C)<br/> Number of Shares Remaining Available For Future Issuance Under Equity Incentive Plans (Excluding Shares Reflected in<br/> Column (A))</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 52%; text-align: left">Equity incentive plans approved by stockholders</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">1,206,360</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">14.75</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">3,774,400</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Equity incentive plans not approved by stockholders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: justify">TOTAL</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,206,360</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14.75</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,774,400</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(1)</td><td style="text-align: justify">Includes 294,949 shares subject to outstanding RSUs under the
NDC Plan. The weighted average exercise price in column (B) does not take these RSUs into account.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(2)</td><td style="text-align: justify">Does not include options outstanding under the DeepHealth, Inc.
2017 Stock Incentive Plan as no further awards will be made under that plan. On an aggregate basis, the number of securities to be issued
upon the exercise of outstanding options originally held pursuant to the DeepHealth, Inc. 2017 Stock Incentive plan was 72,219 on December
31, 2023, and the weighted average exercise price was $0.00.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_013"></span>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents
information concerning the beneficial ownership of the shares of our common stock as of March 31, 2024, by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
person we know to be the beneficial owner of 5% or more of our outstanding shares of common stock;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
of our Named Executive Officers;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
of our directors; and</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
of our current executive officers and directors as a group.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise noted below,
the address of each beneficial owner listed in the table is c/o RadNet, Inc., 1510 Cotner Ave., Los Angeles, CA 90025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as indicated by the
footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table below have sole
voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable community property
laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Percentage ownership is based
on 73,890,704 shares of common stock outstanding on March 31, 2024. In accordance with Securities and Exchange Commission (the &#8220;SEC&#8221;)
rules, when computing the number of shares of common stock beneficially owned and the percentage ownership of a person, we include shares
of common stock subject to options held by that person that are exercisable or will become exercisable within 60 days of March 31, 2024,
but we do not include those shares of common stock underlying options when computing the percentage ownership of any other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Beneficial Owner</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares Beneficially Owned</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent of Shares Beneficially<br/>
Owned</b></span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5% or Greater Stockholders</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BlackRock, Inc.</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 1%; text-align: right">&#160;</td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,894,317</span></td>
    <td style="width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="width: 1%; text-align: right">&#160;</td>
    <td style="width: 1%; text-align: right">&#160;</td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.04%</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandy Nyholm Kaminsky, trustee of the HFB Heirs&#8217; Trust II</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,376,253</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.28%</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Vanguard Group</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,254,717</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.76%</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors, Nominees and Named Executive Officers</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard G. Berger, M.D.</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,550</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(4)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen M. Forthuber</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">768,824</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(5)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.04%</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine N. Gordon</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">11,379</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(6)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman R. Hames</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,912</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(7)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laura P. Jacobs</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,717</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(8)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence L. Levitt</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,066</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(9)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mital Patel</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,620</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(10)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. Gregory Sorensen, M.D.</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,333,597</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(11)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.80%</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory E. Spurlock</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,334</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(12)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark D. Stolper</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">277,685</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(13)</sup></span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David L. Swartz</span></td>
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">258,495</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(14)</sup></span></td>
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All directors and executive officers as a group (14 persons)</b></span></td>
    <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,829,179</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(15)</sup></span></td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12%</span></td>
    <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents less than 1%.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 7%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According to a Schedule 13G/A filed with the SEC on January 23, 2024, BlackRock, Inc. maintains sole voting power over 8,782,211 shares of our common stock and sole dispositive power over 8,894,317 shares of our common stock. The address set forth in the Schedule 13G/A filing is 50 Hudson Yards, New York, NY 10001.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 7%">&#160;</td>
    <td style="text-align: justify; width: 93%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According to a Schedule 13G/A filed with the SEC on October 6, 2017, Sandy Nyholm Kaminsky, as trustee of the HFB Heirs&#8217; Trust II, maintains sole voting power and sole dispositive power over 5,376,253 shares of our common stock. The address set forth in the Schedule 13G filing is 400 S. Emerson Street, Denver, Colorado 80209.&#160;&#160;On June 29, 2015, HFB Enterprises, LLC, of which Dr. Berger was a co-manager, distributed 5,133,114 shares of RadNet&#8217;s common stock to HFB Heirs&#8217; Trust II (formerly HFB Heirs&#8217; Trust), an irrevocable trust for Dr. Berger&#8217;s children and the sole member of HFB Enterprises, LLC. Dr. Berger does not have any control over HFB Heirs&#8217; Trust II or beneficial ownership of any of shares of RadNet common stock held by the HFB Heirs&#8217; Trust II.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According to a Schedule 13G/A filed with the SEC on February 13, 2024, The Vanguard Group maintains shared voting power over 110,970 shares of our common stock, sole dispositive power over 4,088,529 shares of our common stock and shared dispositive power over 166,188 shares of our common stock. The address set forth in the 13G/A filing is 100 Vanguard Blvd., Malvern, PA 19355. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes (a) 69,314 shares subject to options exercisable within 60 days of March 31, 2024 and (b) 10,000 shares of common stock held by Dr. Berger&#8217;s spouse.&#160;&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes: (a) 28,134 shares of unvested time-based restricted stock, and (b) 205,263 shares subject to options exercisable within 60 days of March 31, 2024.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes 3,329 shares of unvested time-based restricted stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes: (a) 1,380 shares of unvested time-based restricted stock, (b) 153,803 shares subject to options exercisable within 60 days of March 31, 2024, and (c) 20,190 shares of common stock held by Mr. Hames&#8217;s spouse.&#160;&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes 4,066 shares of unvested time-based restricted stock.&#160;&#160;The securities reported are held through the Jacobs Family Trust, of which Ms. Jacobs is a co-trustee.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes 4,066 shares of unvested time-based restricted stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes (a) 11,857 shares of unvested time-based restricted stock, and (b) 130,974 shares subject to options exercisable within 60 days of March 31, 2024. Mr. Patel has pledged 182,545 shares of common stock in connection with a loan agreement.&#160;&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes (a) 60,094 shares of unvested time-based restricted stock, and (b) 62,964 shares subject to options exercisable within 60 days of March 31, 2024, and (b) 16,248 shares held in a family trust of which Dr. Sorensen is a beneficiary. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes 4,066 shares of unvested time-based restricted stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes 172,287 shares subject to options exercisable within 60 days of March 31, 2024.&#160;&#160;Beneficial ownership does not include 144,824 shares issuable upon settlement of vested restricted stock units and 24,891 shares issuable upon settlement of unvested time-based restricted stock units, which can be settled, at the Company&#8217;s election, in cash or shares.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes: (a) 4,066 shares of unvested time-based restricted stock, and (b) 37,019 shares of common stock held by Mr. Swartz&#8217;s spouse.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes (a) 791,735 shares subject to options exercisable within 60 days of March 31, 2024, and (b) 60,964 shares of unvested time-based restricted stock. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_014"></span>DELINQUENT SECTION 16(a) REPORTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 16(a) of the Exchange
Act requires our directors, executive officers and beneficial owners of more than 10% of our common stock to file reports of ownership
and changes in ownership with the SEC. Based solely on copies of these reports provided to us and written representations that no other
reports were required, we believe that these persons timely met all of the applicable Section 16(a) filing requirements during the fiscal
year ended December 31, 2023, with the exception of one late report on Form 4 from Mital Patel which covered one gift transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_015"></span>REPORT OF THE AUDIT COMMITTEE OF THE BOARD
OF DIRECTORS*</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee of the
Board of Directors is comprised entirely of independent directors who meet the independence requirements of NASDAQ and the SEC. The Audit
Committee operates pursuant to a charter that is available on our website at&#160;<i>www.radnet.com</i>&#160;under Investor Relations
&#8211; Corporate Governance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee oversees
our financial reporting process on behalf of the Board of Directors. Management is responsible for the preparation, presentation and integrity
of the financial statements, including establishing accounting and financial reporting principles and designing systems of internal control
over financial reporting. Our independent registered public accounting firm, Ernst &amp; Young LLP (&#8220;Ernst &amp; Young&#8221;),
is responsible for expressing an opinion as to the conformity of our consolidated financial statements with generally accepted accounting
principles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee reviewed
and discussed with management and Ernst &amp; Young the audited consolidated financial statements in our annual report on Form 10-K for
the year ended December 31, 2023. The Audit Committee also discussed with Ernst &amp; Young matters required to be discussed by the Public
Company Accounting Oversight Board and the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has received
the written disclosures and the letter from Ernst &amp; Young required by applicable requirements of the Public Company Accounting Oversight
Board regarding Ernst &amp; Young&#8217;s communications with the Audit Committee concerning independence, and has discussed with Ernst
&amp; Young its independence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the reviews and discussions
referred to above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements discussed
above be included in RadNet&#8217;s annual report on Form 10-K for the year ended December 31, 2023 for filing with the SEC. The Audit
Committee has also reappointed Ernst &amp; Young to serve as independent auditors for the fiscal year ending December 31, 2024, and requested
that this appointment be submitted to our stockholders for ratification at their Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Submitted by the Audit Committee:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 60%; text-align: justify">&#160;</td>
    <td style="width: 40%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David L. Swartz, Chair</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lawrence L. Levitt</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Laura P. Jacobs</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The material in this report is not &#8220;soliciting
material,&#8221; is not deemed filed with the SEC and is not to be incorporated by reference into any of our filings under the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act whether made before or after the date of this Proxy Statement
and irrespective of any general incorporation language therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSALS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_016"></span>PROPOSAL NO. 1:<br/>
<br/>
ELECTION OF DIRECTORS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the recommendation
of our Nominating and Governance Committee, our Board of Directors has nominated each of the following individuals to be elected to serve
on our Board until the next annual meeting of stockholders and until their successors are duly elected and qualified:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">Howard G. Berger, M.D.,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">Christine N. Gordon,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">Laura P. Jacobs,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">Lawrence L. Levitt,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">A. Gregory Sorensen, M.D.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">Gregory E. Spurlock, and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">David L. Swartz</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of the nominees is a
current director and all have consented to serving as a nominee, being named in this Proxy Statement, and serving on the Board if elected.
Each director elected at the Annual Meeting will be elected to serve a one-year term. If any nominee becomes unavailable or unable to
serve before the Annual Meeting, the Board of Directors may determine to leave the position vacant, reduce the number of authorized directors
or designate a substitute nominee. If a substitute nominee is named, then the persons named as proxies will have full discretion and authority
to vote or refrain from voting for such substitute nominee in their discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no family relationships
between any nominees and executive officers of RadNet, and there are no arrangements or understandings between any nominee and any other
person pursuant to which such nominee was or is selected as a director or nominee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vote Required</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with our bylaws,
the election of a director in an uncontested election requires the affirmative vote of the holders of a majority of the shares present
in person or represented by proxy and entitled to vote on this proposal at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board of Director Recommendation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE &#8220;<b>FOR</b>&#8221; EACH OF THE NOMINEES ABOVE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_017"></span>PROPOSAL NO. 2:<br/>
<br/>
RATIFICATION OF THE APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Audit Committee has re-appointed
Ernst &amp; Young LLP (&#8220;Ernst &amp; Young&#8221;) as our independent registered public accounting firm for the fiscal year ending
December 31, 2024. Ernst &amp; Young has audited our financial statements annually since January 1, 2007. Our Audit Committee reviews
the appointment of our independent accounting firm annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Annual Meeting, our
stockholders are being asked to ratify the appointment of Ernst &amp; Young as our independent registered public accounting firm for 2024.
If our stockholders vote against the ratification of Ernst &amp; Young, the Audit Committee will consider this in its selection of auditors
for the following year. Even if our stockholders ratify the appointment, the Audit Committee may choose to appoint a different independent
registered public accounting firm at any time during the year if it is determined that such a change would be in the best interests of
RadNet and its stockholders. Representatives of Ernst &amp; Young are expected to be at the Annual Meeting to answer any questions and
make a statement should they choose to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fees Paid to Auditors</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents
fees billed by Ernst &amp; Young for the fiscal years ended December 31, 2022 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,237,590</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,267,120</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,745</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Tax Compliance Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">591,075</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">764,670</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: justify">Other Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">270,231</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Fees<sup>(4)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,600</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,600</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,316,223</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,305,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees in fiscal years ended December 31, 2022 and 2023 consisted of fees billed for professional services rendered in connection with the audit of our annual financial statements and internal control over financial reporting, quarterly review of interim consolidated financial statements and audit services in connection with other statutory and regulatory filings.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td style="width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related
    Fees in the fiscal year ended December 31, 2022 consisted of fees billed for due diligence in connection with merger and acquisition
    activities. Ernst &amp; Young did not render any Audit-Related Fees in the fiscal year ended December 31, 2023.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td>
    <td style="width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax fees in the fiscal years ended December 31, 2022 and 2023 consisted of fees billed for professional services rendered for tax compliance, tax advice and tax planning. These services included assistance regarding federal and state tax compliance, acquisitions and tax planning.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(4)</sup></span></td>
    <td style="width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Fees in the fiscal years ended December 31, 2022 and 2023 consisted of fees for products and services other than the services reported above. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Policy on Audit Committee Pre-Approval of
Audit and Permissible Non-Audit Services of the Independent Registered Public Accounting Firm</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a matter of policy, all
audit and non-audit services provided by our independent registered public accounting firm are approved in advance by the Audit Committee,
which considers whether the provision of non-audit services is compatible with maintaining such firm&#8217;s independence. All services
provided by Ernst &amp; Young during the fiscal year ended December 31, 2023 and the fiscal year ended December 31, 2022 were pre-approved
by the Audit Committee. The Audit Committee has considered the role of Ernst &amp; Young in providing services to us for the fiscal year
ending December 31, 2024 and has concluded that such services are compatible with their independence as our auditors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vote Required</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ratification of Ernst &amp;
Young as our independent registered public accounting firm requires the affirmative vote of the holders of a majority of the shares present
in person or represented by proxy on this proposal at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board of Director Recommendation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE &#8220;<b>FOR</b>&#8221; PROPOSAL 2.<b><br/></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_018"></span>PROPOSAL NO. 3:<br/>
<br/>
ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the requirements
of Section 14A of the Exchange Act and the related rules of the SEC, our stockholders have the opportunity to cast an annual advisory
vote to approve the compensation of our Named Executive Officers as disclosed in this Proxy Statement, including the Compensation Discussion
and Analysis, the summary compensation and other related tables and narratives accompanying those tables (a &#8220;say-on-pay&#8221; vote).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently hold our advisory
say-on-pay vote every year. Stockholders will have an opportunity to cast an advisory vote on the frequency of say-on-pay votes at least
every six years. We currently expect that the next advisory vote on the frequency of the say-on-pay votes will occur at the 2029 annual
meeting of stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend that our compensation
program and decisions will attract and retain our Named Executive Officers and reward them for achieving RadNet&#8217;s strategic initiatives
and objective measures of success. We compensate our executive officers through a mix of base salary, bonus and equity compensation. Our
Compensation Committee and Board of Directors believe that our executive compensation program is effective in implementing our principles
and is strongly aligned with the long-term interests of our stockholders and that our stockholders should approve our compensation program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">88% of votes cast on the say
on pay advisory proposal at our 2023 Annual Meeting were voted in favor of our executive compensation program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The vote on this resolution
is not intended to address any specific element of compensation; rather, the vote relates to the overall compensation of our Named Executive
Officers. We encourage our stockholders to read the &#8220;Compensation Discussion and Analysis&#8221; section above, which describes
the details of our executive compensation program and the decisions made by the Compensation Committee for 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, our stockholders
are being asked to vote on the following resolution at the Annual Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&#8220;RESOLVED, that the compensation paid
to RadNet&#8217;s Named Executive Officers, as disclosed in this Proxy Statement pursuant to the SEC&#8217;s executive compensation disclosure
rules, including Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The vote is advisory and its
outcome will not be binding on our Board of Directors nor require our Board of Directors or Compensation Committee to take any action.
However, our Board of Directors and Compensation Committee value the opinion expressed by our stockholders in their vote on this proposal
and expect to take into account the outcome of this vote when evaluating future executive compensation arrangements for our Named Executive
Officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vote Required</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Approval of the compensation
of our Named Executive Officers for the stockholder advisory vote requires the affirmative vote of the holders of a majority of the shares
present in person or represented by proxy and entitled to vote on this proposal at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board of Director Recommendation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE &#8220;<b>FOR</b>&#8221; PROPOSAL 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_019"></span>OTHER MATTERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We know of no other matters
to be submitted at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the
persons named in the Proxy Card for the Annual Meeting to exercise their discretionary authority to vote the shares that they represent
in accordance with their judgment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_020"></span>ADDITIONAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Further Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For further information about
RadNet, please refer to the 2023 Annual Report. The 2023 Annual Report is publicly available on the SEC&#8217;s website at&#160;<i>www.sec.gov</i>&#160;and
on our website at&#160;<i>www.radnet.com</i>. You may also obtain a copy by sending a written request to Investor Relations, RadNet, Inc.,
1510 Cotner Ave., Los Angeles, CA 90025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Householding</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some banks, brokers and other
nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statements and annual reports. This means
that only one Notice of Availability or, if you have requested paper copies, only one set of proxy materials is delivered to multiple
stockholders sharing an address. If you are a stockholder sharing an address, you can request a separate Notice of Availability or copy
of the proxy materials by contacting the Broadridge Householding Department by phone at 1-866-540-7095 or by mail to Broadridge Householding
Department, 51 Mercedes Way, Edgewood, NY 11717. A separate copy will be promptly provided following receipt of your request, and you
will receive separate materials in the future. If you currently share an address with another stockholder but are nonetheless receiving
separate copies of the materials, you may request delivery of a single copy in the future by contacting the Broadridge Householding Department
at the number or address shown above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director Nominations and Stockholder Proposals
for Inclusion in RadNet, Inc.&#8217;s 2025 Proxy Materials</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide that, for
stockholder nominations to the Board of Directors or other proposals to be considered at an annual meeting, the stockholder must have
given timely advance notice of the proposal or nomination in writing to our Corporate Secretary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To be timely for the 2025
Annual Meeting of Stockholders, a stockholder&#8217;s notice must be delivered to or mailed and received by our Corporate Secretary at
our principal executive offices between February 12, 2025 and March 14, 2025. A stockholder&#8217;s notice to the Corporate Secretary
must set forth the information required by our bylaws as to each matter the stockholder proposes to bring before the 2025 Annual Meeting
of Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholder proposals submitted
pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), must be received by us
not later than December 27, 2024, in order to be considered for inclusion in our proxy materials for the 2025 Annual Meeting of Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The deadline for providing
notice to the Company under Rule 14a-19,&#160;the SEC&#8217;s universal proxy rule, of a shareholder&#8217;s intent to solicit proxies
in support of nominees submitted under the Company&#8217;s advance notice bylaws for our 2025 Annual Meeting of Stockholders is March
14, 2025. Shareholders intending to provide such a notice must comply with all requirements of Rule 14a-19 in addition to all requirements
under our bylaws, including the timing of notice requirements described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; text-align: justify">&#160;</td>
    <td style="width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Order of the Board of Directors,</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><img src="image_010.jpg" alt="" style="height: 59px; width: 110px"/></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David Katz</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Corporate Secretary</i></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 68; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJydzt1OgzAUB/An4B1OuF62toI67hiZ08iMWYjxthtnSxVacug+eCTf0gIxu3Rp06Rtzv93TsNwEq7Mk6qQ4HOxyaHAuqmkRdjgHgn1Dl0ie3lNwJ0bPKjWktR2eP7BzDiDzsRTIbauMERPqsUyARbNRDwTEbB5wgWk6zDo65nRe1WitkpWIHUJ72QaUmgldWOHQl6MNnU3jPpAapXRCfApG8s/IJjr92ZO8mzou4U8z8JgMqwgXJE5Ni61vFjUvYRlhbUb1476uoff7I6tNXWSll/u0seKrkG+xnqL5MqcCcFZym6Evk74wjtfGPnC2Bfe+8IHX/joC+e+kLPb5bM5SyoXSAekf9QvFxoFUQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>rdnt-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaiLiaPty552OYkxvmRzfek6byohK/KqOSKjj32GYZkN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:RDNT="http://radnet.com/20231231" elementFormDefault="qualified" targetNamespace="http://radnet.com/20231231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="RDNT_AdjustmentTypeMember" name="AdjustmentTypeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType1Member" name="AdjustmentType1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType2Member" name="AdjustmentType2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType3Member" name="AdjustmentType3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType4Member" name="AdjustmentType4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_HowardBergerMember" name="HowardBergerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType5Member" name="AdjustmentType5Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType6Member" name="AdjustmentType6Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType7Member" name="AdjustmentType7Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType8Member" name="AdjustmentType8Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType9Member" name="AdjustmentType9Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RDNT_AdjustmentType10Member" name="AdjustmentType10Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>rdnt-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentTypeMember" xlink:label="loc_RDNTAdjustmentTypeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentTypeMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType1Member" xlink:label="loc_RDNTAdjustmentType1Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType1Member" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType2Member" xlink:label="loc_RDNTAdjustmentType2Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType2Member" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType3Member" xlink:label="loc_RDNTAdjustmentType3Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType3Member" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType4Member" xlink:label="loc_RDNTAdjustmentType4Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType4Member" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType5Member" xlink:label="loc_RDNTAdjustmentType5Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType5Member" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType6Member" xlink:label="loc_RDNTAdjustmentType6Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType6Member" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType7Member" xlink:label="loc_RDNTAdjustmentType7Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType7Member" xlink:type="arc" order="70" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType8Member" xlink:label="loc_RDNTAdjustmentType8Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType8Member" xlink:type="arc" order="80" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType9Member" xlink:label="loc_RDNTAdjustmentType9Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType9Member" xlink:type="arc" order="90" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType10Member" xlink:label="loc_RDNTAdjustmentType10Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType10Member" xlink:type="arc" order="100" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_HowardBergerMember" xlink:label="loc_RDNTHowardBergerMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_RDNTHowardBergerMember" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rdnt-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember" xlink:label="ecd_PeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoMember" xlink:to="ecd_PeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoMember_lbl" xml:lang="en-US">PEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentTypeMember" xlink:label="RDNT_AdjustmentTypeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentTypeMember" xlink:to="RDNT_AdjustmentTypeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentTypeMember_lbl" xml:lang="en-US">Adjustment Type [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType1Member" xlink:label="RDNT_AdjustmentType1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType1Member" xlink:to="RDNT_AdjustmentType1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType1Member_lbl" xml:lang="en-US">Adjustment Type 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType2Member" xlink:label="RDNT_AdjustmentType2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType2Member" xlink:to="RDNT_AdjustmentType2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType2Member_lbl" xml:lang="en-US">Adjustment Type 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType3Member" xlink:label="RDNT_AdjustmentType3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType3Member" xlink:to="RDNT_AdjustmentType3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType3Member_lbl" xml:lang="en-US">Adjustment Type 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType4Member" xlink:label="RDNT_AdjustmentType4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType4Member" xlink:to="RDNT_AdjustmentType4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType4Member_lbl" xml:lang="en-US">Adjustment Type 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_HowardBergerMember" xlink:label="RDNT_HowardBergerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_HowardBergerMember" xlink:to="RDNT_HowardBergerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_HowardBergerMember_lbl" xml:lang="en-US">Howard Berger [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType5Member" xlink:label="RDNT_AdjustmentType5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType5Member" xlink:to="RDNT_AdjustmentType5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType5Member_lbl" xml:lang="en-US">Adjustment Type 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType6Member" xlink:label="RDNT_AdjustmentType6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType6Member" xlink:to="RDNT_AdjustmentType6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType6Member_lbl" xml:lang="en-US">Adjustment Type 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType7Member" xlink:label="RDNT_AdjustmentType7Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType7Member" xlink:to="RDNT_AdjustmentType7Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType7Member_lbl" xml:lang="en-US">Adjustment Type 7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType8Member" xlink:label="RDNT_AdjustmentType8Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType8Member" xlink:to="RDNT_AdjustmentType8Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType8Member_lbl" xml:lang="en-US">Adjustment Type 8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType9Member" xlink:label="RDNT_AdjustmentType9Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType9Member" xlink:to="RDNT_AdjustmentType9Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType9Member_lbl" xml:lang="en-US">Adjustment Type 9 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType10Member" xlink:label="RDNT_AdjustmentType10Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RDNT_AdjustmentType10Member" xlink:to="RDNT_AdjustmentType10Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RDNT_AdjustmentType10Member_lbl" xml:lang="en-US">Adjustment Type 10 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Disclosure - Pay vs Performance Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">Summary Compensation Table Total for PEO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">Compensation Actually Paid to PEO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Average Summary Compensation Table Total for Non-PEO Named Executive Officers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Average Compensation Actually Paid to Non-PEO Named Executive Officers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid and TSR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid and Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid and Adjusted EBITDA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Financial Performance Measures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Adjusted EBITDA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Award Underlying Securities Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Award Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Award Grant Date Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rdnt-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember" xlink:label="loc_ecdPeoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdPeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentTypeMember" xlink:label="loc_RDNTAdjustmentTypeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentTypeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType1Member" xlink:label="loc_RDNTAdjustmentType1Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType2Member" xlink:label="loc_RDNTAdjustmentType2Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType3Member" xlink:label="loc_RDNTAdjustmentType3Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType4Member" xlink:label="loc_RDNTAdjustmentType4Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType5Member" xlink:label="loc_RDNTAdjustmentType5Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType6Member" xlink:label="loc_RDNTAdjustmentType6Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType7Member" xlink:label="loc_RDNTAdjustmentType7Member" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType7Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType8Member" xlink:label="loc_RDNTAdjustmentType8Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType8Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType9Member" xlink:label="loc_RDNTAdjustmentType9Member" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType9Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_AdjustmentType10Member" xlink:label="loc_RDNTAdjustmentType10Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_RDNTAdjustmentType10Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="rdnt-20231231.xsd#RDNT_HowardBergerMember" xlink:label="loc_RDNTHowardBergerMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_RDNTHowardBergerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !O -(# 2(  A$! Q$!_\0
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<VL1$P<R [VP&(P3C.,D5=HH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  ^ ',# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:DI:2@ X
MI#WJO?WD=C:/-("0. HZLQX 'N32VGGFTC^U!5E(^8+T'M1;J%Q]M<Q74>^%
MPR@E3CL1U%25F0)]EUV:),*D\(DVC^\IP?T(JQ>ZC#8J@<,\CG$<2#+.?8?U
MIV[ 6Z6LIM1O( DUY9I'"7"G;+N=,G )&,?E6H#S0U82=Q:6DR#4,EU''<10
M'/F2Y*@#L.M(9/249%4VO0=02UC&YMI>0_W1V_$T 7:*3-% "T444 %(3Q2T
MQV"(6)X49- &7M.H:V2W^IL<8'8RD?T'\ZU>E8.EW<@CAB@0/<7+FXF)Z1HQ
MX)]\8Q6U-*D$+R2$*B EB>PJI+H)&7>W<=OK+W$A^2VLRSX_VF&!^E2Z7929
M:^N_^/R<9.?^6:]D'T[^]9QB>X^RR7 (>_NA(RGLB@E5_05IWE[(\_V&Q(-P
M1EWQD0KZGW]!3?9$IC+@_P!HZ@EJG,-NPDG;MN_A3^I_"K.I:@FG6ID8%Y&.
MV*(?>D<]%%/M;2*QMA'&3M'S,S'ECW)/K5"R3^U+_P#M&0#R8LI:@CM_$_X]
M!2T*-.%I&A1I5"R%064'(![BJ%AFZU"ZO#RH/D1?1?O'\3_*GZOJ,>F:?/,9
M%#A<(N<DL>!@=ZHV4-[<64-M"6LK55 ,C#][)ZD#^'/J>:$M+B;UL7+W4B)C
M9V*B:\(Y'\,0]7/]*GL;%;&$C<9)7.Z65NLC>II;2TM[&+RK=0H'+9.23ZL>
M]8_B'7XXD6PL9/,NYSL/DC>T2=VP*:C=V0-VW-/3[][ZYN615^R1MY<;]Y&'
MWC].U7P<UAVDM[':Q6VG:;Y,,8"J]T^WC_='.:T[*&XBC)N[CSI6ZE5VJ/8"
ME):C3+5%%%2,">*Q=9UM+1OLGEL\LZ[%.0%5B. Q[=^:V3TK)LM%"27$]^4N
M9[@G=D?*J_W0#VJHVW9+U(]#$&G:%')*ZJVW,TCG^(<')]L8J!]2M]5NVBEF
MCBM(,2.DAVM+_=)!Z+W]ZO6WAZPMIVDB@0@D,$;D(?;/2G:C;VL1%RUG!-<D
MA(]P +'L,FG>-[BLTC)UC4&N4@N;1A%%;R;C<R  ,,8(0'[QQ5NRU+2+*U"V
M\[.#\S,%9F8^K<=:M6FE*)#<WVVXNF[L/EC']U1V%/U._-A;J8(#//(VR*)2
M 6;\>P[TW)-<HDGN4+G5;;59$L(+@(KC=.S':0O]W![G^5;,)AV!(63:@P A
MX JI8Z;&MJ!=1I+-(?,E9P&RYZ_AVJ>?%C:2/;6WF,@R(H@ 6]JAVV1:3ZG.
MZU90MK2WT$86:T9)99.NXL=H7\LFMK4KB8LEI:/LGF!_>$9\I!U;^@J"TTZ2
MYTB1+U##<W+&27!!(;.1^ P*FFTMYF64WDJ3;=CN@ W+W&.WUJFUH*UCF;&'
M3GO99$>XN NZ,Q2.=UQ)GKM'4>Y]?:M#PNEN=2OI1&%F8[4*KA&0'!V>H#<?
MA701V5O%"L<<2*%78"!SCZ]:I2Z%$[P&&66!;:-DA6(XVD]_?ITJG.]T3R6-
M7%*!5#1[R6]TZ*6=-DN2KC(.2"1GCUQ5^LGHS06BDHH **6B@!#Q61,1=>)(
M8F/R6D/G8]68X!_  _G6N>E9MWI]PU_]KL9XXI3'Y3B1-RL <CN*<1,L7EY%
M90^9,W!X51RS'T [U6L+25[AKZ^'^D.,)'U$*>@]SW-.M=,\JX^TW4S7-R!@
M.PP$'HJ]OKUK1 P*-@"BEHI#$HI:2@"K?W1M;?=&H:5V"(OJQZ57OKN2)$MK
M<A[R883_ &1W<^PJ74;$WT*HDS0R1N)$=0#M8>Q^M)8:=':;W+--/)S)-)]Y
AO\!["FK6%U)[2V2TMHH(_NQKC)[U/1C%+2&%%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "3 3X# 2(  A$! Q$!_\0
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M@N((@&[N>6/XU;HHH **** "N?U_P9H_B%&:XMQ%<GI<P@*X/O\ WOQKH**
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MH/8?K0!1\$^"XO#=M]INMLNIS+AV'(B']U?ZGO77444 %%%% !1110 4444
M%%%% !5'4]-34(>RS+]Q_P"A]JO44 <%-#);RM%*A1UZ@TRNVO;""^CVS+R/
MNN.JUS-[H]U9DL%\V+^^HZ?44 -LM4N[0A(FWH3@1OR/P]*BA^*.AF\FM[I+
MB#RY"@E";T;!QGCG]*R=7OO[-T>ZNP<.J;8_]]N!^77\*\KZ"@#Z$@\9^&[@
M#R]9M.>SOM/ZXJ27Q;X>A&7UFR_"8'^5?.]&/:@#VZ_^)WAVT4B"6:\?L(8R
M!^;8KAM<^)FLZHK0V073X#_SS.9"/][M^ KBZ2@!22S%F)+$Y))R2:%4LP55
M+,QP !DD^@K5T3PWJOB"8)I]JSQYPTS_ "QK]6_H,FO7O"O@+3_#NVYE(N]0
MQ_KF'RI[(.WUZT 9/@+P&=,*:MJT8^VXS# >?)]S_M?R^M>AT44 %%%% !11
M10 4444 %-DCCFC:.5%=&&&5AD$>XIU% '':K\-/#^HEG@BDL93WMVPN?]T\
M?EBN4O/A%J$98V6IV\R]A*A0G\LBO7** /#Y/ACXF0X6&UD]UG _F*6/X8>)
M7/S1VD?^]/G^0->WT4 >3V7PANF8&^U6*->ZP1EC^9Q_*NNTGX>^']*99/LI
MNYASYER=^#[+T_2NJHH 0 *    . !2T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% &-K?A?2]?MO(O(6 #;PT3;#GIGCKU/6N'OOA#R38:L<=DN(L
M_JO^%>HT4 >+2_"KQ"C$)+8RCU$K#/YK3%^%GB-CR;)?<S'_ .)KVRB@#R>T
M^$-XS#[9JL$:]Q#&6/ZXKJ=+^&OA[3BKRPO>RCG=<-E<_P"Z,#\\UU]% #8X
MTAC6.)%1%&%51@ >PIU%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "P 5P# 2(  A$! Q$!_\0
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M^D.H$_:9?/1GDCPWR#RQ)TVG# 8XKH-$TV_L/$NH9CN&TYT_=RW,^YE(( 1
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M<C]"*SR,@BNM^),(A\<79'22.-_QVX_I7)4 ?1OAJ]_M'PSIMV3EI+="Q/\
M> P?U!K4KE?AS*9? U@#_!O3\G-=50 50UD9TBX_W0?U%7Z@O8O.L9X_[R$#
M\J .%K0T1MNKP>^1^AK/'2IK27R+R&7LK@GZ4 =W11UHH *I:MJ<.C:7/J%P
MLCQ0@$K$N6;)   ]<D5=K+\1Z2VN^'[O3%=4,X5=S XP&!/3V% $T&J0R1P&
MY5K&:=BL=O=,BR,0<< ,<_@>]*=8TP.R'4;0,K!2#.N02< =>I(-<UJ/@6*?
M6+>XM=GV-8HX7MWED78%E,FY2.223T..@YJN?AZC6LB,+%I7LKVW\PP#/F3R
M[U?\!^- '47^NZ?I]M=S/<)(UHN^:*)@TBCW7/'6KB7=M)<R6T=Q$T\8R\2N
M"RCW'45QEWX*U2\U.^N)=0MV2:">&+Y""HD:,@$#CC9C/);.35[1O"3Z9XBG
MU"5XYE,L\L4GF.'7S6W%2OW>.F?8<"@#JZ*** "D9@JECT R:6J6KLRZ/>;)
M!&[1,JN1G!(P#^9H ^;I6WS2/_>=C^M$2[YXU_O.H_6MRX\&:Q;C]U'%=*.\
M,@S_ -\G!J+0])N7\5:997-M-$SW*%ED0KP#D]?8&@#Z&4;5 ]!BEHHH ***
M* "BBB@ HHHH X&48FD'HY'ZTRK>IQ^5J=PN,#>2/H>:J4 =_&=T2$=P#3JI
MZ5-Y^F0/GD+M/U'%7* "BBB@#%;Q1IXTN"^59Y!<3O;P0I'F661692%7_@#'
M)X &3BJ]YXOMK"*)[G3=30M%+-(GDC=#'&5#NPW=/F'W<Y[5F0>%=9A@MD$^
MGA]/NII[1\.1*LIDWI(O&/EDZ@G!'X50N?A]>3V4$+_V9-@78,<XD*0><R%?
M+YR=NSOCKVH Z!_&MC#?7=O<65_#':0BXFN'C7RQ&=VUAAB3N*$  9SVJY8^
M([2\FN()H;FQG@A$[Q7<>QO*.?G&"01P<\Y'<"LN[\'37@U!)=19C<Z?;6JS
M,F7$D+.PD8=#DL#CV-07'AK5M8U6:76_L;03V#6BFSDD0PG=NW$'!;)V\9&-
MN.<YH ["*5)X4EB8/&ZAE8="#R#3ZHZ/I4&BZ5;V%N6*0H%RS%B3CD\D_E5Z
M@ HHHH \-^)D@D\;W !_U<,:GZXS_6N0KM_%7AO4]3\07^HVSV\Z2R95!)M8
M # &&P.@]:Y*\TV^T_/VNSGA [NAQ^?2@#VOX;QF/P/9$_QM(P_[[-=96-X2
MM#8^$M+MV^\MNI/U(R?YULT %%%% '#W\!M;Z:+' ;(^AY%5JZ+Q':95+M1T
M^1_IV-<]0!V&C7?VO3TR?GC^1OPZ?I6A7&Z5?FPNPS$^4_#C^M=BK!E#*001
MD$=Z %HHHH **** "BBB@ HHHH *P/$ET L=HIY/SO\ 3M6S=7,=G;O-(?E7
MMZGTKB;B=[FX>:0_,YS]/:@"*MKP]$\MXTA),<2]#TR?\FL6NQT:S^R6"[AB
M23YV_H* -"BBB@ HHHH **** "BBB@#F/$=OLNXYP.)%P?J/_K5C5V6K6GVS
M3W11EU^9/J*XR@#H/#=V 9+1CU^=/ZUT-<%#,]O,DL9PZ'(KMK.[CO;99H^A
MZCT/I0!/1110 4444 %%%% !1110 53U2[^QV$D@/SD;4^IJX3@9/2N0UC4/
MMUUA#^YCX7W/<T 9U3V<;SW,<"D@2, 1VQWJO6]X<M-TCW;#A?D3Z]S0!T0
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MC"C\* ,73])GOF#8,</=R.OT]:ZNUM8;.$10KM4?F3ZFI@ !@# %% !1110
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M_B,U9CABB_U<:)_NJ!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@".2"*7_61(_\ O*#59M(L&.3:Q_@,5=HH HC1]/'_ "ZI
C^.:GCLK6'_5V\2^X45/10 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '  DX# 2(  A$! Q$!_\0
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M[0KR'Q!<0W^JW"F=+[4YHUNPAD_=++D^43UXQG;B@#W:BO Y;Z^UC3?#^F6
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M5<\X_P#/*3\A_C1YQ_YY2?D/\: *L^AZ5<^?Y^FVDGVA$CFWPJ?,1#E5;CD
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MB@"!+*U3=LMHE#  @( #@Y'ZFI&AB??NB0[\!LJ/FQTSZT^B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ J-X(9)$DDB1G0$*S*"5!ZX/;-244 1
M1VT$6/+@C3!+#:@&"1C-+Y$6PIY2;2"-NT8P>OYU)10 T1H'WA%#8V[L<X]*
M=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%1O<0QS1PO-&LLF=B%@&;'7 [XH DHJ,SPJZ(94#N2JJ6&6(Z@>M
M(+FW-NTXGB,*YS)O&T8Z\].* ):*C$\32"-94,A7>%##)7UQZ>]24 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+ZS
MH=Y=^,-*U*UMK?9"NR:XD<$JF22NPJ>3DX92"#G/%=110!Y_J/@B_EDMHK+[
M/##'),4;?S$'F\P'E23Q_=93GJ2*O0^';]-%FM_[/L(]]Q%<?8DE_<L(Q&-I
M.W^/:6Z<<9SS7944 <=HGAF]T[5+.2:"SVQ?O&N$8F108MGD ;?N \@YQQTS
M78T44 %%%% !1110 450UNU:]T2]MDCDD:6)E"12B-FR.@8\ _7BN2T_P_JX
MT.R @:TN([&YMUC$NP1[@/+)4,5#GN5SCVZ4 =Y17"2:->/HWV-=$F^S+=-.
MNG>>@VQLC*J[MVW(<!\9XR",D8JM+X;U;[2'N=.>]56S?$7*C^T%XV* 6'W"
M,_-@<<9S0!Z)15/2H+BVT>S@NGWW$<")(V[=E@H!Y[\]ZL;9?[Z?]\?_ %Z
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MST3_ +X_^O1MF_YZ)_WQ_P#7H DHJ/;-_P ]$_[X_P#KT;9O^>B?]\?_ %Z
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:/L\?H?^^C0!+147V>/T/_?1H^SQ^A_[Z- $M%1?9X_0_P#?1H^SQ^A_[Z-
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MO5P&TCR,QWC\Q****](\L^@_@Y_R(O\ V]2?R6O0*\_^#G_(B_\ ;U)_):]
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MZ<ME;-*XWO*\LS[I)9'8LSL>Y))-:%%% !1110 4444 %%%% !1110 4444
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MH;_-^_[;O]K&,^^:N9F_N)_WT?\ "I** (\S?W$_[[/^%&9O[B?]]G_"I**
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M\S?W$_[[/^%>$_!3_D<;K_KQ?_T-*]ZKQ<;_ !?DCWL#_!^;(\S?W$_[[/\
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M7XA:8LD\C+^]X+DC_5M7T97'7H^RERWN=N'K>VCS6L%%%%8'0%%%% !1110
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M[5NA// .1CZB@"_13(I8YHDEB=9(W 974Y# ]"#W%/H **** "BBB@ HHHH
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MH\(['X6?\E%TO_MK_P"BVKZ2KYN^%G_)1=+_ .VO_HIJ^D:\?'?Q%Z'MY?\
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M7CK0!VX(90RD$$9!'>EK/T.QDTW1;6SF*>9$F"$^ZO.=H]AT'L*T* "BBB@
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M6],_Y"MI_P!=D_\ 0A7AT/XL?5?FCTI_"ST^BBBOU@^;"BBB@"MJ/_(+N_\
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M8Y-T=.Z/,:*N?V3J7_0.O/\ OPW^%']DZE_T#KS_ +\-_A7L\R[GA\LNQ?\
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M0 (9/,= -N-KN<L#GT&!Q6]9Z-#9Z@;X2R/.UI%:-NVA2L98@X4  Y<]..F
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M\.B6DD$4TTS2S-/++,1N=VZG"@ ?0 4 :&!Z"C:I[#\J6B@!NQ?[H_*C8O\
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MP%.1N54 '''R[<@ '-6+_P .V]_=32O=7D45PH6YMX90J3X&!NXW#C@[2,@
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M(NBNN)1$5*!OEZ H#QCJ:Z*@ HHHH **** "BBB@ JK+J5C!(8Y;N!'7JK.
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MZY^T3>?YA,Q.V3&X2IM8'CD#J/0_C0!<MO$.C7DT$-MJEG++."8D292SXSG
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M'+$8.W/!<D9)Z =!BMS2]-CTJT-O'--,6E>5Y)B"S,[%B3@ =3V% %VBBB@
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  [ &X# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (4 KH# 2(  A$! Q$!_\0
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MD9&1D9R/2:* /F3X9_#W]IO5?B;X8UCXI^/O!]AX8\/PS!]+\#07._79'CV
MWGVA0J!3AQY8QG("KD,OFNA?L4_%G3]-T/X377B_PH_P#T3Q(-?M9X;:X'B.
M6-;EKQ;23(\@+Y[D&0'=@ ]#Y=?<M% 'Q=KG[%OC;4O!?Q(TB+5- 6Y\2?%=
M/'5HSW$X1+$30OY<A\G(FQ&WR@%<D?/7G_[<7P:U[X<_!G]KCQ]>WFGR:9XT
MNO"MQID5M([3P_9+FVBD\Y60*"6(*[6;(ZXZ5^B-% 'QJW['OQ+^,.N_$;6O
MC)XL\,IJNM^#)/ ^D2^#[.<10VS3_:/M<\<Q!,OFK&3&K;<;@&7@UQ?[/_\
MP3S\1?#7PQ\1TU70OAOH/B'6_"5[X;TV]\*WVN3M*]Q$59[IKN=HT3<J$B.
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MV\9ZEINM>%-2L99?M6D7UG:F..=_D78P<D?NV8E'<9!-?7M% 'YB:M_P2O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFS_\&S__ !JC_AZUJO\ T3FS_P#!L_\ \:KK_L;&_P GXK_,X_[<P'\_X/\
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M?("+=>?YRQ>23%Y0<1["5VX.*Z#3_@WX/TOQP/%MGI'V;60@5?*NIEM580I
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M2ZA>LLD,E\B*@N_+E>,3A4^4>8$#X7CYN !Q0!VE%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 <]X@']JZSI6DCF-7^WW//\$1'EJ?K(4/N(VKH:YSPGG4K
MK5=:;D7D_DVY_P"G>(E5_!G\QQ[.*Z.N3#^^G5_F_+I]^_S ****ZP"BBB@
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M+1_R->15Z[^R/_R<M\._^PM'_(US8G^!4]'^1UX3_>*?^)?F?M71117Y&?M
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M7_>(?X?U84445]2?(!7KO[(__)RWP[_["T?\C7D5>N_LC_\ )RWP[_["T?\
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M9>(_VBO"WBOP]#H^BZ=::>\-WXFMKN6#4=HFA<VL]NJE+V)E5Q&LK!8C-*X
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M$4LT/^LC1P63Z@=/QJ>NQ-/5#"BBBF 4444 %%%% !1110 4444 >/?M@?\
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M+2)& .'K[^H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Y[QFQO;.VT:,XDU686[X/(@ +3'\44KGL76N@4!0 !@#
M@ 5SVE_\3;Q9J6H'F"P0:?;^F\X>=A^/E+]8VKHJY*/ORE5[Z+T7_!O\K""B
MBBNL84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'<1>?;
MR1YV[U*Y(SC(].]244M] /E+X4? WQ[\/?B5'K,]FLMA9>8)&M[R,&]1@5VH
M">N2&P^T?+U'%?2VC^*+#69WMHY'M[^,;I+&Z0Q3H,XSL/)7(.&&5/8FM>J&
ML:#8:]"D=_:I.(VW1ORKQ-C&Y'&&1O=2#7S^6Y1#)J3HX*3<6V[2\^S2T^Y_
MJ2E;8OT5SXM-:T/_ (]9_P"VK,?\N]TP2X4>BR]']@X!]7JYI?B2RU2=K96>
MVOU&Y[*Z7RYE'&3M/WEYQN7*^AKV8UHWY9KE?G^CV?YE&I11170 4444 %%%
M% !1110!X]^V!_R;-\0_^P8W_H2U^+%?M/\ M@?\FS?$/_L&-_Z$M?BQ7WG#
M_P#N\_7]$?G?$O\ O$/\/ZL****^I/D KUW]D?\ Y.6^'?\ V%H_Y&O(J]=_
M9'_Y.6^'?_86C_D:YL3_  *GH_R.O"?[Q3_Q+\S]JZ***_(S]H"BBB@ HHHH
M **** "N>^(7CC3OAIX(UOQ3J_F'3M)M7NIEB**S!1PH9V5%).!N=E09RS*H
M)'0UF>)K'4M3\/W]KHVJ+HNK20L+34'MEN4@EZJSQ$CS$SC<NY21D!E.& !Y
M_HG[0^AZMX;\%:K<Z)XBT:7Q9=K:6.GW^GYFCW$;997B9XDB*E&#B0@[U RW
MRC4\&_&33O&GC#4- @T?6+#R?M9L]2OH8EM=3%K<?9KIH-LC.!',54^:D>\.
MK1[T.ZN+^$/[-\_P[^$?A/PI=:K8+>:3JMOK$XT?3S;V DC(+16\)<F-6QN9
MB26D:23:N_8NSX2^"^M>$_&$^KIXHLKNSM3?1Z+9R:.5>S@OKZ.[O(YI%G'G
M']TD<3*L>Q5!<3-DD KVG[3&DZA9W<MMX4\3S7#&W;1[,06PDUZ"XDD2"XM&
M,X18V\IW_P!(:%E0!F50RY](\&^*K3QOX8T[7+**XMX+R/?]GNTV30L"0\<B
M@D!U8,I )&5."1S7CNF?LU:WI%K;M;^-+$W^@QV=GX5EDT',.G6EL\OEQW,8
MN UR[13&)W1X 0BE50[BWK7P]\(_\(+X/TW16O/[0GMU9[B\\H1>?,[M)+($
M!(0,[L0N3@'&3UH Z*BO*OV@/CL_P#\/V^NS^$-3\1Z.$E>^OK&\LK6&P5-F
MWS6NIXA\Y<A0N>4([C-O]G[XT-\>_A_'XM'A#7_!EK/.T=K:^(H$AGN(@J,)
MT56;]VQ8@$X)V$XP02 >E4444 %9?BC^TO\ A&=7_L;[-_;'V.;[%]LSY'G[
M#Y?F8_@W8S[9K4KDOBY?:;IOPM\6W&L66H:CI"Z7<B\M=*0O=2PF-@ZQ '.[
M:3@YXZ]J /A7]D?^PO\ A?VB_P#"&>3_ ,)'FZ_X2[[;_P (=Y?E>6^[[+_9
M/^E;_/\ +Z_)MW;NU?HO7YE?L\?&2+Q=\8?A0EQ_;'B3PE9W;6>D7EK8Z;%Y
M6JG3Y&DBS:6:-<1P02[9)$D1=S@M&P&:_36@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "L[Q!JZZ#HMY?LGFF&,E(@<&1
MSPB#W9B%'N:T:YW6L:MXCTO2QS%;G^TKD=OD.(5/UD^<?]<37/7E*--\N[T7
MJ_\ +?T T/#NE'1=%M+-W\V9%W32?\])6):1_P 7+'\:TJ**UA%4XJ$=D 44
M458!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %4]4T>RUJ%8KVW2=5;>A;AD;LRL.58>H(-7**F45-<LE= <V]CKVA'=87"
MZW9J/^/.^?9.H'9)@/F^D@R>[U:TGQ98ZI=?8V\VPU,#<=/O4\N; ZE1T=?]
MI"R^];54]4T>QUJW$%_:0W<0;>JRH&VL.C*>S#L1R*YO93IZTI:=GJOD]U^*
M\A%RBN>_LW6-#YTZZ_M6T'_+EJ,A\U1Z)/@D_20,2?XU%6M+\46>HW(LY!+I
M^I8)-C>KY<N!U*\E9 .[(67WJHUU=1J+E?GU]'L_3?R&:]%%%=(!1110!X]^
MV!_R;-\0_P#L&-_Z$M?BQ7[3_M@?\FS?$/\ [!C?^A+7XL5]YP__ +O/U_1'
MYWQ+_O$/\/ZL****^I/D KUW]D?_ ).6^'?_ &%H_P"1KR*O7?V1_P#DY;X=
M_P#86C_D:YL3_ J>C_(Z\)_O%/\ Q+\S]JZ***_(S]H"BBB@ HHHH **** "
MBBB@ HHHH **** /BK_@I3X:B\1:7X#FGT*VOX-'N6U&35=1O=1AMM/5K[3;
M3?LLG1VE_P!,$JL22B6\VU26Q7T-^S?X/MO"7PDT.6&UUS3KG6;:#5[S3O$&
MKW.I7-E<2P1>9!YMPS. A7;MX&0QP"36;\?K"TU"Z\/IJGQJN_A'I7EW6^'3
MKRQL[G4I=T&QA-=(^$B D!1$RQG4E@%PVG^SEIMKH?PKTS2;?XGW'Q<ET\"W
MNO$MU>074DDP12ZEXLX'.X+(SN XW.W!H ].HHHH *K:E8KJFG75F\LT"7$3
MPF6VE:*5 P(W(Z\JPSPPY!YJS10!\\:9^SUK.DZU!I?_  OCQ(FBP[Q#HMO8
M:-;7BJY#LHNH[03#=CYF7:[==V>:^@X(1;PQQ!F8(H4-(Q9C@8R2>2?>OB;P
M)H_A[2_VR-4+Z+X4O;VZ\17LMOXIN/"NH?:_M!A=WL8M5;_1VGC19,H#@(K(
M.5Q7V[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7/>$/^)@M]K9Y_M*;="W_ $[I\L6/9AF3_MH:?XSN)?['^P6SM'>:
ME(+*%E^\F_.]Q[K&'?\ X#6U;V\=I;Q00H(X8E"(B]%4# 'Y5RO]Y62Z1_-_
MY*_WH"2BBBNH HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "JFI:59ZQ:FWOK:.ZAR&"R+G##HP]".Q'
M(JW14RBI+EDKH#F?[*UOP_EM*O/[7LQ_S#]4E/FJ.>([C!8_20.3_?45<TWQ
M;8WUTME,)=,U,C/V"_41RMCJ4Y*R =S&S 9Y.:VJJ:EI5GK-HUK?VL-Y;L03
M',@89'(//0@]#U%<WL9T_P"#+3L]OEU7XI=@+=%<W'HNKZ"<Z5?'4+(#_D'Z
MF[,R].$GY8=^'#YSU45<T_Q/:W5TEG<)+INH-TM+P!&?UV,"5D_X 3COBJC7
M5^6HN5^>S]'_ ,,_(#S;]L#_ )-F^(?_ &#&_P#0EK\6*_:?]L#_ )-F^(?_
M &#&_P#0EK\6*_1>'_\ =Y^OZ(_.^)?]XA_A_5A1117U)\@%>N_LC_\ )RWP
M[_["T?\ (UY%7KO[(_\ R<M\._\ L+1_R-<V)_@5/1_D=>$_WBG_ (E^9^U=
M%%%?D9^T!1110 4444 %%%% !1110 4444 %%%% 'SO^UY>W-G:^&OLD?B9Y
MF6\V'P]X"3Q0 V(L><&B?R!GI@KO^;^YQZC\$]-N=/\ A1X4?4M&AT+7;K2[
M2YU:SBMHK<K>M GG;TB54#A@0=HQQ@< 5XA^VMIFFZMJW@B&_P!#D\;R+9:U
M)!X1_LJ?48Y7$$6S4&BB=/\ CVE\E,DYVWCA/WA2O=/@Q]G_ .%/^!OLFNR^
M*;7^PK'RM<G!$FHI]G3;<MDYS(,.<\_-0!V5%%% !5#7[^?2M!U*]M8(;FYM
MK:2:*"XN!;QR.JDJK2D$1J2 "Q!P#G!Q5^B@#X'^&GQ:\'^,OVJ-+DTF?0]1
MTN\\1WKV%EIWQ+%]$E^;>=9;Z/2%M=V759CO,GE9E9U)+ G[XKX?\/\ C[7/
M!/[7WACPG9KX4TG1/$^M:O%#H^A:%:0W"06JW)>2:Z#EBSF-'(VABS2KUC8'
M[@H ^9?C1\5_&7P[^/VCO%KS2>"%TMFET/2XK2Y8W?F1Q(+U'1;B-9'N85C>
M"5OFVEX@BR,Z_"_XI_$+2?AG\2=6\5WMOX@U[2M!C\3Z;;QS07,0BFM9I8H?
M,@M[8 %X&_<LKL@8'[1,'4K[GJ7PR\):QXZTKQI?^&],O/%NE6\EI8ZU-:HU
MU;1.<LJ2$9'5L=P'D P';,6B_"CP9X;6V31?"VD:)';ZD^L)%I=G':H;UX6A
M>X98PH>0QNREF!/3N!@ ^>]4\=>-M+O]7\()\5;B8:1#=ZH/&$EAIOG3^3IU
MK<K:3*(A!Y9-RTQ*1H_E*@#@YD;K/A_\2O%/B#XC:3?7NNNVGZOJ-SH\GA/[
M/;"+3UBL$N1<!POGF0L #ND9-MRF$4@,?3H_@G\.X?#%IX;C\!>&$\.V=V+^
MVTA=&MA:0W(SB=(=FQ9.3\X&>3S6W;^"?#MIXLNO%,&@:7#XFNK<6EQK4=G&
MM[- ""(GF"[V0%5.TG'RCTH V2< G&:K?;C_ ,^T_P#WR/\ &K5% %7[<?\
MGVG_ .^1_C1]N/\ S[3_ /?(_P :M44 5?MQ_P"?:?\ [Y'^-'VX_P#/M/\
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MLN>X4G:/916Q7/AXM0YI;RU?SZ?)67R J_;C_P ^T_\ WR/\:/MQ_P"?:?\
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M 'R/\:/MQ_Y]I_\ OD?XU:HH J_;C_S[3_\ ?(_QJOJ$=MJUJ]M>Z:UU;O\
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MJ_;C_P ^T_\ WR/\:/MQ_P"?:?\ [Y'^-6J* *OVX_\ /M/_ -\C_&C[<?\
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M5I%,BE4C41^4T>))E+>8,)7>Z3\#OAYH>B^&-)L_ _A^+3_"\GG:'"VFPO\
MV;*6WF6 LI,<A8;BX.YF^8DGFM2?X:^$;K5M+U2;PKHLVIZ5/<76GWDFG0M-
M9S3N7GDB<KF-Y')9V4@L22<F@#R_]GSQUXC\3ZHC:YXD;7DUKP[8^)18R6]M
M$=&DN)9U:T0PJK-$NP(OF[Y-T,FZ1LX7W2L7P]X)\.^$;K5KG0M TO1;G5KI
MKW49M/LXX'O;AB2TTQ109')))9LDY/-;5 'R=^WLT=O8^$+M?$V@^$KR!;]E
MU#5-6U73;EHL0&2&*;3R&\I\+YBOP=L9'*Y'N_P(O!J'P0^'MT-*BT(3>'M/
MD&EV\;QQV>;:,^2J.2RA,[0&.0!SS7@G[?7CG7?!]CX/70=:\1:)+(99+R?2
M=?M='LUMFO-/LS)<S3VEQRLM]!MP$"HTS,3M KWWX%MIC?!/X?G1;*]TW1SX
M?T\V5GJ3%KF"#[-'Y<<I/615P&/J#0!W%%%% !1110!\8_#_ $G3KW]JK7[O
M3_!]JMO'XHE$VI:AXXB-W!-#%=Y,.E^066-Y+Z>7;YN6\Q7X "5]G5\;>%_$
MFOO^VEJFB7'POTZ%?[0-Q'K$?A-8C!9^5=AKLZGC$CR,+0\$',KQ[259A]DT
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/>),
M:IJ>E:*#E)I/MER/^F,14@?C(8Q[@/70USOAD?VEJFKZT>4FE^QVW_7&$LI/
MXR&4^XVURU_>Y:7\V_HM_OV^8'14445U %%%% !1110 4444 %%%% !1110
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MV;XA_P#8,;_T):_%BOO.'_\ =Y^OZ(_.^)?]XA_A_5A1117U)\@%>N_LC_\
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M;>O_ &?[/PC8>$]2@\&^.]3^(6FQZE(LVJ:IXADUMXYQ'&'A6X=FPJ@*=@.
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M^8!1116H!1110 45\4ZM_P %0O"6DZI>6,G@O6G>VF>%F6>'!*L02.?:JO\
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M&_\ 0EK\6*^\X?\ ]WGZ_HC\[XE_WB'^']6%%%%?4GR 5Z[^R/\ \G+?#O\
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M0 4444 %%%% !1110 5SNB_\3;Q'JNJ$[H;<_P!G6WI\AS,P^LGR'_KB*O\
MB356T71;J[C3S;A5"01?\])6(6-/Q8J/QI^@:2NAZ+9V"OYI@C"O*>LC]6<^
M[,23[FN6?[RM&'2.K_)?J_5(#0HHHKJ **** "BBB@#\#_&G_(X:[_U_S_\
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M'_?]_P#&C^S8_P#GK<?]_P!_\:MT4 5/[-C_ .>MQ_W_ '_QH_LV/_GK<?\
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M '_QJW10!4_LV/\ YZW'_?\ ?_&C^S8_^>MQ_P!_W_QJW10!4_LV/_GK<?\
M?]_\:/[-C_YZW'_?]_\ &K=% %3^S8_^>MQ_W_?_ !H_LV/_ )ZW'_?]_P#&
MK=% 'BO[7EBD?[-/Q"823$C3&X:9B/O+V)K\8:_:?]L#_DV;XA_]@QO_ $):
M_%BOO.'_ /=Y^OZ(_.^)?]XA_A_5A1117U)\@%>M_LEH)/VDOAXI+ '58QE2
M0>A[UY)7KO[(_P#R<M\._P#L+1_R-<V)_@5/1_D=>$_WBG_B7YG[0?V;'_SU
MN/\ O^_^-']FQ_\ /6X_[_O_ (U;HK\C/V@J?V;'_P ];C_O^_\ C1_9L?\
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M#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KG_&DC7&FPZ3$Q6;5I19@KU6,@M*WMB-7P?4K705SMC_Q-_&%[>=;?
M3(OL,/O*^V24_@!$N?7>*Y<1[T537VM/EU_"_P Q'01QK#&J(H5% 55'0 =J
M=1174,**** "BBB@ HHHH _ _P :?\CAKO\ U_S_ /HQJQZV/&G_ ".&N_\
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MBBB@ HKE_B1\3/#GPC\+3>(_%5^=,T>&1(GN!!)-AG.%&V-6;D^U>0_\-_?
MG_H=7_\ !1>__&:Z*>&KUES4X-KR39RU,50HRY:M11?FTCZ&HKYY_P"&_O@3
M_P!#J_\ X*+W_P",T?\ #?WP)_Z'5_\ P47O_P 9K7ZCBO\ GU+[F9?7\)_S
M^C_X$O\ ,^AJ*^>?^&_O@3_T.K_^"B]_^,UV?PK_ &G?AM\:]>N=%\&^(6U;
M4K>V:\EA-C<0;8@ZH6W21J#\SJ, YYJ983$4XN4Z;27DRX8S#5)*,*L6WYH]
M3HHHKD.PHZYJT>A:/>ZA,I>.VB:4HO5R!PH]R< >YJ#POI<NCZ':V]PP>\(,
MMRZ]&F<EY"/8LS8]JIZ\W]J:[I.D#)C5O[0N?39$1Y:GW,I1O<1M70UR1_>5
MI2Z1T^;U?Z?B(****ZQA1110 4444 %%%% 'X'^-/^1PUW_K_G_]&-6/6QXT
M_P"1PUW_ *_Y_P#T8U8]?L<?A1^'S^)A1115$!7[U^ _^1'\._\ 8.M__12U
M^"E?O7X#_P"1'\._]@ZW_P#12U\?Q%\-+Y_H?;<,_'5^7ZF[1117Q1]Z%%%%
M !1110 4444 %%%% !7YW_\ !5S_ )"_PV_ZX7__ *%!7Z(5^=__  5<_P"0
MO\-O^N%__P"A05[>3?[]#Y_DSP<\_P!PJ?+\T? ]%%%?I1^5!1110!^GG_!+
M7_DB/B;_ +&*3_TFMZ^S*^,_^"6O_)$?$W_8Q2?^DUO7V97Y=FG^^5/4_7<I
M_P!QI>@4445Y9ZP4444 %%%% !1110 4444 >/?M@?\ )LWQ#_[!C?\ H2U^
M+%?M/^V!_P FS?$/_L&-_P"A+7XL5]YP_P#[O/U_1'YWQ+_O$/\ #^K"BBBO
MJ3Y *]"_9_\ ^2O>'O\ >F_]$25Y[7H7[/\ _P E>\/?[TW_ *(DKY_B+_D2
MXW_KU4_](9ZN4_\ (PP_^./_ *4C[6HHHK_,(_L,**** .I^%O\ R43P_P#]
M?:?SK['KXX^%O_)1/#__ %]I_.OL>OZ1\+_^1?B/\?\ [:CX3B'^/#T_4***
M*_9SY4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#YD_X*+_ /)K^L?]?]G_ .C17Y)5^MO_  47_P"37]8_Z_[/_P!&BOR2
MK]"R'_='_B?Y(_->(O\ ?%_A7YL****^C/E@K['_ ."6_P#R7?Q'_P!BW-_Z
M56U?'%?8_P#P2W_Y+OXC_P"Q;F_]*K:O,S/_ '.IZ'K93_OU+U/U!HHK$\7W
MDUOHS6]H_EWU\ZV=NPZJ[\%_^ +N?Z(:_*:DU3@YOH?KI!X4QJ4VI:X>?MTO
ME6[9S_H\1*ICV9C)(/\ KI715!8V4.FV-O:6Z>7;V\:Q1I_=50 !^0J>IHP=
M.FHO?KZO5_B 4445L 4444 %%%% !1110!^!_C3_ )'#7?\ K_G_ /1C5CUL
M>-/^1PUW_K_G_P#1C5CU^QQ^%'X?/XF%%%%40%?O7X#_ .1'\._]@ZW_ /12
MU^"E?O7X#_Y$?P[_ -@ZW_\ 12U\?Q%\-+Y_H?;<,_'5^7ZF[1117Q1]Z%%%
M% !1110 4444 %%%% !7YW_\%7/^0O\ #;_KA?\ _H4%?HA7YW_\%7/^0O\
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M_P#%4?:Y?^?*?_OJ/_XJ@"U157[7+_SY3_\ ?4?_ ,51]KE_Y\I_^^H__BJ
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M*WNI;:6:"*:2VD,L#R(&,3E60LI/W3M=UR.S$=":GHH **** "BBB@ HHHH
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M1^Y'T+\%/B?K_C7Q5=6.JW$<UO'9/,JI"J'<)(P#D#T8U[77S3^S3_R/=_\
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M;Z^D/V9O^10U/_K^/_HM*_2_#S_D?0_PR_(\'._]S?JCV"BBBOZM/S@****
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M_P")_DC\UXB_WQ?X5^;"BBBOHSY8*]O_ &3?^1YU;_L'-_Z-CKQ"O;_V3?\
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M\NZLUBEB?!*G:RY!P01QW!JY_P ([I/_ $"[/_P'3_"OR'_B%<_^@Q?^ ?\
MVY]U_K$O^?7X_P# /B"BOM__ (1W2?\ H%V?_@.G^%'_  CND_\ 0+L__ =/
M\*/^(5S_ .@Q?^ ?_;A_K$O^?7X_\ ?H?_($T_\ Z]X__015ZJHTNR4 "S@
M_P"N2_X4?V79_P#/I!_W[7_"OWRG'D@H]D?&2=VV6J*J_P!EV?\ SZ0?]^U_
MPH_LNS_Y](/^_:_X5H(M455_LNS_ .?2#_OVO^%']EV?_/I!_P!^U_PH M5^
M=_\ P5<_Y"_PV_ZX7_\ Z%!7Z#?V79_\^D'_ '[7_"J]UX;TF^V_:=+LKC;]
MWS;=&QGTR*[L%B?JE>-:U[7_ "L<&.POUW#RH7M>VOH[GX$T5^]__"&>'_\
MH!:;_P" <?\ A1_PAGA__H!:;_X!Q_X5]-_K$O\ GU^/_ /D_P#5E_\ /[_R
M7_@GX(45^]__  AGA_\ Z 6F_P#@''_A6"UW\.%\8+X2,WA8>*FM_M0T,M;?
M;C#_ ,]!!]_9P?FQBC_6)?\ /K\?^ '^K+_Y_?\ DO\ P3\W_P!E'_DFM_\
M]A>;_P!$P5[/7U(OQ-^#EGX1MO$P\5^!H/#%U=_8H-8&HV:V4US@GR5FW;&D
MPC':#G"GCBMVWUSP%=>,;CPE#J'AR;Q7;0"ZGT*.:W:^BA.W$C0 [U3YT^8C
M'S#U%?S=Q%P%+/LVQ&9K$\GM7?EY;VT77F5_N/UK*LT66X*E@W#FY%:][7^5
MF?'U%?;_ /PCND_] NS_ / =/\*/^$=TG_H%V?\ X#I_A7SG_$*Y_P#08O\
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M8Y6G%Q>ZM>74S2--9S,[R2S,SL9-/LV)8DDQ'^^^Z/P'\#-*\,^%_$NEZO\
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M$"3)4'K_ !O^SOX9\=>(+34+MKVTM_M=S?7]O8:A=6KWLTMO#;Y,L,R,J>7
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M96L7]R*- B+^"J* -*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_012.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (L MH# 2(  A$! Q$!_\0
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M'_W^/_Q-'FW?_/O'_P!_C_\ $U:HH J^;=_\^\?_ '^/_P 31YMW_P ^\?\
MW^/_ ,35JB@"KYMW_P ^\?\ W^/_ ,31YMW_ ,^\?_?X_P#Q-6J* *OFW?\
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MH\V[_P"?>/\ [_'_ .)JU17S!]85?-N_^?>/_O\ '_XFCS;O_GWC_P"_Q_\
MB:M44 5?-N_^?>/_ +_'_P")H\V[_P"?>/\ [_'_ .)JU10!5\V[_P"?>/\
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M&2XUN-)OM]R5D ,[,K6BM<KN65HB1))M)KZ"HH **** "BBB@ HHHH ****
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M!K\SSO,<)B,>\)2JIU*:]Z*>J]?O7WGZ/PY"4<-)R5KO0U****\8^L"BBB@
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M/[6=/3$X>I#SY>9??!R_%(+GL%%>26?[3'A6.Y6UUVTU?PM=$X,>JV+* ?\
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M  4>_P"39;[_ +"=I_Z$:]#+_P#>Z7JCS<R_W.K_ (6?DS1117ZJ?CP4444
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M=+@O;+4]-EL9+C6XTF^WW)60 SLRM:*URNY96B)$DFTFOH*B@ HHHH ****
M"BBB@ HKF=2^)W@[1]<71;_Q9H=CK#8VZ?<ZE#'<'/3$98-V/;M734 %%%%
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M7U^*'[)O_)R7PZ_[#$/\Z_:^OA.(?X\/3]3]$X:_W>?K^B"BBBOE3Z\****
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MJ?CP4444 >L_LF_\G)?#K_L,0_SK]KZ_%#]DW_DY+X=?]AB'^=?M?7PG$/\
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M:598'!2H.6(Q#YJT]WT2Z1CVBOQ>KU!(****]<84444 %%%% !1110 4444
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MC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6KHK_:+*>U9E= \<L:S(ADA=3E)D!C?!VL<' !Y/^T%\<?B+\/\ Q@^E>"-
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M4?86_P"?NX_[Z'^%6Z* *GV%O^?NX_[Z'^%'V%O^?NX_[Z'^%6Z* *GV%O\
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MV:?#_A_4;'0[?7'U2ZDMV2XG:(1A4#9& <]:]^KX8_X*J_\ (C>!/^PC<?\
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MKC]VUK;6X,9*;G1%9E8ODG <,?MWP_H-EX7T.QTC38FAL+*%8((WE>5E11@
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M% !1110 4444 %%%)UXH \O\9?M">&/#Z7=EI5VNO>(4<6\&FV:.YDF)P%W
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MC_@JK_R(W@3_ +"-Q_Z*6O6RG_?:?]=&>+G/^X5?E^:/S>HHHK]//R8****
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M#P'X>M]'TV6^N+>(LYGU._FO;F5V8LSR33,SL223R>.@P !0!NT444 %%%%
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M.W_[]+_A1_9-E_SYV_\ WZ7_  JW10!4_LFR_P"?.W_[]+_A1_9-E_SYV_\
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MLFR_Y\[?_OTO^%']DV7_ #YV_P#WZ7_"K=% %3^R;+_GSM_^_2_X4?V39?\
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M_HNOUJK\E?\ @G+_ ,G.Z9_V#KS_ -%U^M5?GN??[VO1?J?I?#O^YO\ Q/\
M)!1117SA]0%%%% !1110 4444 %%%% !7R[_ ,%'O^39;[_L)VG_ *$:^HJ^
M7?\ @H]_R;+??]A.T_\ 0C7H9?\ [W2]4>;F7^YU?\+/R9HHHK]5/QX****
M/0OV?;B6U^,?AF>&1HIHIWDCD0X96$;D$'L00#7WQ_PL;Q3_ -#%JG_@6_\
MC7P)\!?^2N>'O^NDG_HIZ^V:_CSQKQ6(P^;X6-&I**=/HVOM2['[YX>4X3P%
M9RBG[_\ [:CHO^%C>*?^ABU3_P "W_QH_P"%C>*?^ABU3_P+?_&N=HK^=O[2
MQW_/^?\ X$_\S]5^KT?Y%]R.B_X6-XI_Z&+5/_ M_P#&C_A8WBG_ *&+5/\
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M=TS_ +!UY_Z+K]:J_/<^_P![7HOU/TOAW_<W_B?Y(****^</J HHHH ****
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M9>J_,^)****_2#\M"BBB@#[C_P""5?\ R4#QS_V#(?\ T::_26OS:_X)5_\
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MXO\ C0!:HJK_ &I9_P#/W!_W\7_&C^U+/_G[@_[^+_C0!:HJK_:EG_S]P?\
M?Q?\:/[4L_\ G[@_[^+_ (T 6J^7?^"CW_)LM]_V$[3_ -"-?3']J6?_ #]P
M?]_%_P :^8?^"C5];S_LT7R1W$4C?VG:?*K@G[QKT,O_ -[I>J/-S+_<ZO\
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MNY_]!:O9R7_D:87_ *^0_P#2D<N+_P!WJ?X7^1]@4445_;Y^2!1110 4444
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M-_Z]H_\ T$5H5G^'_P#D Z;_ ->T?_H(K0K^\,/_  8>B_(_':GQL****Z"
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M,E_]&15]9U_#7C/_ ,E-'_KU#\Y']'^'_P#R)W_CE^2"BBBOP<_20K0\._\
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MPWDN'Q&4T*LY.[7EW?D?67_"]O!/_09/_@)-_P#$4?\ "]O!/_09/_@)-_\
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M:/S>HHHK]//R8**** /9?V5/^2D7?_8,E_\ 1D5?6=?)G[*G_)2+O_L&2_\
MHR*OK.OX:\9_^2FC_P!>H?G(_H_P_P#^1._\<OR04445^#GZ2%:'AW_D8-+_
M .OJ+_T,5GUH>'?^1@TO_KZB_P#0Q73AOX\/5?F14^!GW!1117]WGXZ%%%%
M!1110 5\N_\ !1[_ )-EOO\ L)VG_H1KZBKY=_X*/?\ )LM]_P!A.T_]"->A
ME_\ O=+U1YN9?[G5_P +/R9HHHK]5/QX**** ._^ O\ R5SP]_UTD_\ 13U]
MLU\3? 7_ )*YX>_ZZ2?^BGK[9K^,O'#_ )'&%_Z]?^W2/Z \.O\ D7UO\?\
M[:@HHHK^;S]8"BBB@#[@\/\ _(!TW_KVC_\ 016A6?X?_P"0#IO_ %[1_P#H
M(K0K^\,/_!AZ+\C\=J?&PHHHKH("BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *_(W_@HE_R=)KW_7G9_P#HA:_7*OR-_P""
MB7_)TFO?]>=G_P"B%KZ3(/\ >W_A?YH^6XB_W-?XE^3/FFBBBOT$_-0HHHH
M^K_V3_\ DG.H_P#85E_]$PU[37BW[)__ "3G4?\ L*R_^B8:]IK_ #L\2/\
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MTXKVLGJ0IXN,IM):[^AX6=4YU<%*-.+;NMM>I^<M%>Y_\,/_ !P_Z$*Z_P#
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MA\8?] *X_P"^D_QH_L#./^@.I_X+E_D'UW"_\_8_>CZP\/\ _(!TW_KVC_\
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M^E/;6EQ''97=HD$<3W$C0@+=*VYI)"3&?[V5 /6Z*** "BBB@ HHHH ****
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C&&4\,I*L""0;]% "4M%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140029864826320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RADNET, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140029854346832">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Disclosure - Pay vs Performance Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eecd--PvpTableTextBlock_zmy4QvebPoVl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of Initial Fixed $100 Investment Based On:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Summary Compensation Table Total for PEO<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>1</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Compensation Actually Paid to PEO<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>2</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Average Summary Compensation Table Total for Non-PEO Named Executive Officers<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>3</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Average Compensation Actually Paid to Non-PEO Named Executive Officers<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>4</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Total Shareholder Return<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>5</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Peer Group Total Shareholder Return<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>6</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Net Income (millions)<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>7</sup></span></td><td style="font-weight: bold; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center">Adjusted EBITDA (millions)<span style="font: normal 700 10pt Times New Roman, Times, Serif"><sup>8</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">(a)</td><td>&#160;</td>
    <td style="text-align: center">(b)</td><td>&#160;</td>
    <td style="text-align: center">(c)</td><td>&#160;</td>
    <td style="text-align: center">(d)</td><td>&#160;</td>
    <td style="text-align: center">(e)</td><td>&#160;</td>
    <td style="text-align: center">(f)</td><td>&#160;</td>
    <td style="text-align: center">(g)</td><td>&#160;</td>
    <td style="text-align: center">(h)</td><td>&#160;</td>
    <td style="text-align: center">(i)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 11%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zb1gN72bmHNj" style="width: 11%; text-align: center" title="Summary Compensation Table Total for PEO">$6,700,183</td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDIp_zKs14lVHgZGa" style="width: 10%; text-align: center" title="Compensation Actually Paid to PEO">$10,101,435</td><td style="width: 1%">&#160;</td>
    <td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zk8oeLWwT7ud" style="width: 10%; text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">$2,030,591</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zt44keS1CCqk" style="width: 10%; text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">$3,585,219</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_zUlvVwmlSPs2" style="width: 10%; text-align: center" title="Total Shareholder Return Amount">$171.28</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDYp_zHYIHrtNeLE6" style="width: 10%; text-align: center" title="Peer Group Total Shareholder Return Amount">$143.18</td><td style="width: 1%">&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn4n6_c20230101__20231231_fKDcp_zQL9SVC32p33" style="width: 10%; text-align: center" title="Net Income">$3.04</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20230101__20231231_fKDgp_zD40Bp0NYvWb" style="width: 10%; text-align: center" title="Adjusted EBITDA">$232.30</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zUxbvD7yG4Hk" style="text-align: center" title="Summary Compensation Table Total for PEO">$5,555,517</td><td>&#160;</td>
    <td id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDIp_zR7MzXVMR3Wi" style="text-align: center" title="Compensation Actually Paid to PEO">$5,555,517</td><td>&#160;</td>
    <td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_zsvFZxwDVSeg" style="text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">$2,823,387</td><td>&#160;</td>
    <td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zTurpzCsPDUf" style="text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">$1,962,193</td><td>&#160;</td>
    <td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_z8UPVaEUytf7" style="text-align: center" title="Total Shareholder Return Amount">$92.76</td><td>&#160;</td>
    <td id="xdx_982_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDYp_zKWukHhwKXEf" style="text-align: center" title="Peer Group Total Shareholder Return Amount">$140.29</td><td>&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn4n6_c20220101__20221231_fKDcp_z3f4AREKD3yc" style="text-align: center" title="Net Income">$10.65</td><td>&#160;</td>
    <td id="xdx_98F_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20220101__20221231_fKDgp_zbV4LlTmAU2" style="text-align: center" title="Adjusted EBITDA">$191.28</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td id="xdx_980_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zaqyBA2AEc81" style="text-align: center" title="Summary Compensation Table Total for PEO">$4,567,222</td><td>&#160;</td>
    <td id="xdx_983_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKDIp_zBPgTkqBR1q3" style="text-align: center" title="Compensation Actually Paid to PEO">$4,567,222</td><td>&#160;</td>
    <td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDMp_zAm6l8VW29v6" style="text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">$1,676,763</td><td>&#160;</td>
    <td id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKDQp_zDJRqA6d65ij" style="text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">$2,073,838</td><td>&#160;</td>
    <td id="xdx_98B_eecd--TotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKDUp_zcQGnMltXDJ8" style="text-align: center" title="Total Shareholder Return Amount">$148.33</td><td>&#160;</td>
    <td id="xdx_988_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKDYp_zvSG8dL5ZrSh" style="text-align: center" title="Peer Group Total Shareholder Return Amount">$143.09</td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--NetIncomeLoss_pn4n6_c20210101__20211231_fKDcp_zKhM54jjWTcd" style="text-align: center" title="Net Income">$24.73</td><td>&#160;</td>
    <td id="xdx_98C_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20210101__20211231_fKDgp_zeaq4TRu8ix5" style="text-align: center" title="Adjusted EBITDA">$211.94</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2020</td><td>&#160;</td>
    <td id="xdx_98D_eecd--PeoTotalCompAmt_c20200101__20201231_fKDEp_zG72mIcCj0R7" style="text-align: center" title="Summary Compensation Table Total for PEO">$2,835,761</td><td>&#160;</td>
    <td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKDIp_zBpbghPBXKig" style="text-align: center" title="Compensation Actually Paid to PEO">$2,835,761</td><td>&#160;</td>
    <td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_fKDMp_zPIkWRvBRZqg" style="text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">$1,050,250</td><td>&#160;</td>
    <td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20200101__20201231_fKDQp_z34o1uRgdzfj" style="text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">$1,015,548</td><td>&#160;</td>
    <td id="xdx_989_eecd--TotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKDUp_zNdrFJivLZl1" style="text-align: center" title="Total Shareholder Return Amount">$96.40</td><td>&#160;</td>
    <td id="xdx_98C_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKDYp_ztGOmNFRJHM2" style="text-align: center" title="Peer Group Total Shareholder Return Amount">$113.45</td><td>&#160;</td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_pn4n6_c20200101__20201231_fKDcp_zu2YnCaVwIml" style="text-align: center" title="Net Income">($14.84)</td><td>&#160;</td>
    <td id="xdx_981_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20200101__20201231_fKDgp_z00Ttz0pmaWc" style="text-align: center" title="Adjusted EBITDA">$114.95</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureName', window );">Company Selected Measure Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_841_eecd--NamedExecutiveOfficersFnTextBlock_dU_zRq5CA0huDUj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(3)</td><td>The dollar amounts reported in column (d) and (e) represent the
average of the amounts reported for the Named Executive Officers as a group (excluding Dr. Berger) in the &#8220;Total&#8221; column
of the Summary Compensation Table in 2023. The names of each of the Named Executive Officers (excluding Dr. Berger) included for purposes
of calculating the average amounts in each applicable year are Mark Stolper, Stephen Forthuber, Norman Hames, and Mital Patel.</td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_848_eecd--PeerGroupIssuersFnTextBlock_dU_zM1PCq1mRRMi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(6)</td><td>Represents the weighted peer group TSR, weighted according to
the respective companies&#8217; stock market capitalization at the beginning of each period for which a return is indicated. The peer
group used for this purpose is the S&amp;P 500 &#8211; Healthcare Sector index.</td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">Summary Compensation Table Total for PEO</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6,700,183<span></span>
</td>
<td class="nump">$ 5,555,517<span></span>
</td>
<td class="nump">$ 4,567,222<span></span>
</td>
<td class="nump">$ 2,835,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">Compensation Actually Paid to PEO</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 10,101,435<span></span>
</td>
<td class="nump">5,555,517<span></span>
</td>
<td class="nump">4,567,222<span></span>
</td>
<td class="nump">2,835,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84D_eecd--AdjToPeoCompFnTextBlock_dU_zPPEyF6K1ESb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(2)</td><td style="text-align: justify">The dollar amounts reported in column (c) represent the amount
of &#8220;compensation actually paid&#8221; to Dr. Berger, as computed in accordance with Item 402(v) of Regulation S-K. In accordance
with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Berger&#8217;s total compensation
for 2023 to determine the compensation actually paid:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Year</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Reported Summary Compensation Table Total
    for PEO</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Reported Value of Equity Awards</b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Equity Award Adjustments<span style="font: normal 10pt Times New Roman, Times, Serif"><sup>(a)</sup></span></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Reported Change in the Actuarial Present
    Value of Pension Benefits<span style="font: normal 10pt Times New Roman, Times, Serif"><sup>(b)</sup></span></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Pension Benefit Adjustments<span style="font: normal 10pt Times New Roman, Times, Serif"><sup>(c)</sup></span></b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Compensation Actually Paid to PEO</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 14%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_982_eecd--PeoTotalCompAmt_c20230101__20231231_z0dQEPMiizMj" style="width: 14%; text-align: center" title="Summary Compensation Table Total for PEO">$6,700,183</td><td style="width: 1%">&#160;</td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentTypeMember_z2UNbwxxQxj5" style="width: 14%; text-align: center" title="Reported Value of Equity Awards">($3,125,000)</td><td style="width: 1%">&#160;</td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_fKGEp_zfvsN5JC9426" style="width: 13%; text-align: center" title="Equity Award Adjustments">$6,526,252</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_fKGIp_zhaAOX4bZm47" style="width: 13%; text-align: center" title="Reported Change in the Actuarial Present Value of Pension Benefits">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_fKGMp_zoY99xcozWc" style="width: 13%; text-align: center" title="Pension Benefit Adjustments">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zEaCvE0riG1h" style="width: 13%; text-align: center" title="Compensation Actually Paid to PEO">$10,101,435</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td id="xdx_F02_z4oAbMmkW3ak" style="width: 0.5in; text-align: left">(a)</td><td id="xdx_F1B_zmVP8Wrmrjte">The amounts deducted or added in calculating Dr. Berger&#8217;s
equity award adjustments are as follows:</td>
</tr><tr style="display: none; vertical-align: top">
<td style="display: none"></td><td id="xdx_F04_z2E9F8yTbAi2" style="display: none; text-align: left">(b)</td><td id="xdx_F13_za9C1x58h3cf" style="display: none; text-align: justify">The amounts included in this column are the amounts reported
in &#8220;Change in Pension and Nonqualified Deferred Compensation&#8221; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.</td>
</tr>
<tr style="display: none; vertical-align: top">
<td style="display: none"></td><td id="xdx_F00_zHttPbcGdJyk" style="display: none; text-align: left">(c)</td><td id="xdx_F1C_z4fdET60JgN" style="display: none; text-align: justify">The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#8220;service cost&#8221;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#8220;prior
service cost&#8221;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.</td>
</tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year End Fair Value of Equity Awards Granted in the Current Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Outstanding and
    Unvested Equity Awards Granted in Prior Years</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value as of Vesting Date of Equity Awards Granted and Vested
    in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Equity Awards Granted
    in Prior Years that Vested in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value at the End of the Prior Year of Equity Awards that Failed
    to Meet Vesting Conditions in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Value of Dividends or other Earnings Paid on Stock or Option Awards
    not Otherwise Reflected in Fair Value or Total Compensation</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Total Equity Award Adjustments</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 12%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zMJBiUhXP198" style="width: 12%; text-align: center" title="Year End Fair Value of Equity Awards Granted in the Current Year">$5,590,692</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zWdrxWCfvwpk" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zodWPY1WtSig" style="width: 12%; text-align: center" title="Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year">$935,560</td><td style="width: 1%">&#160;</td>
    <td id="xdx_989_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zrhIGdOi9682" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType8Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zpunzWCo5tRh" style="width: 11%; text-align: center" title="Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_984_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType9Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zB4Nci6AdQB6" style="width: 11%; text-align: center" title="Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType10Member__ecd--IndividualAxis__custom--HowardBergerMember_zW4pHjDZhk7j" style="width: 11%; text-align: center" title="Total Equity Award Adjustments">$6,526,252</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -13.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">(b)</td><td style="text-align: justify">The amounts included in this column are the amounts reported
in &#8220;Change in Pension and Nonqualified Deferred Compensation&#8221; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -13.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">(c)</td><td style="text-align: justify">The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#8220;service cost&#8221;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#8220;prior
service cost&#8221;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.</td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Average Summary Compensation Table Total for Non-PEO Named Executive Officers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 2,030,591<span></span>
</td>
<td class="nump">2,823,387<span></span>
</td>
<td class="nump">1,676,763<span></span>
</td>
<td class="nump">1,050,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Average Compensation Actually Paid to Non-PEO Named Executive Officers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 3,585,219<span></span>
</td>
<td class="nump">1,962,193<span></span>
</td>
<td class="nump">2,073,838<span></span>
</td>
<td class="nump">1,015,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_ziKHkqFdLdp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in; text-align: left">(4)</td><td style="text-align: justify">The dollar amounts reported in column (e) represent the average
amount of &#8220;compensation actually paid&#8221; to the Named Executive Officers as a group (excluding Dr. Berger), as computed in
accordance with Item 402(v) of Regulation S-K. The dollar amounts do not necessarily reflect the actual average amount of compensation
earned by or paid to the Named Executive Officers as a group (excluding Dr. Berger) during the applicable year. In accordance with the
requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the Named Executive
Officers as a group (excluding Dr. Berger) for each year to determine the compensation actually paid, using the same methodology described
above in Note 2:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Reported Summary Compensation Table Total for Non-PEO Named
    Executive Officers</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Reported Value of Equity Awards</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Equity Award Adjustments<sup>(a)</sup></b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Reported Change in the Actuarial Present Value of Pension
    Benefits<sup>(b)</sup></b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Pension Benefit Adjustments<sup>(b)</sup></b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Compensation Actually Paid to Non-PEO Named Executive Officers</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 14%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zHXMp7EpxwSl" style="width: 14%; text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">$2,030,591</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentTypeMember_zXQJFIoXteG1" style="width: 14%; text-align: center" title="Average Reported Value of Equity Awards">($1,071,875)</td><td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: center">$2,626,503</td><td style="width: 1%">&#160;</td>
    <td id="xdx_980_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_fKGIp_zqqEB5qngIVb" style="width: 13%; text-align: center" title="Average Reported Change in the Actuarial Present Value of Pension Benefits">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_983_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_fKGIp_zEgYq3jhyixh" style="width: 13%; text-align: center" title="Average Pension Benefit Adjustments">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_z7XiMt22a3ek" style="width: 13%; text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">$3,585,219</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td id="xdx_F0D_zR4MPK95I2e1" style="width: 0.5in; text-align: left">(a)</td><td id="xdx_F17_ztfk7wQERqE2" style="text-align: justify">The amounts deducted or added in calculating the total average
equity award adjustments are as follows:</td>
</tr><tr style="display: none; vertical-align: top">
<td style="display: none"></td><td id="xdx_F03_zThT4KNxr668" style="display: none; text-align: left">(b)</td><td id="xdx_F19_zrGeOFDuhcKe" style="display: none; text-align: justify">The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.</td>
</tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Year End Fair Value of Equity Awards Granted in the Current
    Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Outstanding and
    Unvested Equity Awards Granted in Prior Years</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Fair Value as of Vesting Date of Equity Awards Granted
    and Vested in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Year over Year Average Change in Fair Value of Equity Awards Granted
    in Prior Years that Vested in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Fair Value at the End of the Prior Year of Equity Awards
    that Failed to Meet Vesting Conditions in the Year</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Average Value of Dividends or other Earnings Paid on Stock or Option
    Awards not Otherwise Reflected in Fair Value or Total Compensation</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Total Average Equity Award Adjustments</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 12%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zt9EU0iIYaa" style="width: 12%; text-align: center" title="Average Year End Fair Value of Equity Awards Granted in the Current Year">$2,032,116</td><td style="width: 1%">&#160;</td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zgPPGOpL7w0l" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years">$309,243</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zjPJR3MKWsI4" style="width: 12%; text-align: center" title="Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year">$286,517</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zl3Tv4e6SuO6" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year">($1,373)</td><td style="width: 1%">&#160;</td>
    <td id="xdx_988_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType8Member_zTtCfNoUS4t" style="width: 11%; text-align: center" title="Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year">&#8211;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98A_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType9Member_zecY8eyfSs0c" style="width: 11%; text-align: center" title="Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation">&#8211;</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">$2,626,503</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">(b)</td><td style="text-align: justify">The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.</td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid and TSR</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_846_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zuM1ingWbM4c" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Actually Paid and TSR</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_007.jpg" style="height: 4.66in; width: 6.14in"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid and Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_846_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zDraBwHdCyL1" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Actually Paid and Net Income</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<img alt="" src="image_011.jpg" style="height: 4.43in; width: 5.81in"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid and Adjusted EBITDA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84B_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zXN5Cgs1Wl9k" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Actually Paid and Adjusted EBITDA</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<img alt="" src="image_012.jpg" style="height: 4.64in; width: 6.09in"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Financial Performance Measures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_849_eecd--TabularListTableTextBlock_dU_zrZ5NtElSywc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Financial Performance Measures</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described in greater detail
in the Compensation Discussion and Analysis section. the Company&#8217;s executive compensation program reflects a pay-for-performance
philosophy. The metrics that the Company uses for both our long-term and short- term incentive awards are selected based on an objective
of incentivizing our Named Executive Officers to increase the value of our enterprise for our shareholders. The most important financial
performance measures used by the Company to link executive compensation actually paid to the Company&#8217;s Named Executive Officers,
for the most recently completed fiscal year, to the Company&#8217;s performance are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">1.</td><td id="xdx_988_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__1_ziE6pWbjgSOg" title="Measure Name">Adjusted EBITDA</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">2.</td><td id="xdx_981_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__2_zG4A7oMPh7gc" title="Measure Name">Total Shareholder Return (via equity grants); and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">3.</td><td id="xdx_987_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__3_zd6RhC7CX7se" title="Measure Name">Strategic Objectives (via discretionary bonus).</td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 171.28<span></span>
</td>
<td class="nump">92.76<span></span>
</td>
<td class="nump">148.33<span></span>
</td>
<td class="nump">96.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">143.18<span></span>
</td>
<td class="nump">140.29<span></span>
</td>
<td class="nump">143.09<span></span>
</td>
<td class="nump">113.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">$ 3,040,000.00<span></span>
</td>
<td class="nump">$ 10,650,000<span></span>
</td>
<td class="nump">$ 24,730,000<span></span>
</td>
<td class="num">$ (14,840,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Adjusted EBITDA | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">232.30<span></span>
</td>
<td class="nump">191.28<span></span>
</td>
<td class="nump">211.94<span></span>
</td>
<td class="nump">114.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dr. Berger<span></span>
</td>
<td class="text">Dr. Berger<span></span>
</td>
<td class="text">Dr. Berger<span></span>
</td>
<td class="text">Dr. Berger<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure [Axis]: 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure [Axis]: 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Total Shareholder Return (via equity grants); and<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure [Axis]: 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Strategic Objectives (via discretionary bonus).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (3,125,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="nump">6,526,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 4 [Member] | Howard Berger [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">5,590,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 5 [Member] | Howard Berger [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 6 [Member] | Howard Berger [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">935,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 7 [Member] | Howard Berger [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 8 [Member] | Howard Berger [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 9 [Member] | Howard Berger [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Adjustment Type 10 [Member] | Howard Berger [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,526,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,071,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 4 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,032,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 5 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">309,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 6 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">286,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 7 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,373)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 8 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Adjustment Type 9 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (b) are the amounts of total
compensation reported for <span id="xdx_90B_eecd--PeoName_c20230101__20231231_zbMEwARGj3R2"><span id="xdx_901_eecd--PeoName_c20220101__20221231_zeYebgkyielf"><span id="xdx_90A_eecd--PeoName_c20210101__20211231_zTdluKUxdXva"><span id="xdx_906_eecd--PeoName_c20200101__20201231_zZtDOpfVbuXh">Dr. Berger</span></span></span></span> (our Chief Executive Officer) for each corresponding year in the &#8220;Total&#8221; column of the
Summary Compensation Table. Refer to the above Summary Compensation Table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (c) represent the amount
of &#8220;compensation actually paid&#8221; to Dr. Berger, as computed in accordance with Item 402(v) of Regulation S-K. In accordance
with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Berger&#8217;s total compensation
for 2023 to determine the compensation actually paid:</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (d) and (e) represent the
average of the amounts reported for the Named Executive Officers as a group (excluding Dr. Berger) in the &#8220;Total&#8221; column
of the Summary Compensation Table in 2023. The names of each of the Named Executive Officers (excluding Dr. Berger) included for purposes
of calculating the average amounts in each applicable year are Mark Stolper, Stephen Forthuber, Norman Hames, and Mital Patel.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in column (e) represent the average
amount of &#8220;compensation actually paid&#8221; to the Named Executive Officers as a group (excluding Dr. Berger), as computed in
accordance with Item 402(v) of Regulation S-K. The dollar amounts do not necessarily reflect the actual average amount of compensation
earned by or paid to the Named Executive Officers as a group (excluding Dr. Berger) during the applicable year. In accordance with the
requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the Named Executive
Officers as a group (excluding Dr. Berger) for each year to determine the compensation actually paid, using the same methodology described
above in Note 2:</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Cumulative TSR is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share
price at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents the weighted peer group TSR, weighted according to
the respective companies&#8217; stock market capitalization at the beginning of each period for which a return is indicated. The peer
group used for this purpose is the S&amp;P 500 &#8211; Healthcare Sector index.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported represent the amount of net income
reflected in the Company&#8217;s audited financial statements for the applicable year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Adjusted EBITDA is defined as earnings before interest, taxes,
depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other Financial Performance Measures
income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.
While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company&#8217;s
compensation programs, the Company has determined that Adjusted EBITDA is the financial performance measure that, in the Company&#8217;s
assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the
Company to link compensation actually paid to the Company&#8217;s Named Executive Officers, for the most recently completed fiscal year,
to Company performance.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">The amounts deducted or added in calculating Dr. Berger&#8217;s
equity award adjustments are as follows:</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">The amounts included in this column are the amounts reported
in &#8220;Change in Pension and Nonqualified Deferred Compensation&#8221; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#8220;service cost&#8221;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#8220;prior
service cost&#8221;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top">The amounts deducted or added in calculating the total average
equity award adjustments are as follows:</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top">The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentTypeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentTypeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=RDNT_HowardBergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=RDNT_HowardBergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=RDNT_AdjustmentType10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=RDNT_AdjustmentType10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>27</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>15</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="radnet_idef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="radnet_idef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="radnet_idef14a.htm">radnet_idef14a.htm</File>
    <File>rdnt-20231231.xsd</File>
    <File>rdnt-20231231_def.xml</File>
    <File>rdnt-20231231_lab.xml</File>
    <File>rdnt-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
    <File>image_010.jpg</File>
    <File>image_011.jpg</File>
    <File>image_012.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="69">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "radnet_idef14a.htm": {
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "radnet_idef14a.htm"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 4,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 12,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 27,
   "entityCount": 1,
   "segmentCount": 15,
   "elementCount": 109,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2023": 69,
    "http://fasb.org/us-gaap/2023": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://radnet.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_idef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_idef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_idef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_idef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "RDNT_AdjustmentType10Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType10Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 10 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType1Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType2Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType3Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType4Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType5Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType5Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 5 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType6Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType6Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 6 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType7Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 7 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType8Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType8Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 8 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentType9Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentType9Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type 9 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RDNT_AdjustmentTypeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "AdjustmentTypeMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment Type [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r83",
      "r93",
      "r117"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r128"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjusted EBITDA"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid and Adjusted EBITDA"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid and Net Income"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid and TSR"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "RDNT_HowardBergerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radnet.com/20231231",
     "localname": "HowardBergerMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Howard Berger [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r135"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Compensation Actually Paid to Non-PEO Named Executive Officers"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Summary Compensation Table Total for Non-PEO Named Executive Officers"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r82",
      "r92",
      "r116"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid to PEO"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Compensation Table Total for PEO"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure - Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r78",
      "r88",
      "r112"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r79",
      "r89",
      "r113"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r86",
      "r96",
      "r120"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r81",
      "r91",
      "r115"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Performance Measures"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001683168-24-002737-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-24-002737-xbrl.zip
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M=;7.Z#F8R*ZI4S%.7:".F3J.2 SQZ6QKVM&"M7W()LEMJ(O>FC1S?M:>V%/
MSIH#*2IVR(:^.U')T\AVQLAZ_?SHVG@5T<&\J+-'B.LU>N3C;5V:S_APA&X
M\R'(?*C-='P-_1DN$W%[K3#U5.EDO6<%O-)/ZY1GAMM/R^E<M6']LK$0#7LM
M66SI@WN)[\VW&A<G GIB26I5"=L&1YC< 9#E_>T(:_NA!_T@V]"N1<:UU)\S
M5T:(@*.C-K8[,02ER.%AB<6U3-V>1?_LI!E&_R3LUA'N/\,TGD@G:LP&<B+"
M\PWV?SB /_[6Z-)+\QQ&1$ YR8VG/%DJ,UVW(>P;J8FB%-Q;>&(V6;QZ_SOT
MB4DMRV9:;E4W]%WBUPZ:X3N#>1<[[HT] /VDZP#\VZ8<,NSB9V5*9RT4=BAS
M0=<I';G#A,-JU4D%;\I#="D6&)TMAM)F#$<XAE2S1A4"9R3%GE7UE=K8Z36D
M(VZ%^DIB3_S+M/SG7B3N=.;3)!K30*W&<II&1%Q<2_FS#*E)51U)=EH5NV^R
M#9 %DYQ9&-RN:<H D28+]ESWQ:G3-"P[ G0;*HX&EXVG>X2*?8!42%+6&P8"
M() ;!^PBGP^0#WEC7P1U/^Y&VID3@8W<IK3FR'EL^%ROQ!;&!A91XW<*!!"!
MKS(3>]3C4/6M2@0C;,XRTM(#%T67OV9?4:]'!%[&[07\N=]O"/&W:\>+07^I
MYQV-U=C@7X2V-T#S(X_.17 ]&]<3VM7W>GG1:MG\U-N2&='88'40?BH #CCW
M5JC7'S<?-636=K!LV;R8U24=,9+($AC*;4B>+DCO>Y%Z\RE:F))5J4M8LQ9B
M$(>R7["XMB9)8_=R]AV3W'M[2,@7"G 9YT*M ^@P2T ;<;^QMJ'ZE9EBW _/
MAY6^-RIXY  4/B-.AW5UNPIE:F4G'.O!@A0.^QGQQ(=$2NZ1!T;.("'N1)Z+
M;+P*_3;,V6ZJ1T.O$^[U75Y%^HP>>D&YF#*>1_\KY_N1(AJEG@5V19LD++^\
M [@ PDDW,&BL,W]*#V<L?2W5F>(0&TM%R0[TWS(#MP@6=IHJ]W)K#G=4C$IK
M4 /&$>KL.Y_N!8LKLNX9V:67M**F+/@:U7DB[7A]KO'24))YC7A@FAT'(*+;
M]&3(+X18GJMBR:(5- C"_NS^KQ]R'K#P??W CH1O865 -E09KR9H$7+&T>_"
MNDV#Z&P.:?*:NY8R[UR[(0(]BZ[9\ ;NOPVRK!8I7$T/]WMI%Y]PW,9#!)3*
M-$H#NUA,1D]X@DFNK]I8R8J?#>V>5")8 !S5_J^H]*\6M#OMR(P?P;.AE0LG
M2F6<$$Z6-3E02?R5#K$W9J[- SN\\M$Z/:%R(79A\DN_S41][ GIO512L7-?
MEL_W,QV.0B_)W&86$WM"]B5%CC:OP'=/%\(*"RL)&785'ISLX<J25G#R?S%8
M4)=27N49XOX6N?Q'0M@^OY_A/K4-F]'54?4$R-M0H:P-Z: )WNWP\+A?*]FT
M9BJX_ RK9ULU@O:[[?$W>-*Y*GC(K[4Q<3X //W X1;:?RHWQB>>>3KBPXMD
M'4 7DGIBV7+!Y_WJFK^*_^O@$+V3>/\29S^DL>SALS+15@4#J?&87%'P[CI^
M3!]UZX-J0>8S0[VIK%>@32MJU[L<4/KRUOIZ?] ^F JQQ[+IC+@]G*XQL/'Q
MRIFQ<E$PE@W9+YFC2,:@]^^P=TXZRKA;O_;:'3T6#W=H'VC2'API/G$ 1Y0@
M+WRK/%!/.*F^FU!$!/;'[B15ZTNXB*$UD46%D]]=W?(R _+L.?*:@2?>W3EQ
M2Y2<&9+)@@RH/)IH2)%$!;JRLY*KIQRM,+(&=",U!S:\CTP#M1Q*$FV[K<H4
M&HX26K3MNY[,"=&\<E8/*GD#HFB%/%Y@2U35\9AA'+"8O!WL='!(92K=J6B=
M?]&3@B=1"?AIR( [R*BLSKK[XMNG7WV;\5^B>?@CO/K+3(&.Y@:<;1\U:166
MN^DA)#WU%F,L]9?55/<O'*.^&D&B+IQ/XW.M%0<!F0L]RSRG0Y0',JBN-H*9
MQ M7U56-ZT_J$$*B9?DO$2PN(:Q#N6DFE\>WDDS,X!6@>YX ?_BN-'@L#)[3
MC'OC_TZ%QM9K^=9[$/I"]YG<%ON-L6H13MP92B)EHLOU5IY0=5+"O,P#SULG
M/\\DEG$M"=P,SG=SP-3-Y12=%,RS)ZC^<E1:@$5F5*66.]W])#VF-/ZG3'K]
M]]Z'L=N_GW!<,K!W95-P=@N.9(TW/=>CN99K,\_=J?F*7.2GUNKW#8\2=F"9
M?AV^,'K)CM$F3=>YX+$#SG:*%2O\>>*IQ[0 >+CEHNFEJR@_-4"- O$&,=1\
MK\$J)L!D6 [F8J'9ZZW=%HE9.OZ,7V$<U04I,3/)GYM&A9#MM*@@Q+S6<Q]S
M,\V@=2_L0WD$..GH/L+R:,&=1C366S^)[$JY[>;XH?S(,6PY#N?(XV?K5Z"J
M01?7*-:J+QNIR#&*.^YX7NKXW,:'_^2NZQ_DW4M_;+3-5!"!=8RC%7S"TMSQ
M,,G25'/0_ XV"5.'3W ZZ*? ;_6VBQ?4=&NYJM-:\R^F3$/WUA79??[Q7?Z&
M?U=[_V61&I2#E+Z=?PQ!2Y (&"&G"<C%?90E'!_C7L";QG(G5IX(3#NJ"4+Q
M=77+JY;RP@D29<*E_3P5=KXRPCKZ#J#4B1/I@7LE\Y)-J3><'\92RK/HS,$P
MN%+]GIX%O>;H[T,W^-J_U3"<WQ1/@\GF2LBAM [EXRK1'KM:5Q6.LPH)T <"
M8,N_-8FT-NU2=D(YGGD_TZ,/G#I+U]8FKF]F42JLT[;$C-6CWOJ+N'$PJS+K
M+)TKK;WB2(3U=[M9Y'3*"2JW#%'Z7 L#)HO8+I^^;#!PZG!^@X#0Z/\T</C9
M]&2^';>5]J#.X[3 ,__.YRGVJ=-;@<--)@MO8;1W!NX8+>OQ+(;K4&XMUPT7
MEUT:D:0NT2>882<RG&/OF22L !N0 L!(AC?94X<W:[]B+OC"B=(\M?-%:&KF
M;OD94Y=5?^&"\=K'#4:&*O&O1<R\65^;,5^R+A.!*"_UF<=YQ\K+%\3/9C<B
M5V=^A,GFJ\0S7B0S/&_(&*K_.I7'"G(XT8,OP?>U%"7)8,W/'O.#B8#=F<^,
MGB),3+;:#;W6L_:XIXT4IBP(XHR@)&6+@&H>6C'Z7='9YI2F4"G-AESZ@#O[
M?NLT )/H',(R&H00UU8>39.;L]?)D")(N^<LA4E7B\8&=+XJ)EMA>=J(D^ML
M#PMMGMDN_:6#?S/7.TKBN%B5N&\RL'!&8&:<VZL&[3U2X!O8NBAAVOS\_%6T
M1T)O:",[6"Y4+EE8HZ&.Y^Z)QTKV 4=N&+!"!@1:%FRK*5;IB]!@AGSIWH^>
MMZ)O86@,<IT(7/0I\3 E\[!UF&+*YA>6QQ:?B)L7L,L.@(8+M%Q=Y1?[?,<&
MY8;16'T)9F%G9T5<2,4\OU%M6(=SEIL=*?_<]&>J U$:_&UM7!]L97UI6JP]
M'0Y]TQR3?0 K ?1P.A'SN.FZ2;?:WN*^>E^V9S&']PE9^YA_,0UB5#,8-M"-
MJ>S[[$$$<@Y0([H0,@FX6<^@YE/V@,B[I9,'7ZE7#OJ:$AH7/F!N!.9-FR2W
M!HU_;LDK'-$%N]1H?5*FO_HC:E;U)*%M*#=F_F6T^]6Z1JUG<@U4E,KNJJV=
M?LM['S,MCX^EU1H_06B+:Q&'V/ CGQ.A'@(50*"',N/=9J&B)M7+52W#A/G\
M](X6CBC;_;>B7Q^$I@;]4I4O F/+SOC]? ?5(TS*8.71<,C2>"FK.?[-Q[6X
M@0FRX5G$;M^2,N+')IYJ?E4 I"'<\3JY_6>RIT;.'U5DAL)]CP%F7@+5Z*"<
M] =\Q(.,8)2<?]M=(B#LO.^^ G?&- G-BB#:/KG9<O_2[2(LP:X%<F[NKRLR
M*Y#@F(>IG":K;3;K^\0X@I!>9Y@= B9G\&\%G.!YZ3 IHV?!]# U6HEC/E,%
M\)@L:].!KO%E4>17O#JL<[D>.BT78ERJOSMW.8?9QK88V]<<5:2+[.5N]HP#
M<$<*3/@WM)=93>3''B->%R3,Q<2:GPQ.JIWM'9TI8NH&%3ET;''1JZ]9-XT$
M,(VMS#9'[T*OK5<C8UI@0V\>'0M^>NVU9)Z)5^@=WBO]$ <HDH0! "WPS[_G
MOP#3Y,S3O>80++KI:=B%)@GM\N7W?NLC^Z4<QW-0WG&G+O;D>>$SU!GCFH0N
MY+D6#M4NT,Y;"T_0$Z(Y<[YK]32+QZ:[TLKKO)F8=\8*9$/YJ_&W_?H4)CZT
MLAQ>[#0^JR\MU,([SVW>1/52_^B1F7X\<6Z8&\40<A@K%4#JYA#3V,TD/8:'
MAJH Q]?,OXTO_A\!(D[\&U!+ P04    " "M@)I8"9T(H&P8  !4&@  #0
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M[5G4L7[*B%I2:'>^7S1=E=DZ87J0[R,C(P=75H0%O]T4;M*G^&5 Q8?UE&V
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MPZ.\S.L#XN:[$_EL,J&QC1WD]1EU#?&F:NBOR5OH2Y4P]IZ5.-HR"PT%]]-
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M95\P,#<N:G!G[+P'5!3=MBY:9 0!07)64%!RDDR#9% !47*0G$%RI@$E"K2
M@" Y(Z&5G)$,DK/DG"7GINF^[9_VG\[=>Y^[[QOGC??:,<>@NZK66G.N&;YO
M5I7(;\@%X(:2G*(<@(:&!KQ _0.0TX T@(N-C8.-A8N#@W/M&B[>=5*"Z_CX
MUZE(;A*1TE$ST--1T](R,G.R,-YF9Z*E916\Q\[-P\_/S\ B+"[$*\;)Q\_[
M8Q TW&O7KN-?IR0@H.2]17N+]]_^(+\ Q+AH7]"?8*#=!M")T3"(T9!M  ,
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MK3>);W5,@AO3SCJ1@($_<V;6M"#\6.42E4Z@<I--ZYG@>88K+Y1C0&SGCX9
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MB3+K\9\7-) 4FY#_&<#\4WE&(5A9:56[ML:J.2Z/#]] ]Y(SDV7O)9/L9E[
M6SY)HY^:5(C>/'A3EI82]5S^TW)2A57N['DP+HJ;O3K5)E6D>\?\<>%0D#Y[
M$//((U!W4F?B817%TRCJQ?-@4&?3(FPT/I5.^B67@';DU;SQ\IG5]\+A2L9
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M*/TV_\O*(DNVB+@2<K1Y* 0-/3^!71G<$&DI5G/6#TYUG.=%@X,TG>) WN(
M;(P.[ZN9MBO;$.*#^Q$WBLA93<I?()X_SUX;HSR9/35<.S5\@#4MM&/+OE3Q
MZK;0!,:JV&6:5]IO1G_V-+STF^E?5'Z$V_B+J@R_'$*5T'O6-SM<>C['(G*0
MP&M4/$QTLQ1 2RK^W"TYX:91..2C6SXB"6>%*AP.I$L0*84MV)* E[>>= [9
M-/ZB88O/[VN (2@4P=Z@DMT*QI9X_9?E:'V(_ILMN/W)*'KXD^MCMSV5@[LI
MQAR+EV1=K?W?)X^NM:1_N:6XC/6)\"6AK,,86R33D[K1X@J:-T*F]968TGR<
MVGP;X'Y6C*3:@[B=G/H$WLW!CSI[WOGP)3W6=VT90LVV$<D'W[S&NN#2^72\
M#KSCH];XSF2U6'$1PN_8[K%0+8#$G"%>WV+E1\Q3J58^5WD:N<4(6C;?[W5J
M\U4!Z42*@;+EC<<5<Z<Y"K$);D1@"3.F2J3[20_[\Y:GW9RUUJQL+F:,FM)\
M\%TFN_J]G"GS]1>Y:,#)GC;X!F=)>OTG+2[.<,H5#C,+_@.E3K;+OL&.G7(G
M;DDJB8H)Z:S-RC,K=X+(>G?BMEN*)-QXZ1M94S4,H2)1<4:.QJX$_'K"\I.\
M6R!34RHJF@#,5YU4G:1HPQXZVN;[?:]C#3F.@T%)B\Y'3AXK&-&#*.G"KM@&
M2;_6W8A_&REFM7B3P8R0H6<]=['Y9*#!4A5-[RQR*=X!=ZZ3E/AQG<7[F.PG
M=8(ERV$*CX*Z::)XV3)*#)<8)HD"'>+/T"EX<I=YV_([9/%Z>W'QKF&NT.,H
M 36+S-$^(.*$/L[^W4?1+4&E;>LW8M*B8>.KCO,$T/)IR/4/NC3YN4E3%A02
M^BV/C^)!W*RD=K8D$FJ=UM\M_RL4]6=!%WX1_!)SB#G@B:0K#LY! 6MF7/P"
M"JYP_].GV ZG!R(?N+E/D'?*)4;P\IO5[_.]@BB=W+_@TD,";Q%92,"0%[PA
M5_?R789:H^E+$YLG,7H1)TWG!AJ&QYAI""0 0=S]P-)Q><W$<F4PQ]0H6%V(
M$7*Y5F\0O@=+H>],.9F:10(8DW#1HKXE_$O^3U'RGY0#6";UJT(]UQUA%L5>
MJQY[7YH:2GP9D<#D]K?"]8R *)+L90J7V2L*V4/Q9+%9)>M'*,PU.O.O/F+P
MGP5?+YN(R3?CAXS+Q^Y41NNSQ$^MR00*" TD16,PH?,->JV$[Q;V^]VMMW',
MJ[-Q?T" >X3^,.;SY99@ ,WUMX(O)RDQ#UZ])9*!T.LL4W[9?)+;(16I8/<E
MX,CK<B0?*''H3'#6]I#;LF2Q9.@->A2HPH5GJNHTK97?+!;$[$8VK E:FA3;
MD>"X2U,1>*D::U9O-BNVDR::87H1K52 %?)H$-WC_K.TUNA'L>RK*<WO]#Y$
M+$(.WCUT/%ZJI5X7(VROYR&W'U^V'<X=BY&_8=1U6*6 D5(]'4^U/$(V]!^\
M&?^+&-[93CMD& 5OKZE<X4Z,QQT:U""!6U?RB$935&:,]-(B6/'TC!JZ>(?:
MQ1,BQE.& +"W'DP*"91-?-:,@N-?3JT/$UVE-H37BQD>)!Y3@A:@V_EJLF1?
M77_=$3)4JL6:_4-C>ET-Y:;Z\U>.X"O,B:[. J@Z6CF$B6<.Q(.:Y1C"#B/Z
M/?\^0@)_:+1]:0.3&^0-__%AD,SP9;B\68'BTBSG;L?XEEVT"/F16TMB_Q-I
M].*NK2(B#%I5'"-9S]38K.U]&A-'*S\EA4A[A-L0/K8T&Z]G9"OPQ6E2>-']
M^97NH[$2@<1U7;:+6U;2 Z4+K$D3UR[C])>O4_*(BQX=J>)X&]@=B*KJLDT3
M)4TR'][!9]OL=CJPOY]3NIO.(L2(S3(R43V845,UN'.[?HY%:[]YWIGU^[5=
MR2\LJ7%]'KN=>@W598B>TO@U(1-/BJ^Z)F'-^A_@>PL+*YQ$=%ZH-5K>T17"
M'"XJ#9WP"?\@G>PDN9.FE%0XJ2+0]TY=3Z>AJ(AWL.NK-E'&?05XI%8Z>JEK
M$U%K\0?MQV-C*;-99<VNUE\4/@13^GP)Q-W"%<?)L5&3I((]@-AE;/:8V0Y7
MSQW6ETELWHG^5B9*OQ+SV/)W/=9_5\A6_/C.,XK/W=O=:_5S&MXT8_<5L]MJ
MK9)%O6RM@>I!/TC< W?+CDE\1@5X14DO+9-PQ1U?0G8[Q8=)CFZC*!P1-+$$
MNC@> >^-(($#%W#+]@$#'&;5=+:)!,YKCZS91F -7*ORL2=)\[T#;N>>!T0:
M!^9- I%P<L>V^#Y6[BR,MU]%/R_'&GPPP-]71\C30&$'X"L"MKG"K^T/N0LL
M"^D[")U2V+IG48ZHEZ?UV^,8W5[K\) 3!MA%+!)X*'"2XY-0 NX"HSP2F@@Z
M9C*(Q_"D-S I]S-#9=H&Z2[QD 7#N0F)M^#O)]^?+S>A(TYKCE\A 0NH,92(
M F[NBTUTS@;;0MG#*<7H;Y],^;_5@/I5V/H0=^5%#;_U.8!]'9C)A[MD<Y+/
MKA?&S;3VF#T7ZKHHFZCD,XC6HX!40(DWO7+3"-^>$4_W4<T,6JVME(698+HL
M$U/1>NVT VZGL?AOA.ZJ,6HS::#+WI^)."22WE'7X'I=4L$VC_]M9FNKQ_=V
MF6(CU[W0&;>8M!:E':'BCS\O(>* HP-JL]0G\?@!VV73S"?R4!TAJIJ+Q,Z>
MS;?G.^5K=2*L&*'**=KUHG2-F;5%FN@'4^O=-'G<#K:DAT<!*5GX_4.;?:I!
M]3+&2."Q2-?;Y4OI'HTO$"_;0S=(0Y7;3O+5]Z/P8VM6#)"TH(5TF>"<Q91/
M1E/?)6*Z::J#;R^I)K&I.NUL" G@Q80#$#ZP(VBO#$%J[K#+<G4*;LG.]&?J
MG9]1N?R.\CFJ#Y=A2, W;;^ -1WW2/#L)N(2M"AGCE@"SUO [RNQHHOU7;6A
MD-K N=I/@T[^OW50LB-P^W4DT-(Z)@@0FFPX(P'V\<9W?XK*[T0'#!GK:PPM
M!GD,J*K[R2,DVX><7<S(M1S=K^7J"2B2;?;7F0UN_C'(VCN0 ,4*Q!L#SO#A
M;Q==PE?^[RH( RT:LFQ[(N9&4<L%_8 PC>70F).!"Z(MT,D1"^*US? 7!Z:>
M7C=(;P9JN?F>.% X 2>-WK>/'J\*.L^VO_']NECI?:X]FS0%T*G7Z?W] W"'
MQ> +)!#85)+M^>ND6;_:Z0ZJ5D6O_;+ B%]M^NR=*N;?G$N*IJS*!S;77[U)
MKXP$B!&;I] 8%75#?6O0(7X=$BCA0@+I21>4)P);+QY$KYB+=J[=(54SB%Y-
MD_2AYR7"\/F8[?OQ27%4SXX^XI>=9/MCZ#>"_W'?Z&]VG>VFT]]ONVR_Q NT
M4_YRC>=[H;:V A[ED_5[(@HZ;F81[R*Q_<S%0[#]!2R+\,&4FYIW9QAKZ9UW
M>G0_78LA4Z;_$@-(-+X7BCEJU[&+6ZF,P8^/Y[WA^9+O&O/RF:5W(R6M]R4M
M8#<1[R.3H#)V\KH"-'77CITBN974]C/+[DQ77<J3!5P&3A5Q0K81=NBMIK+P
MW=DWLO=WGTKA;$AM^!;V-[+<"2J>K?C^=@/A&);8/CSM.1S$A":3W]X8Z"]^
MC^?S2T5*VM3<%-6IK)S2:W=XJU@<5>MOON46QV$(>OPOWLSYWXC/Y($R0HFS
MX 2"!&2+?5D,'_@\11'7-Q]]39# D(W^-X8ED/1 +^AUPQ,)%/%[<4"D>'X/
M"3!%3EQY-"&"X_:>+S1A@58<:U'UX0> &6[8JM=S./!3.'L):K[XA,(?$;N_
MX?(_X>]_YKR??@^?W']79Q:7D$#$0'HS$L "ZS\,9RU1+_H_ -+YY_AJ]17[
M75'X828JXOUD772%>8BIT:;U4_#E.;BC>@\3-60M:!OEOTH;A0<^:PU::V0Q
M'ZKXMN#U X.?;KQI&1G)1#FVG;7AT27H"@Y:UD'0CD(Y73V6D]8T'Q(^3XX>
MG.#3325%Z3X#ED/(U>R3;=4_YU]#W!E# HD-EK+J\2F$,)1UAR&8;#BZ^_4B
MNUE6CLZNK(%8+\:W"H.[.J1-G$Z:FU=>:)R0HGV=.J>>&FJ5S]<+[,TUTUI^
M_NX6%O9@^G4RG(B;_5ZC9WXDX5LG)4WE]EF.C*F,&3RDYT 7;_T**Z4P;:IP
M213*1'E:G;F;^Y-M_=LDR\YIB9"G*C7,2<L2MV95KH\[3AOZ1EE$GBJY8MB3
ME7(KA<Y[,*CIKWI"V]BFO:</S*[GF%7*Z88]Q:^R,;NEVWO5<W]1&MTY;5V2
M_HV=F#OY)O/3:Z0K]G37<'!.L'-R\V 5K?8+SMM/_HM;%7\G;"T2?#,J1!%V
M\<+9DK9O%[4"SN8JLY2G!N)/N:&:D]))$^)SX1=$.Q/@HR/!JU/+2]=Y.+P/
ME8>2=F A9TT8(9>R8*XE7T]9G_7]QJTEPU =XVZQB*:&A1JF*UW-H;A. TAI
M L>NV^*VM^613K,LJ0:.Y&_@IR^-M&DE<RM-"X5-=":&78\LVKDN6&OSQD%7
MY!6S 0BF8S%XZ[GRZ/)&9O@IT8WCM,"T0Z%9\,0/Y[(R./DSTOJE"+C_* *H
M"*CN7_B5W_[1\[>5_A0:#>S8AV+UG9;PKRCHY!7RUIOH]WRRTP_K:L=Y$P<Q
M8-!N0,]UW@N[SK"O>3**"H!5D99?+(DW]6?']W7^<W 4^$_)1[_?8WC_#C6+
M?+P7*!"\HL]P@F(C.2[/^\]9$+(HT* _#].4-0RS,#SD@2)88 R99DA@M_SJ
MAL9Z$&A%D&&H*;I(9&8_#QZ\#!,\%.A+0 (-PTB 1(0-"1 :A/BB@FP+9^ ?
MW%."OV*_C3J_9M3EFL-N=D!>30Q5??';NX/]7VKW.C0#8AR_LS66B':*F*7F
MVF$-A++S%Q@3GB(!FZJJMWO+A(V679T,[J1H$QE/PS5WHSN'4[1A-$^F. JJ
M1XU&S:;[9NZ3F:\L^M.Z;$?Q)0W^XE+W4_JA>=KZ[5:NO@X$;1_[H[L9-<SH
MGA 925*P?F28UC$\M3A-.(V$?O/RS>K33^SGJ1/:;B<JL>*YRO++LVPRE_4L
MXT7LZ&:([1/*263Z<PT]"M=:"[L3-JXP@ZVI_O;+,>,9Z7_]6@);LX0 RNZK
M=DC  )4Z,QJ\9SU8.IHN:(N;MMM!QX(EO10'?H\6.\$X:Q!!5,*<$F/Z?*Z-
M!.Y0H$IH91.,HW#S_D75H@7\G3X78@JUF970[,+.3C"Q%_V<(9SE![A^F>K_
M'W/A:_O/XWR,7+3]&8S\\J[*H1Y')C^__^&+=\!3?+^)V?L;UF7:!P99OC[(
MCS=CCEE_/N%B@H)WUUT;DAE^__5/_.=/5-G7ZH]<.L=_3C[A_0Y#(BJ!0U4/
MB8S.*<XJ!K(9+L6]R?[8/FE%,06J-*E7"#Q$[1_("IKNGXERB>N?R?2?^Y;R
M^RKP-UF(NJ;CDO":^3^F=O9MA!QJJU#P0?KX4=/5>%HFWC\<.^3W&;P4"9S5
M&B[)RX(7>P9__)<#5Y(7"R4JA@<$_;%+#0^^S72PYT0D5$7Q,!\*"K6LT#HV
MJWKVR[$5Y?+SB!6PR44R>WY;E6)+K18ODZ3%RHMTV-U-\!G4Q:J9/K6RFZ4V
MLR)S0S\7C=9U9'0])C-Y?O#\I+&,HUSS]&7+2"BN1_.#H46B*<KUN#N?^W&8
M4@F]7Y':2ID^E5-@=AD@#:;\(!Q)N#KEE!6]>9R.IT/VO38JS,I=8H2Y(*:+
MN[A?$&W#"R'0Z:,VQC_MC>\K<=B7JCUI%K6J<?O%Y.T;DF\CD<"#F?0M7J$N
MJ!2 %O"E!'])?$M'X+4Y$E M3[+KL1^?4)5+-9?#9T].)A&F[,SO2B?,:O7B
M]V/8/TE-I.WC;<GCY<6<T8IGL=SL%G,KU@F?7(F9U=%*8EDA,[ZVL"Q&(KQ]
M/OK+<V]<T WJ%$25'3BWVX0XBES>*J[;KUI.U:V6Q#LBRG&\-IP5X]T;F?&;
M3X)HOM^%L4$J^8MZN_GS&'<I,5]ZNWPA>S+=[!64K''0ZFZYU%X__?3@$Z^H
M2-TU;@^@!%N\07AG(QU/1/R559)L1:P"W=(C/M8O+ 5?O@LO%7O*@[9-X5LH
MEL#%C 0&M$$B8BBZ*X[Z2>?_L9_V(9%L51T/LIP%87BNH)T&[]5_GA9T^ YN
M/J)BNG)@0M0(^-*LI%ULLZP;"ONP_\!L.4A@VO"*?.PXSN-\;XE+>KH'";R^
M4JC_>>J-0Q7X2>Q1@67)S<';/_^=U0TZ&E?IS\GT_Z]^@";[L4;XR(QA*R*!
MY]V@XSZ;39&+LJ4$5"Y2WV9 O-'9_8*"^3!Z/R/XG2W'8S59;YQ05WI,9AMG
M$X3O]$6Q%_G:B<!Z(^:/P)D_V9WOLQFT.31 K38:M:CKX+N^'8J(C0:MN@^C
MP\',)_Q3:N.-6J<JZEI10Y>3(E[#%RP(K^Z+T3=G\L/Q37KRO=&>/_TP]+/>
M/VYHP']6;GOERB'26VTE[3A1! G4__."ZB78TF#PF'6K42?X"%.[^W@6(;"!
M!/834!<-W+I(.X#>W<?1E]YD0/3I%_MIMU%%W8\R>9HB7!Y7YV8@/[WZ[%[/
M-9P[)4V)P^ 6?109$PM9 W?DE!_(MK?/<+__0J+P48$E(EF30^-XX )O"CSQ
M(P,&>1R7V=I^E!6!N$[7'HI?,RI@;7(YAO[90=B.U5O_LAWWK(F)<_73'JB<
M<,U?Q1HRI^8VUOY=TX3K]Z0J%;*0=D$A?^4.WM0G<VZ\AK*Z"WC"'1$WI+FD
M/0&/L$$"88B0C43P93%(AJQBT6RV6$Z0N-4%1MU>/( '[K('98&9]";!E[-<
M!TR93?NK&^X2*#](+?5S^7D?1LM_E';<+,L.Q3/^\E\*O&=5V_2TC>@V#W.J
MHK=V_:&#&*2\.6X6N)I>_1#A.P<_,HB5!30_U54T?0Y>^_HL?DJVUSZ$,2KY
M^;^,$%%2?W/9$!ZE,7^RE :CF6B8"/1!*1/]=1I1KXY*WE[?F\$4*_VT[OM^
MED=>K)D-62VB#$%IAVHN39>H\S*G&F.@'QK)440?!51VH(AP:YA<O8_[ 47&
MSBH2:/'[P3^N;?SW.1)AUI>T0YH/B(8?$4#@>1: PDF"5]Y51SK'U/"$-Z 5
ME#NT,G2G.<: :[DT2+.*[[!N&[)[LQ1QS3(HZ<A>9FTJ&Y9P0!)1D/$]UA_[
M;X8Z?VK0;;X0C%Y=$Y5?4T7EB%&Q5^7_\%M' V [WY<)540+*Z"='@D(N3@_
M0YB2Q!DK$G .&3@R^H-W/BOTLH 'V8&V2\$;#^M%&-HA'^%#FRJ+%GE#LF2P
MYB.C_U[K3IRA&73("8&AD.AP[?UUGYLH,H^*M)*]*[9,:%L9]()RXL=S;$1#
MO*B2JN,7RN;<@K(=9&.^:YS.WD,=(>UX17-!O89*97.;X# Z,B00PB7=B-+U
M!&,],,L[U"1)R,!R7)OO,S[0%U5-=_!4\]X2 1[LJ)W:+<O"PN9V^TWFTL>,
MJYX7#^+$G?V_2E$)=RWYB\C45[R5+UTC/[KV;&IAERF?OCI/?*S^T3;SP:U(
M]VH+#&M8FM2>'EU:D( 4OSO)9I++3?[0_ML)^/9J8V4W<+EQ]5,@0(QU?]ZB
MG=R>9LR!';NIFE"MA&F:P)>I5UW@=XM2>J^ZN@Q$!G'L<<VN9]^0DZ+;M %)
M?XY]/&1GNW9O3>;]+8FMHY2L;R[T+>7_TLVPWP2*>8XR&%-<U95''B+X9,]U
M(8T:":PX5:(<!(5/!N?JN W;+_A"Z. ,26)S*'>TW(\<P*EC"6>?5,1T6 '7
MVHPBQD#P$X?^>FB+X2&?#OC+C\TT2#%,<'QE0T<#*FUZX!O_L&DR#;H1UOCS
MF0&N$O)[ND?Y5O)JA@Q]G.L-IEYN[Q2';;N98_%,T](+7550:>&M;-J5H\K*
M_56_0NESU6/#& DG\$V4!U<RLZT-A!L>JKFJ%(%A'/]: ?E]O1BH1V6N6S5-
MV[--21/I$ROU*&S,Q(*@1#RZC(B]&O+ZE$-G=4]>Y\)D4MS(;P/V=/BG*+IR
MM/7I0H&,+VPK#<X(:1CDRJ<;!;ZI8<.-RA.@%1"*"DWTIL&(H<IH]1 NGBD0
M+PI:&F2LT.7YBVPQ*""!4^L=F_#?%0'1MJ9#_L)#E!NKG=7(7R9+@#_@5>6"
MNS1&$'4H#G<_1W<$M,)FA>)+/^*2;'$0P>ZKN091 N.+_\@*XT0_&* _VU\Z
M82?]J!K%6-<$6T("L&O0:(BZ02Z&%;V<2;V?L9HLV2:]]@;B]ZE;]'=)W>].
M"KBKH^D\;<,O#,6[:D>.I7Z'4C]M_Q9+$P\,$6?*<(4-*%S8B^Z$5,TPGT'L
MO[Y[H=>6RLVDT3!B/)P;LW:-G-6$-Y._+5 12 [ZPBPH#=$!-C<^GFHZSG_3
MG9.MEA6SN1U,R4B<ZKME^ !TL9&6 DB$6Z0P_'A3?$-M7?ZGM\EAI #L7JH+
M^,?K]AGROQQ4Q=C(]40QS)]>M0^B_^6H)%%FXF]7_>/POS[H]E\(5^<OQS2#
MX29EM74'ON7QXR-/ KO1++,XT>;@IIKF!%/0.4>36!>770A/9@G8=,OPF+ >
M"301($A__X7L^Q'G>D@/)RH!7@-W]:%V&^,'T?!R]9P(<ID^ARM:'FK-WHZ<
M- _R9[AW"E6ZY$<"1QTJEPL3:[2&5,IT%&1@5S_;2]HWCT2;P$/$3Z,RLW\[
M99 CK^NJ-^VL&0HY=49HGH$.Q>?,9HY36!!2Y*B4"WI;&">O'$VA6*[A>OV6
MI)2X$)E#_\\,C.U$B:$E)!,>?11[_OZO%M%H@_RQKPW-%D.EX!^O^S]L]#A/
M-/)V/,!0C\<7#3-QX"*B??05[-;PI>0[?H6\7R>VN.!CW9I6-4U0J2L7#,<
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M1>6I[PE?IL_*IL]"WDH>U'D9K_K+M8[3*'6LWU/&:A+.Y@*PS<>WR,J(@9J
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M,BP-?LZLN/Q@JH)V]'V"XX/4"_IZN<3-6$H&#9JM];BZ5=$S%2#KN;QH =A
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M!-O6TTK3?CY.DL*U!CM*6LVL'N2X^C&-FG=&94D"Z3?,^'TJ., [T<F=$!+
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MV: CG<=4NU/2C1!J%[^A=2R6>L[K8Z?BDR6C$]4!:XVJJ(=[3=E0+:7!]UW
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MSG>O64>,W.O7+WW >@U!\KSE7=TW_CCH2'&Q\%#9Q(._FJ=:\C$.LY/[(X3
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M+XI P1@*(/$VQ 2.S @P_!S@(O!2 7'H3=7A #]%E%1_+ZT;0?,:@>-V]L3
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M8 \  <B\V(+</ E<Y[['=!#><0U%#/Z@0"$#FO\E@#CO(7JTK\UP6;\=FL;
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MB@$P^LV6QL#3<DK$%QR>RK.E X1L]CS5;"]D7IBE/H"71@%H?P/ 44^A4>_
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MC6%F0LQ#=1MKF,4#+T9<P7LNQ9=+E)N3D%-/+8O]PU+FUDT!N02J5C/X ]N
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M=Y4IS#_<^?[ ;K:>MRYN7XR43EX%S,'>JC3FF1XJAN<Q<PST7<BF-B1(0(+
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M=.5CT)LS*)YQB#<D>EJ$&(Y%B:[H:-0UX$L267KV'-_(*SCX<)SKOGVN6L#
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M&L?4![<YJ.-VX.P;6O"2DM2"-1M.+3UE?0530^$9F8P/KO,_[ZC1@$R1CZ]
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M3R8XXD;NA&*-KNB[*PV!SE]<![Y.K2_WO@(5NZ$R6WDCQ\4E\9A$'44B=/8
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MM\TOL_#]@^2/X59$[6#BJ:>;AW;I"'YD?:>OS#M0[-Z>K=VWZ@M&KEYBU;+
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MN:XQ?+OAO*-=1S##JB@AWH+(;>7V9BBCQHX!&ZE%R:P%"83$JHHI[5.Y^X(
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MOW*O[ FI#(/G.;]^Y;S(NM2KPC#^+[/*@$>E05P=6+O XC(_5.3ML=-([)=
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M3GGT6=QS$N)\HDX$]>3MHOF(*J?3]S%5F;I156]M+Q]49>OXF3B<H=69]PZ
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M+4ZD+3$@"Q^F<:-FKFET7PE=!F3',-42M,*0,<SFT4)M*C- S'$.I#O3.QJ
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MX]C&[ 2^/*)^2X5Q^-^*TY@9SM#.I4 /WG64S9N^$<^KA6M)J%!V@U)E&OR
M:=X,8/@P T)\ M1<=W6A/RM+HQ%A# @74H)>\@"^R@5KH(:FTIOK@=8B]S6.
M"3BADQ\,I-[9I3,@GJH,2%U/J!\:;JDDU),MTV>SE#U18ILI-'=4>21!#;#N
MB.&8B)I5B5*\;IS<H6EBU/]>JMG1(2@R_9-@I^7?ZW_9-;\XP[\$KAB6E(*A
MTJH8$("+:DGO GT-I@2^- ;&G!##;2' PO#?'NZMP1%N4TI.*T)'+K.W?U%)
M<GP5#*7F(36VL>RW"_\ARR()-V*3O$EQG?RJ^KV4"TN39L_H.3A]!N3W-O0G
MX?E?-*[W&^SF?Z+M_XE>V[98X>P?,+WA1S\@ZV4/GV_W#!M0%@2L\)X9(YCR
M/\GKKOXMK^O"@# !$SFN'O0R=9 %$BJ_8P/0.^(]C0@D8.I_^X@,NA2QAJYZ
M%+FYQH 4J]&?$N;HRFM;AZP5@7&G^$8Y[>Y/T_"N84"6F3J!.3R<MDO/Q\P5
MT"DPV7MCS^PAY0)@N0UXXM$-RH>_]>/O(YD_<D2*B49[G]C@E:\W($=8,#UE
M^TZU*[M:!*#/N#;4P M2?4:9*1+G:JIX"@L6K)QD0VJ+N4+93[3\&+@V'U82
MKI5PO5UDY%UR\+=#/W^V2_0I7<Y3AZCJ]R1;'/&QDRI,W&O0+9&=6-A3?E[(
M8::HHV_ U W+;AB<.B[0X>K[L,AA7/+(77'G7C@;%3EF[X=CS5$\SQ^41$ZJ
M&U7\7FCDMF23%?A=T_%T7_NHVV77%Z@8[:CFE6(SB(<$Q\KZ<Z6+KFD-/,6^
M:_XV!6\D]PUKIUG%N#^)7BEZ5XPP-+3F]WR\N/]'&F:7J4&0Z)'S80Y'*I]M
M4R0'N<:*J^R9J>:YG0OEZJPSG-+)A):T6;;OS<^$'BE>)UZ("?BJ7LK[VX+>
MT8<JALYP2/G)I+DX4FZR.G8:[UL@3+F52^1_%SVFZG-O1:?KJVV'<HC@[7NP
M1D&M$KQX^X=W4)#:?)A'K)QL[6^5ML?1QPWSXJKI"G--4\71W$EJBV?M%N^'
MI.BWJ4T'=M@V<\IJK)!LR%X?7.U8#RYIX,KR7\ZBBN.\[#86%Q-N+T\:O4F"
MOW4\%E#(?_)M>Y2@3K( TTS7S9VW.&5N*Q_(.,.A N&/G/WW:1M!8"01N?PD
M;IWF]AT,Z'RPO6+;?5QEQ&]@M V, G%*1OZX@5YRS$1KW-9.S5W4KBVHT4Z
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MTD*5SKI:C)T.29]%[R\KRBUVD6HF93KC66SV,A^_J+: U&% _D "= UBZ.[
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M?_1QW]T]_OSYX.SLX/CH+F;QIP"VB2ZR&)[?:^^VW5YG>^O5+8^L/@LB]-K
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M](>7M)?JU3P)I8"K B=!,GL43UA<FVO: 2&;QL!"&'6-TS0 ^[B-NCT3#M8
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M-?0@IV8DIXB)0FDFZE(V1QX^]7%E=,ZG(DD$(]M29!$HG'L9+S0!"FA$VK%
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MDSN^EQ]N^O?W.N]U8MQ/Z"(^\T9Q'+;</Y17&B0S?T2\M0MB1%X$?*$PWS:
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MI<=XEA"2]L(NL5N&3ZT<8QLEMDBH4#5_)JRK:X401C5#^)@"&[=%)8&<4ZU
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M:D+#;,%#P!E!.M*/C05<#O!?_-MR;D5#."]9D04%SUEGB!_\?M\Q?J,2#^S
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ME"A7T*WF8KI-<5;-S*@DE^=&E2BF.*Q2ZX=2Q6KW"->NC')42GD7B /Q8*=
M0GPO*<.ATJ._!6-2H/%B534A)4?&7J+EI84.97>P'&+(!'9:QUARWD"U#8[U
M#6C5B:\I0"MB"A9#:++ 1;C=X8L05H'*>"I"Y#^U<!>+7K!-F4A'H&Y%.<U
M)RK\3Z_=<>&2#HG5]/E[1#?=<?7 ]M#72M%CZ<,E@RJ7&TJT 2H"XM.']^XG
M4'U24'-A!+AMF+6X,2(2UV(:8*$7[=XO^@1CG3DZ@96[:QRC(R/VOK;F8)*$
MJ^]:4+^</((C:%TQ2(Z_X@2>T_^FQ0W.9&[:6NSA)QR3$W1JF!6ZV\1%<')
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M4<,7E:Z,\LX5GNRX .NE0"-*Z*J-Y.[.X.O?HF"(1YV2IA0@CE/@4:BC/*-
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M4QOD5,\2_ST0?C8ZM//YJ)BRHS/PW# ?3S##4.%'W -9)-EJ((\K!\H%D>9
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MW84?&L+LX'HCRPLSG*CNTJ#JPC[ [![94E-=O!H,./N"9_W2N/ECRX#!#T1
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MOP!?M"P1K@?<#W-R($G5V&C:+UPM?H:!J3\:UPW9*@=]SXD_D)66F1^D;XE
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M2IZMU4E,3PVHZ,7Z<W:,D>J%"C99+,B5![.2IUI+(K#%GQX!!Q_953WZ8$V
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M$X[4L1?RVP7QE4X!ZK18T'ANUVN>G'N=[GGI^W=H/_BW/BC.N+%HA^J MXJ
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ML )!HK_]-AX(Z_'VP?@0?G9+F_-.S69_SG;HG%5PI>I\:?3K8DMNK!D!#.7
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M&I/3JV%0O@ LA:O=-.LKK(.WI4+?*>@Y,C/"@F^99KQ&Q2DK-UP%1 U+&TI
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MHVX73*D,L9L_([6#-6,M(D_50(HT[1_JR$<C2Q_2E:6^_DD\3A1Q7"92ZO[
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MGA^_5%!FUSOOSC#Y"UF\U?)^CTA],CNP4XC4A9E.6Q"PVY6E)^?-%RI.6B?
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MP1&HM4Y__H=KUG!\['7/9THP[$-H%H4>PXN\9&XK-=8]/]ZI[O:[%D8[>8P
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M*0_^7=0S7E5_??';%(T#HX J27$&?U$];EA.P2)3"F2J\KD)N_\2,X YY&!
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M8M:!3^Y)5\ZI;NE#IV?,2V\OR&>P S8Q>W1&M:GY3[FHH*>+\A43&,G1V:;
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M_4M\HI[HB'YQ5-U*ZEY+Y:,%K()[H@Y^4:FB*)BP9!B"!N'HQ0<L0A^OAI^
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M@);C\,,N[L[ HEG)N#_O#9N:%5$$A:8#&P[+$L#D.):'<* ?9A*WXT/,8I%
MRR44)C!,SYPH)EXZU'/G&<,RI)-*D$Y.DZX L3DR=3[$2AG$'LL?I\I4>E")
M;8%H("&;1S1VVI'N#"1SHY+R7?:,EXXD94^DIP' @V>#](+ZM.\0H(7/N:N.
M_1QV*-Y0'H7>R,5H".<O&H!4I(F@"!A*44[@D& J*=9) B7B1=$FZA3@$3PW
MM%Z!(#W$XZMLW8(RNIA%=-R^Y!/OWDIM,QR?GO73^R!8@T0I-6!!1$N1P3PI
M!:)4!**<!R(@ B-S :N2T@V#%- !<90Y W)I\*7<@-Q8[(KZ3J!9GX?]J4N3
MQM>A@Z&QP'HF XSI@<;6!8(G&Q@_\XZEZ$)DUJ9_X'760-?W0I-=CDE5H.%Y
MK+B@.%P*X\9OT6PY)K$PFV)6Z1_$D$1SIB= 3-T'G TAOEB8)G(LG]CV#!3[
M$C^JYG=W4%>%P]"FWO;0]4C,A,5D9M>!\H!-[@5%*$)W'30BV_.@3P+XE?<#
MNX]N0SW Y\>C/EXMH E:<8 [M43RTR0C+D.B^XP@G8)!B(P+"B)+&53"L@\T
M0.LB"J?G1=&E!:+HT:[)'-L#&FG=03Z)ZQ >T*9+,>2)!&IJ?:2NFDJ++V*1
MHX#]2OJA[DVVQLHC+Q3(%!JM%2)G:X6DG3NGES)X, ].S@\=T>.*M 7&K,K<
ME+*I=JW'B_YD,DN&(0()2($=AK5H*%QH2'GDWOV.9T<(M4T"EC/+MV,>!R-K
ML3M[+A,Q/-_[4>H1!G]\<7&/..4MQG=HVK!/KT=;S.R)>@=2IX]?:\1=+.X/
M<BOPC?4;C<F^>6G]QHU B1GBB49 HY!M.X?Z)%39<#$5-V$4L=:-QEJLY>7$
MP?X HR%*:4.O%^22@3+W+K3L@"8,.Z[MTHV$ 1 T/=Q#^>#DD'))'[:B0Y\Z
M>,N^&5I^CR 7T<SN>]>^1]G;]XRPQR7K %C+IU=-\CJY8@2B3SL8F$3B-:YZ
M #Q6*(39F3''&!/]$W![K"#L%=Q2$='>!3EL#A;#1.M^:$<7RFF(IB?W#<L.
MO5EI+UC ,1NZX-1/DSWV6PY2103BLJS11$DE/AI" J"8A>6ETK .8SOOP<,@
M%RA^,L1[4BRH$,.1YL'D@OJ4J]8]8ELL/#(KJYXY+&Q:V4(1AZU5J2\EP7<.
M*V;"W1KJB%-;@->'*P)AP",UN;B$-Q)LBGVRW'WR?%E,B<<W$<;NG#OP4:F]
M J(4PX>A&4B,(>!)&A,P#2=E"](J%C]'<>U*=!@5O$:#&3/(S48/@X^1[R&S
M.)S\'L/0KV$X<0ZR3(ZX?SY#Q(3#M @@^WC-$8G?\&'B,!)E1K:(2DQB$2#]
M[=*5#61\+]86 ?_&D4IEOAE>P$/6]$:MXUL]*NVY8<UW;Q18#1T>)YQ2ML7D
M1:2Z!M65P0")&F5.&)F;O:!;2'\L66,*L(89>;@N"!"?VE9&7%"J"Z87+:OI
MD>3,+>*3_?&'-C-OB;RWCLA[VT#>6UWDO>WDAKMQ;0S"<:,<'HC2WJ2""CEQ
M6(T*3 PCIB1Q4F,GD<;LYB8WTZBY'GKX\-0#K?3=,U3=!YIZF%1P2$6,4]7$
ML8V%29*)J<QFRN$>H0VH'<D:"-(N*7%^7JED\52*7W(A%2^J@3/A(0Y-JC8G
M5LS\<?0[F!_O1Z?8[+(OVD,\=$L='EI]R/'Y!O/CK'8CL/P^TUQ3ZA?Q(F4>
MZ3[*QKUK]<;OY)71C[DKM?H@2N5,4+6(13A?@.1-<\2Q?!9ZM#(SK\:&WI?E
M]L"5(TX>P2@A,>!BQ;IYY+DF/Q5@O4JL.P,]6K#^:1&^PZD\A87DZ%E15-&I
M1P_%6!H+OV#L,F]CX@GF7K"F1LR1YM$9@"$(J5=-1^!I+BPLGYPSI^A_2*L1
M4F XHE*[AE66FYK/@!%O5DX"2P' J ZK1?>2WEPGM%;Z-)N-N>OPE6T](=@,
MZ[ FH"8R',4 #4D9)D4V<"![AB8>^<2G:1')@<W,6Q;CB1P,E_%)$S]:B$RZ
M="'$]*L\=S;F2"7%,XA!/(?S"XW B7/M%),SJE+.H.7*\ZZ>LQ3:U)3Y] /\
M#PP/;5</%#Z_B9$L0L(TJ<RJX@GVRKB,@NU)X"D=<<_&VOWDL-2(1 9R?I1Z
MH.DJ4PB]E'AY(#90\T!C25%^Q)KT6#8>A"4XA:R6@2$C+V !6MA&@T<?K3(I
M+O\X75F!@ J=J"Q+%)^C^M3',R]T5/NA8\9IFAAL^M?MTC4!3RN\.FCBWJ14
M*H(X'+HL(^]8PA/K2 C/)=035"=^&JTI@YHBR;6C*[=@Z_E1KP^75YRDD1-V
M="^Q+9!X<1[-C!N& 9Z.)VXV@(9;EBNE8I'&S@BQDB9M0Y4]+-S+C4$1G-X3
MT4Y(*I1%UH(!6,243+QE@'TK++*?!W>I^Q'3A,FLDSNF!S)I$+@CRU__BZ)-
M5.X I.(D< M. M.9K;."BW)><%%*I%[4]6Q\LTYAH<(@LSAV6.WQ'"BZ$Q[[
M/XT3F\Y"+D3W/2I<F#8KF39SEP#/2ESUO "14=!W4A*G(K$^B9)4#&XG!<9W
M$EO]W+]!?=>-',ZX4J.4347/<4F5Y\OQI%4K.G\L\RBK2B21!%(M&5!2!*12
M&LMP!VM'@9:"'WBA&80>4238(BR?"AP%;!T&?Z.!S\_G@4&HN1_[ ).LE&B=
MG@6F?9AN8(;UXS#7F2=<*ECV;^!Z%DL^L<D]H=FR,-P(#UZ8E2^.L3>B3Z),
MU?158.J_GO.JHNAWL0M\*%PG<CFD;.[RT+*Q#NF#\<C"-M1/\BS:\>3!];[+
MMLL*F(H:M!O)6C!84GLZ0%52C- 2D.G<7)%HL*%$ UKS-V7HL_)V6#\E3D+N
M6SY&1]A- FN(T1(0U_9CHNLE]F;\6)*CE)<RCX$1VJ21.9I^N<L]-+4[+__>
M89<2HF+DV1:+Z8M$ (MAF_R6Q/A[V4QQ+#GC8S-%O"5!"\CPSU$U&1R5W;7Y
M14,Y97-+KD%OM4B&S%N:P$PC$&F%</,K KE L LKPA)/4O]+7?JE*?5C56+'
M2DA,#VC2_/SH!FED"$?G:V[&V.;W.!S+(<&C=-!1#UDTEF\FFF=N\-8X]*@B
M\B-LFV 65PHF7G0CKIS-)Z3 I)*Y>L0W/:O+CDGP2"S) .3AR<+;DFYR8D,R
M,T?^>3%4H-+I/=+00>7>LY)[3.EFW*D(M>1;/\%".VA&&$E"3#GW9M,'F73Q
M8UB?%4/E2,JAO#1&^8AB*?#R#E;9<7!<HC/;'B&&.KM&F:+F,<*!E;J?*T58
MZEGLI@<]+76]Z!5ZL#*.]#V*8]YF;EZPXLO\:D:Z%Q3V/O90=2LH&[$N!#\L
M@Z^8A]!G*;-4L-,,779\<8?'8PXRGVT\T"+V(]P#>.QGATF#JZ2Q</+"E.L]
MZ2QY-(/VEV /> ;"^L6Q,@@2ZYX<-1=GG>CJ]%"<Y5OPEN9,[,3=BNAQ:[8A
MMA]+O!Z+OASR"Y*,]+17V433-2ZO  YP.JGJ[>T1<:J;OM901?K:!M+7&B)]
M;2<WW"U-V,7+CORBXQ.[*9*V?Y*3F<AX/AU@OG!..0]JK6 NL LF#+NJ2B^^
MN*Q01]J_HXUKL>)!\E+<#)*:AIGF!++A2V-2?(_$,69ZQ.W8WG1_.Y;?O.S^
MAJ>T25T#FG9EE"I 0)NVT52B7EJ_:IU.G;78,6C:5EX33O9^Z/.WN8X.'2)I
M.AU!3Y<R8@4"4AK6PDM$#VE"YTX2MW%A+D%:G:>YI<NR_+"$060TL*M4F!R'
M;A;^#0N*CA[R+(J:0@?#-M"LXD.ZVVK&-IB!624*7%'+6QHK2Y.^6%9\%?P0
M/]Z#00EVJ_?(W1$V0'P/@!W#F#2G*KX.@/U:\KJ02.F^W#[+;[!9)DI29CBI
M@Q>U)LDO#DQKE 24PW$N7=54QDE11=U4Y(%>(DK*:"@2]<GXB-0XA[FHML6
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MCJ8 95 !9A988("-[B.7X_'J *Y'JJV[S HQ/ H=-W3B(11JB&9?E?!5;J*
M%0;FE@?T&D=-@@EERIHM9YR25FIV_UB^'8"=. :V8?L Y@@S+HAD.2D8@,6
MY3R+SY3\<$=<L/5&8.0DQK"":T=]EWH.8QD*LV"2+SUR3YR0+LKPT*QGHP/C
M?R<!P#_"ZY#6$U.@^ N,ZX?=?RD=W<Q =S$5J4:]-GI@@5?,*%K,868N^1?B
M^:$O7Q&O3WNDF$MURC<GK$[\V-?&S70#I,6=UVG4#HQ#B5M59VZO=_0.7(KO
M\E<THFX"CP"#7&.$9TA9YA0H'PYA,UUY;L#'.#$#YDY\!$M;KJOZP?TA31V*
MF46^.?I#B5Q^<![NK5XD]ICIB)\LAV*<\6#7#0,6!R"<WP;6"-@R>" $A53D
MGV?EGQF 3 1A!GY=CTD9+M7ZE@.D1.=JE! VLB5/Z=Y\I%LU"D*$X-U)W)F@
MOD<P %/7YRMFRR"^Z5E=CL]8_M-MR_P(A^!=)I"]-FYYH!$HQ6 @@XV<GI<%
M']ZZX*[!/[WXI]BBA0]#*PA ;]Q;A+UJ6T"B"!NIL6(ED5XF0H0QPYY\'N/M
M$XMKH*1BM'.(Q>UDPF"!%4R%!32+/Q7]/GT;E)E%E2+J$21SYI4>,2TJ8AGR
MP2H CO%21(@<YQ2?4#'H2P\@D6+1RVADF.@3TC531.<2I1\BB+'_SAQ/"CGE
M$M"L0S"BJ-N1 14E)U=$7KQ4B2Z5ZYP"'/MR+_0B=D=E"Z8;:JH^+!*F>X2!
M8?GH;/5#C](@M1/018<QXE#,!)V-QR-X^"A%;PF4!"#/'0V8PSO&;O&KE"/]
MHKU$$3B#LQ14]L@S+-@&F_9^C%TPM!GZ--J!H)P ?A_]9"-53&\\<]XXAM\M
MU"3=WU8Z<V9QUL]7CNM<HK0&HP'X"-\ 4?Z?%^\\=XB.^9&JP?\"E_Y;TX]J
MV@NP=, <0(O>"\D+V>K!T\#L*ORGU5[(#K#X?UX0L_?JZGYTBVQ\"X.^!8OD
M>^D3&ASS9^_GMW:[]HW 4$='$V-]>QH^UO][3[I7[A<;W-]P"(M_I*^]2H7+
MY2.\]"W?9Y"<^GT!Q[G<N=&+52;ACQ-SOH1E\?8NO,V\Y/+UH$I,/?\CZ=U3
M/GUAQF%_>5P]#QK8;R!TG/^\J(V?"1<>0Y>$_(MAA]1V_.A8 9J4[ZR?H/=_
M <$ 7]V#JXAE*.2WU(O_Y+Q:)E%65RFLY.+_!FME)D6B8W7\^17:D4/#GEV+
M; D0YTV;MXH;IE"R@4>J@G@ #^W5J_-/;Y"%LDJ$#2NW@-BS]0GH1#\<_::]
M>8E_P9\PW,29_/:A+X.VD\CJO^*F\/+PIN\8WDY@LV("0RGVNW2=(PS&%GD5
M2\)Q;4=Q/)U'UX3<^HXAEW'GS<#PR !>!-?OF@2AYRP)78T=0]<5 0R]!_M_
M)*\8<\T=P]PE"<"6,MTAD0^&EFUCB.AP2;AJ[1BN3GH8\$ Q]O;C[=G)\A'6
MSD'8^JZM1LL\, X7]:P.NHN_:B[^:F_Q5\GBK_87?_5N\5<'B[]J':[LFED4
MLM$*LFTQ\%60(JO]FK^?H^A5IZU%T2OB4NF.%L?),/AFXJBJIFK?ON&_-/C?
MM_X?9^>C;T]=[>ZRI7>''R[_?2$'5H#SE?5%7I1=U"\\\O>.'JK"8*F@71;4
M%Z6C@IDX8..%S.+3_WEA_0Q>.>&PYP88R0?)\D+F__!IK"\$%YD._OGF#&]B
MQ'D-61"+\I3G(D)DY*&--X,6'X$6?_A:W?[RX>Z?]T9,BYF.S001U(6(D /J
M@K1H+4H+#0BA:DJ]UE@>,>J<&&!=PR(O89WW=V6VQ@60XWO;)7]^?;AMA;V8
M'$OUEY9!NJ*%+4B\SJ+$TQ6UIBJ-CK8\VIWET(ZN+L6J4TCX7R!A4*]_)S?:
MZ>F/[Q,D?)X[MFS:Y2QL,1+JVJ(DK"F-=D/1M<[R2/B6DY!R9LK5N X<I-QH
MI(_4(OI]!OI]MN^_/ SMFRM?C^E7Y+?()_24=!F$R0=W07K42M(#5HBGKR1/
M,K:T8[V]/+*T8A5%/.H,+D*?OX$^'_[^^,$++LF?Y\V8/B5<S"62:L82%J19
M67MB&LWJM6-MB313OY'0/[HSC!%(1!(P5_1/U_>_C9RZTRRBD@E4^N^?G9LO
MIS5]5*O%5$K<V>=2@4/U*@/4@G@O:SL<U6/$-R?$V+%:7[X$.W5O^*6!"V+@
M22[='Q9LCQ!FO:*,YQ<1X0Z(<%97WX[4R[_OOW83593UDY>Q'_+@7) 896V!
MCY?OBK8!QPN8!S7]N*86D&7]GCNL69_J'4Y:D'D^E1Z36D_[5)]_=N_/6H_O
MZQ^^+^Y3K<"/TAG)Z;]R"%Y;V')H*(T&_%]K%>Z[\D@N\IER<(T^TW7KXNFO
M+Q?7M:_6 C[3ZORD6;@N:Q4L']?-,BY1#K;1)?+OW_WS\^'LRPVY6[%+M$HW
M:!9M%HXFZ$I;KRFU]L*TT>=P>7)(A"[/;>B-GD[]J[//_56Y/&MP<V:1:/$@
M _:A4[1.<<"GI%<ZTV3.H0^Z-.W/5U^,\\^/0;\UMTNS.C=F%K[+V@)3#.*.
M?MQJ/G=CE/=8<M"/'LL?7\/O'P8/?_QUWG^.Q[(&+V4&2>IEM?54'T4]UHO=
M_25X)#E40(^DUJ^?7)__<59[-*=Y)"OQ0F;AM:QFGN:#:.IQLSB*.0.O[^9V
M.7*PC"Y']TO]3_MV>/)9G^EQK,K+F(7LLJJVC(^A=:9$259<ICKE6&CEMT^A
M8Z'%!-72CH7QX_'MB7YR;K:U2CD66DQE+9?*"VOKNM)HMA0=G;7%]E)MMF.1
M@VMT+-Y>W=U^__'V6OM1JY1C,0O7"T?PGXWK=V4<BQQLHV-Q,FS:[2]?]<Y]
M<XL=BQFT:2SL8&M*L]546LV%K=;:'(Y%#HG0L3C[_?K'2;/7;%C_;K%C,8M$
M"_OENJ*V:DJ[5ASR7=9920Y]T+$P__O>N;"#O\Y^;U?(L9B%[Z5$VMO'M85W
M1GMNSR('_^A9W-^\;_?^;/SCW0PJ[EG,HDE9=3WC]$-=V+-X5\*SR*$">A9_
M#"X:]7___7IK]M;N6<S":UG5/,VST.O'K85Y_71NSR('R^A9$.-'_?8Z;%L_
M&QMS+69@NUE6V98ZOM"TXT[1J=)&CB_4.<-5>5Z&&A-737L9[UOZ\*-Y^J]Z
MW:J4EZ'&!%=S"?X,U=VN-<"Z*LY=F8'DSFPO(P?7U,L8=>\&5V__^L.ZJY27
M,0O7SPF1/P_7C3)>1@ZVT<NX^OC]Z_7]V^M_?FSS\<4LVCPC-JXV5$5O%)W3
M+O7X(H=$Z&74ZJX67M_UGOK;[&7,(M'"3CJ02&LHC?K"7D:GK)>10Q_T,BY[
MWKO?K?L__[&U"GD9,_#=6D*LO-,\KB^\,4[G=C)RT(].1O#^T_#RW?7O'R[T
MBCL9LTBRC+0XK79<7SC,7BOA9.10 9V,4/_;.36^/'P<VO,Z&0?/]C)F(;:L
M:LYZ&3Y "=]-^G''[4F[=_K-BLE4^/+^1@["T=]0U=O@21T-C:_FQOR-67@O
MJW9+'64 WCM%G#W6BB!ZBI=564%K@MQ:+EL[18F> 771,V #/0,ZHF? *K91
MV>*^"\(QM8CO6(FBZ5Q)*_XFZN.=^N[;TY]!Z^[GE[]Z3]_[X]FQM'I6'B<?
M:+%^2@;36M^>K)\]_^+KI].3;KZ.3MJ*@$3MNV[@N %A0IY_H(*^_4+^.;1?
MV08BCCA'GV]>_$;K].'>]'BQ-C\I%(KU.%T['#KR0?>0%NJCI<GX8UCQ#ZVJ
M;*GT^&7T.MFEV5BMJF^3< -NHMRLXZ?NQ?G#R?7[?VO7.EZ:S8Z@Y8PPGD3P
M1/XFW;OOC\"S_<D13G)&& \6/MWV[/"/SS][?]T;DR,T<T885_]/_P1GGT;]
M+]WPKP$CRP+UPS):NO,B&Q#!J<N,/".1H:TN..Z,*"8>]"\T[@QKI:WGCIM4
ME!ZW*N;_S*]FY_PE'V!MPM.!1?J3?OHA97EBF -8E@?6T,AU:&E.K$K(REX2
MF5>[INX(KW<=[3%605,J#N<<8_'0\1*!4QZG*XND 5-%$E,KB33K6?[(-A[Q
M,KL#VJ.,<#L'7]IY^\]M_9^OI*N]*!@I1[KI>=*M]NWIXL;]ZYU^_GCU>ZW,
M:.6$7;NVN+ S#\=K6M*'L;(KIU]QK<Z(J$"D=$\4@]7W# NJ:TZM]GH,[EGJ
M#2DN)\F+T&*)+"J.9]2,S9;^-*@7PMZE]3^'1H]DP1XKDYUI#1 U)* UC:-N
M%W2*8MR\*N1(Z7DL"?*V=W7?>"!AQW3('"Q9RV/)DV]/?U]\J9LW]^].?[?S
M1YO%??7%N:]W2.M['I Q+I0,'DWDI78GQNCS(K.%M5.!"0WL"!*.8'3:-@89
M(:'WX6PI%54WGA)TYEU$6!5:%-64-ZE<Y"\7 E@(%:\=C"L<A=[(]8F/D(S7
M?8\P%*$&:[#CO*E*L508HRES87C?Y9O M4>X/V\",AH0!TO'!H.PBU]=TB*8
M\@=C&+5XN<#2WF#X!\0N%J[/9.7ZMZ>^^=2]Z]3OOW;FD:[U/%9^^^WIQ";#
MT>?SR\<3:XG2M;$X?X_S=40U*2D6/(^4?1['CTMF:4[)G+/FG(+5J3K^47WD
M+*N.5TB6,A62H\+(S]S<^:63<4.,:9BX8+&T&@T3K7U2K13),&F.9<96&-WJ
M<Z@G10[]"$$^S)]J8H =G7B%<HG97<#0E[@S])4IM<ZWI[^LQ_#W#\/?_^@4
MJ*%<2=#(DP0@5ZY_7/SU^?JG[7RJ+Z;4FCF;_C0<4A8 E-S>7&-7JU0=<6#?
MGI4J4.^'PT@'F/%[J7U/'R9.SX_Y8,A"F[0** AJR^TIK&4$#AD]#OO+BHN%
M*G&9\ZC5 C#TM/+N/H8NI1'8_K OV![%,:-1NN3.<FC-\+AYTCA(N,["D>7,
MR"5&6YEJ 2OIM/5T\?W3=__O^_X<#-7,8RCUV]/-I6K]:9W^=7[=68RA6CD,
M=1WI!E;SGM7Q EX:X6$1V_C :$KR Y-;E,5<B9G%_@AKHM^G6H5PF@"4KOD]
MOUE'+HFH(.%41IYDG=$,F(.>3EEH8_0 \0 (4P8(IL3 #/W8*(/GN-V"KU #
MZO^,X>CUE=Q05:KN--!F'XAA!P,3F09[2KCH-?;(SY4Q1//;TV.S]>='O6?6
M?B\@82Y#M/(8H@$,\:[F7[3/'S]<M!9CB'DC5'EN&I+-(=C^!4^CI$S7N]S:
M_:!"J/D<][7P Z GTUN1'!I7F"LDR3O]>]/\X#JG];LY2-+.(\GIMZ<'R^@V
MO__SXY^WI79\2?.ODT.G\=IYP.@]TJ<]$$%IQ\UR6+B:M0X$D0U&@_$3#&RI
MAZ0$] =1@P.@)N"+[4UJIAG1!*#3>==+V79][)T!5+HS+,>/NA_B"ET?2(E;
M&$R8$=,,K'?1NYC0Z5+W_!"-=BK!6HDP) ZNT#]EVE^C&\"\Z&R$EC]@(W8-
M#R?&W6T.#-C>%(ST2T?8&!+/6=C* *!_75@\<(,3X'RL8XCK')F&/^#=)S-&
MRK'T=6#9),V[K&&(@Q$K-_13G!N-E=^CA>N:A*LCF818NC?LD'E2Z5?ZJ<8E
MJ4V3C?F./.RG-.0=IR(8 1T3?3!S>(3:C-/ I6\J!;M7,I#^/B.&EU4=0]<'
M*8#]*@.#:=>)H0\H5  %6NR4.QXL/^FDBYS6C?O8)"*$GDL<,@'/=+\4K1K>
MH UEIG1SX9;\N!PJLNR5Q!C"!<$F83U&<0:;,,D5=S]1L%%9!$MJQ=,$5MQ
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M:E:Z-,BFS@1;N>PT1]"V\%"PUIJ41HNWFFE7Y0 FJF'Q=!N<]B_=SS?U8*I
MVME:'Z78JYW+7I6HZW%2%8Z**DX\$?/O-GGLW_BJ.<%2>UNNHQ2;=7+9;(.E
M.<I6J!C+9-AXV8;=O&2T[K(-&S_<F/=VX,FWI]&?;OODYOYI](>QI)MM5;C$
ML=]\G\O=C>1.\&DXI >BP'JW-]=XW3YU2[_[*-,J/O$-I7 8F3!F_%[J#ETO
M5DS1G:HA,?R07>;B=07P]AN,@T-&C\L>L:A?CX^QFZ[X;L_J]XE'[V9T2?!
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M#9<2.PE'><4:T JI\/RCW<"%JR0)@SA&G0RX8.61;5G ?28'XX;LDO<[H.J
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M*?4#Z/;>4:'Y%AT<A;)6UC,'%AG%$^$\2W%Q902NH=ZDU-^-KM-YKC24T8_
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M7\##?#>93%(>ZZ8&SL.O;TT!)^P@*5P.2UYQC9[-_!1HT_A6"A-RJ5^G87G
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M?E1AXL=EQ(\K3/RDC/A)A8FWRHBW*DS<K9=>FO7_B7K'R=X\N/P74$L#!!0
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M(<395:JJ1 QBK,T+F-JO9@IT 5[09.JR,YO XL!V)V$9^0Y<(4121%C;1-,
M/!'[.PLA_H+1\F6<94LM94JUO=V'6LO;_8A2J1=,Z?UU.CDT O 04,3XP='Y
M$W7)CA4H,J3F2*FVUKKI+5=MG%SJ!4=Z?YWV+H\ 6Y[\X&@"$3_=@>_J7+1G
MQX0*B[N>1=9J>Y_KE[W@0NRIS<+#<K$(\*:Y.99WL &/!K3##":7=_91&(5D
M&23)9A+$D9((H= B& JC-3X$*E\PD5L3]90K2LHPP.+8!FO[F/!-X#0'S)>Z
MU9$JK6ZOEUMM;+3ORKQ 1>U-M8Z*L]&H8_QH<:HU0:/57-/TR*76UUQ)S'86
M7[5T7C"D,=>!: 5Q,(? J)FJUFY)WKH<PL5S6:MF]8P)(UR@IK N(DX@]PX\
MN4<9?^J&SS/P>#U=Y=>P;93KK;:0.MN-=E(F]@(X$X?J VOJ:U$; /K0=%[^
MOHS)AAW<R3V-LFRYX%-I%_%L!C&D1:VFKF\"UHXX>U/&JK//>D5[ >J;+'=6
MVO!$0)4*V"8#MNGXT>MK5__?,MZ'>'@*,'Q"203Q/5$/8?5,P-Z<S5LRMIW,
MZ1/M!;IOLMSCI39((S!]N'?.YRTDXS1$"^5<LEF8.Q;EF9 3V(WQE#NIT9ZT
MT71 GI!SZ#I3J/W@4X6[@U"?*3F,\EA/H=0:[@EGWCUEKSB?Q].+D65"!57[
MMZR:]E#!:1QIB\N>62F1- SS@L9^7ML@YH,ZM7!P#\D2I^!;5INV\JL3>4>>
MV"DT;Z@J)9'N:DEE5N05I##,"QK[>>U1+:ZR7<"3JA8-.61R&CPNDP!?QQG1
MKCQ4:*W5@CJ[5;TG$WK!ELY=FZ:K. W2,*;U6WT]8H&/[;%"034M'IN6"1TV
MF8*1:+'*#TQ4UHS;O]$"+5/B:J&8,2W:".L+QLSXT<B] ,G,HV+QF$VX9D'V
MR/.US ;S('@I"$M(5GZR1:WXX'OU+GV-LO81"!*-#9R4]AA 0H%S9%2N.NM5
MW8T^M-Y4Q=6*6.9L2;R@ A%IG".@,2:>A7+UFL][TZQGI"1!J+(%@L)BR8%
MX@4&<E]M"O*W&D$7U4T?9/M['T(>FI?M_V9*EX#Z-2^*7F!(MMR!_QXC0#-P
MP0Y)AFF4 80!XD1<!CB-TWF6O__2%^('0M]UV/6[?+IOQ([:S4"*2/YF_!IG
MD/8P9L7FFC@%5T&,RWO@HCM2?\>VO]A4L@>KNF)Q.:EHGU7QL1<8-;V(?E?)
MP;8I]58Z)QOH%-OF?-LLI]\BYW)''$J_T/YKX:"V9UNY)<X@R.)B.L,,U-;3
M:2*\P,;8INB0O2^CT:3J4=1B78Z?CJ(H9AZ"Y&C_8+7=(:Q>/*>-L=<;,;2_
M[:)H KS S-1E]S6FC ,T\.^K?S2/!'"W<@YCUMFYAR$[H6XC.PA"++.V"DYA
MLEKK)M!X08S"6&?=&L8HA6B9)9N\XTI[J(WIGC(11X=(W,.,! 3RHTWH_R6'
M@@I5ME!16"Q)$4B\ $7NJ\U)34E;*P+Q(DYS0%B@FU^&K;NO6Q*<+J:7NZ!%
M9EJ$35OK'3\2@_U LMWAF<])45E*AE5: FM=&:&QJM_2N.H%"4)+G1[)?([Y
M;ZN#JMEI[2QQ,;)6VJ8=I4T69\HU^U*IY7Z)U&RK;]+1>0&+QIRTC]*"I0AW
MV9=](,\3'-[A:88O,Q(ON+,;2)Y0I.+(+,P64WTR4?)E$N,%:SV,=LX&X .[
M$QR'^3CMPSW8)@'R-%S"=[<DM"U-HSB=:QLRA=;:K)'.;C5W)!-Z 93.76<>
M::L'?C: M6S<(O(?6/7EH+(2,PMST&/29D+0CY+&>,%<#Z.]^UPT04!3!-LD
M7=9I5_2!4)?EJ,,XC21S&C*A+=[41DO"Q"HOF%):ZZS9S,75:- [4/L!60>3
M(BWS%TLX19=K!C6\FUVF,T0?$GO%%#>&O:(= 662)0EEJE ?T3/PJ^,11$O(
MMHP7J;"I^UHZ[]RTJZ)L?HM1PNO=N]FO: '/F2V\N0Y>S4E5)^$25Y/,J9A5
MQ7L+KH%I4WJKI!B_+#%0I 9H<AY!?!%GO].*/Y[%89'S:;#^#%,XBTEF#K(^
M&9<PFV92!;0N#6^A-C1N"G8[.<8W31"4*?K!-FT\:&Z*_(X7+^QGLZCAQSB)
MR4;U)O3&=!S1W2^;$KS-$O&1[U[.]?W@6G*,ZG:"GHP/Z=^G5&('(T2:]RJY
MT@ODM/94@T2^O&,),F$TOM@1.\1'/\+84OJ*C_D88]7VNA]8K$\/(YC=(G(/
M?U_&N*J+58UJGV 7D_=F&1)-Y:LCO2"PMUWE-#]-@0\S%FG4UQ2Y6^O(5^F?
M)RBCW=V;]"5FB^-D:]%48FL#W%K#U;"V5.D%6UI[G2'L?$,%CV#;)Z;Q@K]5
MW-Q.QK4UC=D/6:+VE@V<W/"4WD"P7$VBL;F!4VBOOH&S(7#.C,J5$)7\=^N=
M+$G+/2[F%=:J^3.YUFJ=HK+;J%)$0N=TF+B34!(O6'^I58LX;Y-8/K0+2*1*
MZ^2HEXE(9'Y18[08I,F,\[4?I?D)AA'!BS02_(*J0F<;$Z'--B0-D5>(B)PI
M 6$!M?ET%N:R*3I/LPCK$&D+731"7:.B%FBK\HH2H35]VW..TBR.('8-RJ_H
M=9L#D\9'%F ;'+7Q-D!BM5<@*2VJ@'H':&B7*G?-5-4CHZ]LT17B*YB^!8FD
M)E*JK>U;UENN]C'+I5[PI/?7V>?<Z@SS2/[C(HW1Q/SL G>UE7#T0%MEZ:+<
MC^2H*R]UB!?$F?O\@X,\P+.10_G$FEKNE#G)Y)I*ZR]EZ@DV4[Q<3[IQGU_3
M"">;^0,,ES@F,92LJ5%HK6*ELMM@2B3T!RB%.W&?BP9 &L$Z\ML@1TOXF:'+
M-0[Y;A59#FL"JX!TC#6HJ*[Z@T+;DKC\+]<0A^QP)RYU4>)?<)#OW&8G2O%.
MF2Q'(J55!N16&S!T9?Y0(?4FQH/+\^WQVP._+%/2K-,V-\^$LWK^E,XGH:A-
MT0788L;,>(F.6NT%0486VR!U6Y@-N GP,R3%ML3\IZS?L6,*0VB]U9GB@&^#
MP_@S6]\DFST7RZP=G*TP61V;+=!X08W"6.?([%P*J)8QP59>T-[LXZ;>H75S
MALLV$Y+C6]H"^VB(#FUI7O4,!\4<N  $-Y/A-P0G4X@7V=ULBB-J1S5"HQ);
M&_K3&JY&_J1*+SC1VNN,^]%>"F8_R<"C^/+\+D76JPWF7#ZPTKINK](0V-K6
M&;6+7J @<M0YC]#^.$=E:QH32:>A*;!>O UCG?+E5_TJX+JE3IO KME>_;M,
MX'#_\7C(FJL(O1 HFX&6*JVMZU5;K1;QBF5>8*#VUEF>2]6 R0?#1C^AB+1_
MQ*TY+"JQQ2-M#9&1*[V@1FM/='2M7_#D]1^_M_SL/Y'(;HLB,MAL5>H*+^"0
MVNJ>-(M>7!WA5\=WBA<I,6EDZD(7;4S7J*B)V:J\P$%IS;2!F18'/KIN8Y2H
M*+2.6A@Y,%*A%\SHW/5I7IRA4[Y"ZPZ8E>CLMC,2F\VF9NKA6;(J9YW7&;?'
MQN96+Y:8.Y#F92NPBT#;6+/LRZL>%7K+4J=[4:L$2JF3$J\M#9C/1ZL@3B2_
M%:I2VV5!:;D)AE#J$24J?_)3[[B0S7I8)F:<+[\MAE$G*(E#ZGR"47@=IW!,
MX$(T$V(498N@'EDH23((\8(H<Y]MLHK(:GR\C 5!&@&6 (SR98HL(<!3LCWO
M4F4NJF=,/:IB$&,=.YW]#G2R +^0T[A\*W!%2FY698LS=XM(X4HU\]<CUBV"
MBNRH410$>HRDW.U;T61G/U1XJA=NUS^B->@S_;C\B/[Q&&20?O)_4$L#!!0
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MEWE8(7J;SS1LG$+@XAWQXREDB+_R?U!+ 0(4 Q0    ( *V FE@/@Q1#+0X
M #H/   -              "  0    !I;6%G95\P,#$N:G!G4$L! A0#%
M  @ K8":6-74E"-7!P  W0<   T              ( !6 X  &EM86=E7S P
M,BYJ<&=02P$"% ,4    " "M@)I8G652-RH6  #,%P  #0
M@ ':%0  :6UA9V5?,# U+FIP9U!+ 0(4 Q0    ( *V FE@)G0B@;!@  %0:
M   -              "  2\L  !I;6%G95\P,#8N:G!G4$L! A0#%     @
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M2P$"% ,4    " "M@)I8R,[)%[1Y 0 P_PT $@              @ &3F@$
M<F%D;F5T7VED968Q-&$N:'1M4$L! A0#%     @ K8":6$:^]POM P  2Q4
M !$              ( !=Q0# ')D;G0M,C R,S$R,S$N>'-D4$L! A0#%
M  @ K8":6 :>)"5S!   @R8  !4              ( !DQ@# ')D;G0M,C R
M,S$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( *V FEB/PKE:31$  #OD   5
M          "  3D= P!R9&YT+3(P,C,Q,C,Q7VQA8BYX;6Q02P$"% ,4
M" "M@)I8(A@3!!@-   &LP  %0              @ &Y+@, <F1N="TR,#(S
B,3(S,5]P<F4N>&UL4$L%!@     -  T ( ,   0\ P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>radnet_idef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:RDNT="http://radnet.com/20231231"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20231231.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentTypeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentTypeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType4Member_custom_HowardBergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType5Member_custom_HowardBergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType6Member_custom_HowardBergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType7Member_custom_HowardBergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType8Member_custom_HowardBergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType8Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType9Member_custom_HowardBergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType9Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType10Member_custom_HowardBergerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType10Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">RDNT:HowardBergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentTypeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentTypeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType8Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">RDNT:AdjustmentType9Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000004">0000790526</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000011">RADNET, INC.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000013">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eecd--PvpTableTextBlock_zmy4QvebPoVl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value of Initial Fixed $100 Investment Based On:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Summary Compensation Table Total for PEO&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Compensation Actually Paid to PEO&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Average Summary Compensation Table Total for Non-PEO Named Executive Officers&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Average Compensation Actually Paid to Non-PEO Named Executive Officers&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Total Shareholder Return&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Peer Group Total Shareholder Return&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Net Income (millions)&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;7&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: normal; text-align: center"&gt;Adjusted EBITDA (millions)&lt;span style="font: normal 700 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;(a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(d)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(e)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(f)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(g)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(h)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(i)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 11%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zb1gN72bmHNj" style="width: 11%; text-align: center" title="Summary Compensation Table Total for PEO"&gt;$6,700,183&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDIp_zKs14lVHgZGa" style="width: 10%; text-align: center" title="Compensation Actually Paid to PEO"&gt;$10,101,435&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zk8oeLWwT7ud" style="width: 10%; text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;$2,030,591&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zt44keS1CCqk" style="width: 10%; text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;$3,585,219&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_zUlvVwmlSPs2" style="width: 10%; text-align: center" title="Total Shareholder Return Amount"&gt;$171.28&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDYp_zHYIHrtNeLE6" style="width: 10%; text-align: center" title="Peer Group Total Shareholder Return Amount"&gt;$143.18&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn4n6_c20230101__20231231_fKDcp_zQL9SVC32p33" style="width: 10%; text-align: center" title="Net Income"&gt;$3.04&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20230101__20231231_fKDgp_zD40Bp0NYvWb" style="width: 10%; text-align: center" title="Adjusted EBITDA"&gt;$232.30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zUxbvD7yG4Hk" style="text-align: center" title="Summary Compensation Table Total for PEO"&gt;$5,555,517&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDIp_zR7MzXVMR3Wi" style="text-align: center" title="Compensation Actually Paid to PEO"&gt;$5,555,517&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_zsvFZxwDVSeg" style="text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;$2,823,387&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zTurpzCsPDUf" style="text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;$1,962,193&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_z8UPVaEUytf7" style="text-align: center" title="Total Shareholder Return Amount"&gt;$92.76&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDYp_zKWukHhwKXEf" style="text-align: center" title="Peer Group Total Shareholder Return Amount"&gt;$140.29&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn4n6_c20220101__20221231_fKDcp_z3f4AREKD3yc" style="text-align: center" title="Net Income"&gt;$10.65&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20220101__20221231_fKDgp_zbV4LlTmAU2" style="text-align: center" title="Adjusted EBITDA"&gt;$191.28&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zaqyBA2AEc81" style="text-align: center" title="Summary Compensation Table Total for PEO"&gt;$4,567,222&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKDIp_zBPgTkqBR1q3" style="text-align: center" title="Compensation Actually Paid to PEO"&gt;$4,567,222&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDMp_zAm6l8VW29v6" style="text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;$1,676,763&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKDQp_zDJRqA6d65ij" style="text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;$2,073,838&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--TotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKDUp_zcQGnMltXDJ8" style="text-align: center" title="Total Shareholder Return Amount"&gt;$148.33&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20210101__20211231_fKDYp_zvSG8dL5ZrSh" style="text-align: center" title="Peer Group Total Shareholder Return Amount"&gt;$143.09&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pn4n6_c20210101__20211231_fKDcp_zKhM54jjWTcd" style="text-align: center" title="Net Income"&gt;$24.73&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20210101__20211231_fKDgp_zeaq4TRu8ix5" style="text-align: center" title="Adjusted EBITDA"&gt;$211.94&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--PeoTotalCompAmt_c20200101__20201231_fKDEp_zG72mIcCj0R7" style="text-align: center" title="Summary Compensation Table Total for PEO"&gt;$2,835,761&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20200101__20201231_fKDIp_zBpbghPBXKig" style="text-align: center" title="Compensation Actually Paid to PEO"&gt;$2,835,761&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20200101__20201231_fKDMp_zPIkWRvBRZqg" style="text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;$1,050,250&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20200101__20201231_fKDQp_z34o1uRgdzfj" style="text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;$1,015,548&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--TotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKDUp_zNdrFJivLZl1" style="text-align: center" title="Total Shareholder Return Amount"&gt;$96.40&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20200101__20201231_fKDYp_ztGOmNFRJHM2" style="text-align: center" title="Peer Group Total Shareholder Return Amount"&gt;$113.45&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLoss_pn4n6_c20200101__20201231_fKDcp_zu2YnCaVwIml" style="text-align: center" title="Net Income"&gt;($14.84)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--CoSelectedMeasureAmt_pip0_uUSDPShares_c20200101__20201231_fKDgp_z00Ttz0pmaWc" style="text-align: center" title="Adjusted EBITDA"&gt;$114.95&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000015"
      unitRef="USD">6700183</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000017"
      unitRef="USD">10101435</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000019"
      unitRef="USD">2030591</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000021"
      unitRef="USD">3585219</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="2"
      id="Fact000023"
      unitRef="USD">171.28</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="2"
      id="Fact000025"
      unitRef="USD">143.18</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-4"
      id="Fact000027"
      unitRef="USD">3040000.00</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000029"
      unitRef="USDPShares">232.30</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">5555517</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000033"
      unitRef="USD">5555517</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000035"
      unitRef="USD">2823387</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000037"
      unitRef="USD">1962193</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000039"
      unitRef="USD">92.76</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000041"
      unitRef="USD">140.29</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-4"
      id="Fact000043"
      unitRef="USD">10650000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000045"
      unitRef="USDPShares">191.28</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">4567222</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000049"
      unitRef="USD">4567222</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000051"
      unitRef="USD">1676763</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">2073838</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2021-01-012021-12-31"
      decimals="2"
      id="Fact000055"
      unitRef="USD">148.33</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2021-01-012021-12-31"
      decimals="2"
      id="Fact000057"
      unitRef="USD">143.09</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-4"
      id="Fact000059"
      unitRef="USD">24730000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact000061"
      unitRef="USDPShares">211.94</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000063"
      unitRef="USD">2835761</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">2835761</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">1050250</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">1015548</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2020-01-012020-12-31"
      decimals="2"
      id="Fact000071"
      unitRef="USD">96.40</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2020-01-012020-12-31"
      decimals="2"
      id="Fact000073"
      unitRef="USD">113.45</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-4"
      id="Fact000075"
      unitRef="USD">-14840000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      id="Fact000077"
      unitRef="USDPShares">114.95</ecd:CoSelectedMeasureAmt>
    <ecd:PeoName contextRef="From2023-01-01to2023-12-31" id="Fact000079">Dr. Berger</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31" id="Fact000080">Dr. Berger</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-01-012021-12-31" id="Fact000081">Dr. Berger</ecd:PeoName>
    <ecd:PeoName contextRef="From2020-01-012020-12-31" id="Fact000082">Dr. Berger</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000091">&lt;p id="xdx_84D_eecd--AdjToPeoCompFnTextBlock_dU_zPPEyF6K1ESb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The dollar amounts reported in column (c) represent the amount
of &#x201c;compensation actually paid&#x201d; to Dr. Berger, as computed in accordance with Item 402(v) of Regulation S-K. In accordance
with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Berger&#x2019;s total compensation
for 2023 to determine the compensation actually paid:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Reported Summary Compensation Table Total
    for PEO&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Reported Value of Equity Awards&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Equity Award Adjustments&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Reported Change in the Actuarial Present
    Value of Pension Benefits&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Pension Benefit Adjustments&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Compensation Actually Paid to PEO&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 14%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--PeoTotalCompAmt_c20230101__20231231_z0dQEPMiizMj" style="width: 14%; text-align: center" title="Summary Compensation Table Total for PEO"&gt;$6,700,183&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentTypeMember_z2UNbwxxQxj5" style="width: 14%; text-align: center" title="Reported Value of Equity Awards"&gt;($3,125,000)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_fKGEp_zfvsN5JC9426" style="width: 13%; text-align: center" title="Equity Award Adjustments"&gt;$6,526,252&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_fKGIp_zhaAOX4bZm47" style="width: 13%; text-align: center" title="Reported Change in the Actuarial Present Value of Pension Benefits"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_fKGMp_zoY99xcozWc" style="width: 13%; text-align: center" title="Pension Benefit Adjustments"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zEaCvE0riG1h" style="width: 13%; text-align: center" title="Compensation Actually Paid to PEO"&gt;$10,101,435&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td id="xdx_F02_z4oAbMmkW3ak" style="width: 0.5in; text-align: left"&gt;(a)&lt;/td&gt;&lt;td id="xdx_F1B_zmVP8Wrmrjte"&gt;The amounts deducted or added in calculating Dr. Berger&#x2019;s
equity award adjustments are as follows:&lt;/td&gt;
&lt;/tr&gt;&lt;tr style="display: none; vertical-align: top"&gt;
&lt;td style="display: none"&gt;&lt;/td&gt;&lt;td id="xdx_F04_z2E9F8yTbAi2" style="display: none; text-align: left"&gt;(b)&lt;/td&gt;&lt;td id="xdx_F13_za9C1x58h3cf" style="display: none; text-align: justify"&gt;The amounts included in this column are the amounts reported
in &#x201c;Change in Pension and Nonqualified Deferred Compensation&#x201d; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top"&gt;
&lt;td style="display: none"&gt;&lt;/td&gt;&lt;td id="xdx_F00_zHttPbcGdJyk" style="display: none; text-align: left"&gt;(c)&lt;/td&gt;&lt;td id="xdx_F1C_z4fdET60JgN" style="display: none; text-align: justify"&gt;The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#x201c;service cost&#x201d;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#x201c;prior
service cost&#x201d;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year End Fair Value of Equity Awards Granted in the Current Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year over Year Average Change in Fair Value of Outstanding and
    Unvested Equity Awards Granted in Prior Years&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair Value as of Vesting Date of Equity Awards Granted and Vested
    in the Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year over Year Average Change in Fair Value of Equity Awards Granted
    in Prior Years that Vested in the Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair Value at the End of the Prior Year of Equity Awards that Failed
    to Meet Vesting Conditions in the Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Value of Dividends or other Earnings Paid on Stock or Option Awards
    not Otherwise Reflected in Fair Value or Total Compensation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total Equity Award Adjustments&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 12%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zMJBiUhXP198" style="width: 12%; text-align: center" title="Year End Fair Value of Equity Awards Granted in the Current Year"&gt;$5,590,692&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zWdrxWCfvwpk" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zodWPY1WtSig" style="width: 12%; text-align: center" title="Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year"&gt;$935,560&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zrhIGdOi9682" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType8Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zpunzWCo5tRh" style="width: 11%; text-align: center" title="Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType9Member__ecd--IndividualAxis__custom--HowardBergerMember_fKGEp_zB4Nci6AdQB6" style="width: 11%; text-align: center" title="Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType10Member__ecd--IndividualAxis__custom--HowardBergerMember_zW4pHjDZhk7j" style="width: 11%; text-align: center" title="Total Equity Award Adjustments"&gt;$6,526,252&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -13.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;(b)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The amounts included in this column are the amounts reported
in &#x201c;Change in Pension and Nonqualified Deferred Compensation&#x201d; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -13.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;(c)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#x201c;service cost&#x201d;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#x201c;prior
service cost&#x201d;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000093"
      unitRef="USD">6700183</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentTypeMember"
      decimals="0"
      id="Fact000095"
      unitRef="USD">-3125000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType1Member"
      decimals="0"
      id="Fact000097"
      unitRef="USD">6526252</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType2Member"
      decimals="0"
      id="Fact000099"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType3Member"
      decimals="0"
      id="Fact000101"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000103"
      unitRef="USD">10101435</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType4Member_custom_HowardBergerMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">5590692</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType5Member_custom_HowardBergerMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType6Member_custom_HowardBergerMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">935560</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType7Member_custom_HowardBergerMember"
      decimals="0"
      id="Fact000114"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType8Member_custom_HowardBergerMember"
      decimals="0"
      id="Fact000116"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType9Member_custom_HowardBergerMember"
      decimals="0"
      id="Fact000118"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AdjustmentType10Member_custom_HowardBergerMember"
      decimals="0"
      id="Fact000120"
      unitRef="USD">6526252</ecd:AdjToCompAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000122">&lt;p id="xdx_841_eecd--NamedExecutiveOfficersFnTextBlock_dU_zRq5CA0huDUj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in; text-align: left"&gt;(3)&lt;/td&gt;&lt;td&gt;The dollar amounts reported in column (d) and (e) represent the
average of the amounts reported for the Named Executive Officers as a group (excluding Dr. Berger) in the &#x201c;Total&#x201d; column
of the Summary Compensation Table in 2023. The names of each of the Named Executive Officers (excluding Dr. Berger) included for purposes
of calculating the average amounts in each applicable year are Mark Stolper, Stephen Forthuber, Norman Hames, and Mital Patel.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000124">&lt;p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_ziKHkqFdLdp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in; text-align: left"&gt;(4)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The dollar amounts reported in column (e) represent the average
amount of &#x201c;compensation actually paid&#x201d; to the Named Executive Officers as a group (excluding Dr. Berger), as computed in
accordance with Item 402(v) of Regulation S-K. The dollar amounts do not necessarily reflect the actual average amount of compensation
earned by or paid to the Named Executive Officers as a group (excluding Dr. Berger) during the applicable year. In accordance with the
requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the Named Executive
Officers as a group (excluding Dr. Berger) for each year to determine the compensation actually paid, using the same methodology described
above in Note 2:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Reported Summary Compensation Table Total for Non-PEO Named
    Executive Officers&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Reported Value of Equity Awards&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Equity Award Adjustments&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Reported Change in the Actuarial Present Value of Pension
    Benefits&lt;sup&gt;(b)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Pension Benefit Adjustments&lt;sup&gt;(b)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Compensation Actually Paid to Non-PEO Named Executive Officers&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 14%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zHXMp7EpxwSl" style="width: 14%; text-align: center" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;$2,030,591&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentTypeMember_zXQJFIoXteG1" style="width: 14%; text-align: center" title="Average Reported Value of Equity Awards"&gt;($1,071,875)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: center"&gt;$2,626,503&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_fKGIp_zqqEB5qngIVb" style="width: 13%; text-align: center" title="Average Reported Change in the Actuarial Present Value of Pension Benefits"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_fKGIp_zEgYq3jhyixh" style="width: 13%; text-align: center" title="Average Pension Benefit Adjustments"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_z7XiMt22a3ek" style="width: 13%; text-align: center" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;$3,585,219&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td id="xdx_F0D_zR4MPK95I2e1" style="width: 0.5in; text-align: left"&gt;(a)&lt;/td&gt;&lt;td id="xdx_F17_ztfk7wQERqE2" style="text-align: justify"&gt;The amounts deducted or added in calculating the total average
equity award adjustments are as follows:&lt;/td&gt;
&lt;/tr&gt;&lt;tr style="display: none; vertical-align: top"&gt;
&lt;td style="display: none"&gt;&lt;/td&gt;&lt;td id="xdx_F03_zThT4KNxr668" style="display: none; text-align: left"&gt;(b)&lt;/td&gt;&lt;td id="xdx_F19_zrGeOFDuhcKe" style="display: none; text-align: justify"&gt;The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Year End Fair Value of Equity Awards Granted in the Current
    Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year over Year Average Change in Fair Value of Outstanding and
    Unvested Equity Awards Granted in Prior Years&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Fair Value as of Vesting Date of Equity Awards Granted
    and Vested in the Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year over Year Average Change in Fair Value of Equity Awards Granted
    in Prior Years that Vested in the Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Fair Value at the End of the Prior Year of Equity Awards
    that Failed to Meet Vesting Conditions in the Year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Average Value of Dividends or other Earnings Paid on Stock or Option
    Awards not Otherwise Reflected in Fair Value or Total Compensation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total Average Equity Award Adjustments&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 12%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zt9EU0iIYaa" style="width: 12%; text-align: center" title="Average Year End Fair Value of Equity Awards Granted in the Current Year"&gt;$2,032,116&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zgPPGOpL7w0l" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years"&gt;$309,243&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zjPJR3MKWsI4" style="width: 12%; text-align: center" title="Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year"&gt;$286,517&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zl3Tv4e6SuO6" style="width: 12%; text-align: center" title="Year over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year"&gt;($1,373)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType8Member_zTtCfNoUS4t" style="width: 11%; text-align: center" title="Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType9Member_zecY8eyfSs0c" style="width: 11%; text-align: center" title="Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;$2,626,503&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;(b)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000126"
      unitRef="USD">2030591</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentTypeMember"
      decimals="0"
      id="Fact000128"
      unitRef="USD">-1071875</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType2Member"
      decimals="0"
      id="Fact000130"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType3Member"
      decimals="0"
      id="Fact000132"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000134"
      unitRef="USD">3585219</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType4Member"
      decimals="0"
      id="Fact000138"
      unitRef="USD">2032116</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType5Member"
      decimals="0"
      id="Fact000140"
      unitRef="USD">309243</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType6Member"
      decimals="0"
      id="Fact000142"
      unitRef="USD">286517</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType7Member"
      decimals="0"
      id="Fact000144"
      unitRef="USD">-1373</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType8Member"
      decimals="0"
      id="Fact000146"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AdjustmentType9Member"
      decimals="0"
      id="Fact000148"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000150">&lt;p id="xdx_848_eecd--PeerGroupIssuersFnTextBlock_dU_zM1PCq1mRRMi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in; text-align: left"&gt;(6)&lt;/td&gt;&lt;td&gt;Represents the weighted peer group TSR, weighted according to
the respective companies&#x2019; stock market capitalization at the beginning of each period for which a return is indicated. The peer
group used for this purpose is the S&amp;amp;P 500 &#x2013; Healthcare Sector index.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:CoSelectedMeasureName contextRef="From2023-01-01to2023-12-31" id="Fact000152">Adjusted EBITDA</ecd:CoSelectedMeasureName>
    <ecd:TabularListTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000154">&lt;p id="xdx_849_eecd--TabularListTableTextBlock_dU_zrZ5NtElSywc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Financial Performance Measures&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As described in greater detail
in the Compensation Discussion and Analysis section. the Company&#x2019;s executive compensation program reflects a pay-for-performance
philosophy. The metrics that the Company uses for both our long-term and short- term incentive awards are selected based on an objective
of incentivizing our Named Executive Officers to increase the value of our enterprise for our shareholders. The most important financial
performance measures used by the Company to link executive compensation actually paid to the Company&#x2019;s Named Executive Officers,
for the most recently completed fiscal year, to the Company&#x2019;s performance are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;1.&lt;/td&gt;&lt;td id="xdx_988_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__1_ziE6pWbjgSOg" title="Measure Name"&gt;Adjusted EBITDA&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;2.&lt;/td&gt;&lt;td id="xdx_981_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__2_zG4A7oMPh7gc" title="Measure Name"&gt;Total Shareholder Return (via equity grants); and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;3.&lt;/td&gt;&lt;td id="xdx_987_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__3_zd6RhC7CX7se" title="Measure Name"&gt;Strategic Objectives (via discretionary bonus).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_1" id="Fact000156">Adjusted EBITDA</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_2" id="Fact000158">Total Shareholder Return (via equity grants); and</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_3" id="Fact000160">Strategic Objectives (via discretionary bonus).</ecd:MeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000162">&lt;p id="xdx_846_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zuM1ingWbM4c" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Compensation Actually Paid and TSR&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;img alt="" src="image_007.jpg" style="height: 4.66in; width: 6.14in"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000164">&lt;p id="xdx_846_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zDraBwHdCyL1" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Compensation Actually Paid and Net Income&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;img alt="" src="image_011.jpg" style="height: 4.43in; width: 5.81in"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000166">&lt;p id="xdx_84B_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zXN5Cgs1Wl9k" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Compensation Actually Paid and Adjusted EBITDA&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;img alt="" src="image_012.jpg" style="height: 4.64in; width: 6.09in"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000015"
          xlink:label="Fact000015"
          xlink:type="locator"/>
        <link:footnote id="Footnote000078" xlink:label="Footnote000078" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (b) are the amounts of total
compensation reported for <xhtml:span id="xdx_90B_eecd--PeoName_c20230101__20231231_zbMEwARGj3R2"><xhtml:span id="xdx_901_eecd--PeoName_c20220101__20221231_zeYebgkyielf"><xhtml:span id="xdx_90A_eecd--PeoName_c20210101__20211231_zTdluKUxdXva"><xhtml:span id="xdx_906_eecd--PeoName_c20200101__20201231_zZtDOpfVbuXh">Dr. Berger</xhtml:span></xhtml:span></xhtml:span></xhtml:span> (our Chief Executive Officer) for each corresponding year in the &#x201c;Total&#x201d; column of the
Summary Compensation Table. Refer to the above Summary Compensation Table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000015"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000047"
          xlink:label="Fact000047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000047"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000063"
          xlink:label="Fact000063"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000063"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000083" xlink:label="Footnote000083" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (c) represent the amount
of &#x201c;compensation actually paid&#x201d; to Dr. Berger, as computed in accordance with Item 402(v) of Regulation S-K. In accordance
with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Berger&#x2019;s total compensation
for 2023 to determine the compensation actually paid:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000049"
          xlink:label="Fact000049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000065"
          xlink:label="Fact000065"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000065"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000084" xlink:label="Footnote000084" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (d) and (e) represent the
average of the amounts reported for the Named Executive Officers as a group (excluding Dr. Berger) in the &#x201c;Total&#x201d; column
of the Summary Compensation Table in 2023. The names of each of the Named Executive Officers (excluding Dr. Berger) included for purposes
of calculating the average amounts in each applicable year are Mark Stolper, Stephen Forthuber, Norman Hames, and Mital Patel.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000084"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000084"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000051"
          xlink:label="Fact000051"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000051"
          xlink:to="Footnote000084"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000067"
          xlink:label="Fact000067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000067"
          xlink:to="Footnote000084"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnote id="Footnote000085" xlink:label="Footnote000085" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in column (e) represent the average
amount of &#x201c;compensation actually paid&#x201d; to the Named Executive Officers as a group (excluding Dr. Berger), as computed in
accordance with Item 402(v) of Regulation S-K. The dollar amounts do not necessarily reflect the actual average amount of compensation
earned by or paid to the Named Executive Officers as a group (excluding Dr. Berger) during the applicable year. In accordance with the
requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the Named Executive
Officers as a group (excluding Dr. Berger) for each year to determine the compensation actually paid, using the same methodology described
above in Note 2:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000085"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000037"
          xlink:label="Fact000037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000085"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000053"
          xlink:label="Fact000053"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000053"
          xlink:to="Footnote000085"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000069"
          xlink:label="Fact000069"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000069"
          xlink:to="Footnote000085"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnote id="Footnote000086" xlink:label="Footnote000086" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Cumulative TSR is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#x2019;s share
price at the end and the beginning of the measurement period by the Company&#x2019;s share price at the beginning of the measurement period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000086"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000039"
          xlink:label="Fact000039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000039"
          xlink:to="Footnote000086"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000055"
          xlink:label="Fact000055"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000055"
          xlink:to="Footnote000086"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000071"
          xlink:label="Fact000071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000071"
          xlink:to="Footnote000086"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnote id="Footnote000087" xlink:label="Footnote000087" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the weighted peer group TSR, weighted according to
the respective companies&#x2019; stock market capitalization at the beginning of each period for which a return is indicated. The peer
group used for this purpose is the S&amp;P 500 &#x2013; Healthcare Sector index.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000087"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000041"
          xlink:label="Fact000041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000087"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000057"
          xlink:label="Fact000057"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000057"
          xlink:to="Footnote000087"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000073"
          xlink:label="Fact000073"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000073"
          xlink:to="Footnote000087"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnote id="Footnote000088" xlink:label="Footnote000088" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported represent the amount of net income
reflected in the Company&#x2019;s audited financial statements for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000088"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000043"
          xlink:label="Fact000043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000043"
          xlink:to="Footnote000088"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000059"
          xlink:label="Fact000059"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000059"
          xlink:to="Footnote000088"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000075"
          xlink:label="Fact000075"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000075"
          xlink:to="Footnote000088"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnote id="Footnote000089" xlink:label="Footnote000089" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Adjusted EBITDA is defined as earnings before interest, taxes,
depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other Financial Performance Measures
income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.
While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company&#x2019;s
compensation programs, the Company has determined that Adjusted EBITDA is the financial performance measure that, in the Company&#x2019;s
assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the
Company to link compensation actually paid to the Company&#x2019;s Named Executive Officers, for the most recently completed fiscal year,
to Company performance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000089"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000045"
          xlink:label="Fact000045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000045"
          xlink:to="Footnote000089"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000061"
          xlink:label="Fact000061"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000061"
          xlink:to="Footnote000089"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000077"
          xlink:label="Fact000077"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000077"
          xlink:to="Footnote000089"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000097"
          xlink:label="Fact000097"
          xlink:type="locator"/>
        <link:footnote id="Footnote000104" xlink:label="Footnote000104" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts deducted or added in calculating Dr. Berger&#x2019;s
equity award adjustments are as follows:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000097"
          xlink:to="Footnote000104"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000099"
          xlink:label="Fact000099"
          xlink:type="locator"/>
        <link:footnote id="Footnote000105" xlink:label="Footnote000105" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts included in this column are the amounts reported
in &#x201c;Change in Pension and Nonqualified Deferred Compensation&#x201d; column of the Summary Compensation Table for 2023. These values
are $0.00 since Dr. Berger did not have any values reported in these columns in the Summary Compensation Table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000099"
          xlink:to="Footnote000105"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000101"
          xlink:label="Fact000101"
          xlink:type="locator"/>
        <link:footnote id="Footnote000106" xlink:label="Footnote000106" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The total pension benefit adjustments for 2023 include the aggregate
of two components: (i) the actuarially determined service cost for services rendered by the chief executive officer during the applicable
year (the &#x201c;service cost&#x201d;); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable
year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the &#x201c;prior
service cost&#x201d;) calculated in accordance with U.S. GAAP. This value is $0.00 since Dr. Berger did not participate in such pension
programs in Fiscal Year 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000101"
          xlink:to="Footnote000106"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000108"
          xlink:label="Fact000108"
          xlink:type="locator"/>
        <link:footnote id="Footnote000135" xlink:label="Footnote000135" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts deducted or added in calculating the total average
equity award adjustments are as follows:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000108"
          xlink:to="Footnote000135"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000110"
          xlink:label="Fact000110"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000110"
          xlink:to="Footnote000135"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000112"
          xlink:label="Fact000112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000112"
          xlink:to="Footnote000135"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000114"
          xlink:label="Fact000114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000114"
          xlink:to="Footnote000135"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000116"
          xlink:label="Fact000116"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000116"
          xlink:to="Footnote000135"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000118"
          xlink:label="Fact000118"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000118"
          xlink:to="Footnote000135"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000130"
          xlink:label="Fact000130"
          xlink:type="locator"/>
        <link:footnote id="Footnote000136" xlink:label="Footnote000136" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts included in these columns are $0.00 since none of
the Named Executive Officers participated in a pension benefit program in Fiscal Year 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000130"
          xlink:to="Footnote000136"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000132"
          xlink:label="Fact000132"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000132"
          xlink:to="Footnote000136"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
